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CHAPTER I 
INTRODUCTION 
A. Immunosurveillance as the rationale of tumour immunelogi-
cal research 
The hypothesis that immune mechanisms are a defense sys-
tem net merely for the eliminatien of microbes, parasites and 
other foreign material from the body but also for the de-
struction of aberrant cells of the organism itself was al-
ready clearly formulated in 1909 by Paul Ehrlich: 'were it 
not for the defense mechanism of the organism tumours would 
appear "in einer geradezu ungeheuerlicher Frekwenz"'. The 
theory of immunosurveillance, first mooted by Thomas (1959) 
was refined and presentedinmore detail by Burnet (1970; 
1971). He postulated that eliminatien of malignant cells is 
one of the major functions of the immune system and thought 
that it may be a very ancient if not the most ancient mecha-
nism. It would have evolved at the time when multicellular 
organisms first appeared and the need to deal with insubor-
dinate autonorneus cell variants may have been at least as im-
portant as a proteetion against foreign substances. 
Immunological responses to tumour associated antigens 
(TAA) are now thought to play an important role in modifying 
or even cantrolling human malignant disease. The rationale 
for this concept is based on the experience obtained with ex-
perimental animal tumours induced by oncogenic viruses or by 
chemica! carcinogens. These tumours showed tumour associated 
transplantation antigens (TATA) which under certain conditi-
ons can provake a tumour rejection response (Bauer, 1974; 
11 
Baldwin, 1973). These experiments were earried out in highly 
inbred strains whieh ensured that the immune reaetions ob-
served were direeted against tumour assoeiated antigeus rath-
er than histoeompatibility antigens. Furthermore, the phenorn-
enon of concomitant immunity could be dernonstrated in animals 
hearing a progressively growing tumour since these animals 
were capable of rejeeting a "smal!" subsequent graft with 
limited numbers of cells of the same tumour at a site distant 
from the progressively growing turnour (Vaage, 1971; 1973). 
These findings strengthened the belief that the immune 
response of the host played a significant role iri the turnour-
host relationship effecting the tumour growth. This concept 
of immunesurveillance against neeplastic cells has, however, 
also seriously been eriticised by several investigators 
(Nehlson, 1971; Prehn, 1971). 
The literature on tumour immunology has beeome vast and 
this introduetion is not an attempt to review the whole field 
since many excellent reviews on various aspects of turnour 
immunology have been written (Hellström and Hellström, !969; 
1974a; Klein, 1973; Baldwin, 1973; 1977; Herberman, 1974; 
Prehn, 1976; Bonnard and West, 1977). 
This chapter will discuss the role of the immune system 
in modifying tumour growth and present literature data dis-
cussing the pro's and eon's regarding the validity of the 
concept of immunesurveillance and the types, specificity and 
immunogenieity of antigens whieh are associated with turnours 
of different etiology. The evidence for eell-mediated meeha-
nisros against tumour assoeiated antigens, the speeificity of 
these reactions and the characteristics of the effector eells 
wil! be dealt with in the following chapters. 
B. Virally induced tumours and immunosurveillance. 
Tumours induced by the same oncogenie virus have a com-
12 
mon antigenicity irrespective of their tissue ar species of 
origin, and within the same host strain different oncogenic 
viruses elicit different tumour associated antigens (Habel, 
1961; Sjögren, 1965). 
Viral antigens that result from lytic infection of cells 
with RNA tumour viruses are found on the surfaces of tumour 
cells and normal cells (Old et al., 1965) and immunity to 
theseantigenscan occur dependently (Sjögren et al., 1961) 
and independently from immunity to the virus particles (Khera 
1963), indicating that at least a proportion of these anti-
gens are distinct and different. F·urthermore, tumour associa-
ted antigens may be found on the surface of virus induced 
tumour cells which are not tumour-specific and could be pres-
ent on normal cells during certain embryonic stages. These 
foetal antigens are found on many tumour cells and will be 
briefly discussed later. They may appear as a consequence of 
transformation. It should be noted that these foetal antigens 
can be detected in small quantities in normal adult tissues 
(Coggin and Anderson, 1974) , and blood levels of these anti-
gens also rise during some non-neoplastic diseases. 
2. Exp~entai ev~denee &o~ ~~v~ee againht tumo~ ~ndueed by on-
c..oge/U.e v,i;uu, u. 
The observations of many workers that treatment with an-
tilymphocyte serum (ALS) or neonatal thymectomy increased the 
frequency of experimental tumours induced by RNA or DNA virus-
es in rodents supports the theory of immunesurveillance (Law, 
1966a; b). 
The restoration of the crippled immune system of neona-
tally thymectomized or ALS treated animals by thymus grafting 
or inoculation of syngeneic mature lymphocytes prevented the 
majority of tumours induced by viruses such as polyoma and 
SV-40, demonstrating that the increased tumour incidence was 
specifically due toa T-cell deficiency (Allison and Taylor, 
13 
1967) . 
This experiment does nat allow the conclusion that the 
immune system acted exclusively through killer T-cells but 
shows that the immune response is in its essence thymus-
dependent. One could envisage T-cell dependent antiboclies as 
being responsible for the prevention of tumour growth and 
this in turn could be either a complement dependent cytotoxic 
mechanism ar a lymphocyte dependent antibody cytolysis. 
Polyoma virus is a widespreaà natura! contaminant and 
yet wild mice do nat develop polyoma tumours {Huebner et al., 
1962; Huebner, 1963). 
Neither did captured animals, when kept in the laborato-
ry for prolonged periods of time, develop turnours. Antiboclies 
with specificity for the virus could be detected in the serum 
of most of the animals and virus could be isolated from their 
tissues. 
The lack of oncogenicity of polyoma virus under natura! 
conditions and the fact that tumours could only be induced 
when the virus was inoculated in newborn mice during their 
first 24 - 48 hours of life favoured the view that the anca-
genie properties of the virus were no more than a laboratory 
artefact. In fact, the contrary is true. Newborn animals are 
protected from the virus during neonatal life by the passive 
transmission of antibodies from their infected mothers and 
are therefore as resistant to the oncogenic effect of the vi-
rus as laboratory mice. Indeed the naturally virus-infected 
newborn mice wil! only develop tumours if the passive trans-
fer of maternal antibodies is prevented (SjÖgren and Ringertz, 
1962). The resistance later in life is due to an immediate 
recognition of the virus induced tumour specific transplanta-
tien antigens on the surface of the tumour cells. Furthermore, 
congenitally athymic nude mice show an increased susceptibi-
lity to tumour development after infection with polyoma virus 
as well (Stutman, 1975a). The tact that immunosuppressed 
adult mice develop polyoma tumours after exposure to room 
infection (Law and Dawe, 1960) shows the potential oncogeni-
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city of the virus and faveurs the immunesurveillance to be 
a real eperating mechanism under natura! conditions. The po-
lyoma induced tumour specific transplantation antigen was the 
first virally induced tumour antigen discovered (Sjögren et 
al., 1961}. 
Another example sustairring the concept of immunesurveil-
lance is that treatment of AKR mice with anti-lymphocyte se-
rum potentiated murine leukaemia virus induced tumours and 
shortened the latent period of spontaueaus leukaemia (Allison 
and Law, 1968}. Vandeputte et al. (1963} demonstratea that 
neonatal thymectomy of rats, infected at birth with polyorna 
virus, increased the incidence of tumours and prolonged the 
period of postnatal susceptibility to oncogenesis. Similar 
results were obtained by Allison and Taylor (1967} with SV-40 
infected rats. Moreover, polyoma virus infected adult mice 
showed an increase in tumour incidence fro~ 0 to virtually 
100 per cent after anti-lymphocyte serum treatment (Allison 
and Taylor, 1967; Allison and Law, 1968}. 
In genera!, it can be concluded that immunosuppression 
leads to an increased susceptibility for tumour induction by 
viruses. It may be assumed that the frequent natura! exposure 
of wild mice to polyoma virus has selected them for a high 
immune responsiveness both against the virus that lives in 
symbiosis with thern as well as against potentially neeplastic 
cells carrying the tumeur specific transplantation antigen 
induced by the virus, thereby alerting the appropriate immune 
rejectien system in time te prevent the malignant outgrowth 
of these cells. 
Immune response genes are known to influence virtually 
every type of immune response (Munro and Bright, 1976} that 
exists on several levels ranging from the antigen recognition 
by T-cells (Shevach and Rosenthal, 1975; Rosenthal and She-
vach, 1976; Erb and Feldmann, 1975} through cooperation with 
B-cell antibody formation at the B-cell level (Kindred and 
Shreffler, 1972; Katzet al., 1973; Katz et al., 1975} to the 
action of helper and suppressor T-cells (Rosenthal and She-
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vach, 1976; Pierce et al., 1976). The differences in immune 
resistance of different mouse strains against the oncogenic 
effect of viruses may be explained by the differences in the 
genetic make-up of the immune response genes. Furthermore, 
it is known that the cytolysis of virus infected cells by 
immune T-cells requires at least partial identity of the ma-
jor histocompatibility complex between the effector T-cell 
and the target cel! (Zinkernagel and Oldstone, 1976; Schröder 
and Edelmann, 1976), again emphasizing the importance of ge-
netics for anti-tumeur immune responses. Genetic make-up in-
fluences the level of immunoresponsiveness to a given antigen, 
the class or type of antibody produced and the timing of the 
response. The latter is likely to be of extreme importance 
for the immune response against tumour associated antigens. 
C. Chemically induced tumours 
1. ChenU.ca..Uy ,indu.c.ed .twnouJr. a.n.tige..n.ó .ópec.i.ó.-i.c fioJt -the -Lndi...vÁ.dit.al. .twnouJL 
a.nd embJtyonic a.nüge.n.s 
In contrast to the common antigenicity of virus induced 
tumours, tumours induced by the same carcinogen and of the 
same histology, organ, or animal of origin, often possess in-
dividual distinctive neo-antigens at their cell surface which 
are immunegenie in the tumour-bearing host (Prehn and Main, 
1957; Klein et al., 1960; Baldwin and Embleton, 1971). The 
immuno.genici ty as measured by the degree of resistance to the 
growth of a challenge inoculum varies from tumour to tumour 
and ranges from non-immunegenie to highly immunegenie (Main 
and Prehn, 1957; Prehn 1 1960; Old et al., 1962; Bartlett, 
1972). 
Prehn (1975) demonstrated in the case of 3-methylcholan-
threne (MCA) that there is a direct relation between the 
average immunogenicity of the induced tumour and the concen-
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tratien of the ancogen i.e., a decreasein the concentratien 
of chemical carcinogen resulted· in a lower tumour incidence, 
a lengtherred latency and a decreased immunogenicity. Similar 
types of new antigens may also be demonstrated on the surface 
of cells transformed in v~o by exposure to chemical carcino-
gens (Mondal et al., 1970; Embleton and Heidelberger, 1972). 
Besides the individual distinctive neo-antigens almast 
all chemically induced tumours of diverse histological types 
have been found to express and share embryonic antigens as 
well. These embryonic antigens are widely expressed in tu-
mours and no relationship to etiology has been demonstrated, 
i.e. they have also shown to be present on tumours induced by 
oncogenic viruses and on spontaueaus tumours (e.g. arising 
without an artificial stimulus) (Baldwin et al., 1974a; Bald-
win et al., 1974b; Coggin and Anderson, 1974). 
The individual distinctive antigens are in general the 
cell surface components of tumour cells that serve as targets 
in the immune tumour rejection process since immunization 
with these antigens provides resistance against the immuniz-
ing tumour exclusively (Baldwin and Price, 1977). 
The potency of the immune system to cape with chemically 
induced tumours is, however, less impressive than its inter-
action with tumours induced by viruses in their natural hosts. 
The influence of immunosuppression produced by for instanee 
treatment with ALS or immunosuppressive drugs on chemical 
carcinogenesis is equivocal (Baldwin, 1973; Schmähl et al., 
1974). Several investigators did nat find an effect of neona-
tal thymectomy on oncogenesis by 3-methylcholanthrene (Balner 
and Dersjant, 1966; Allison and Taylor, 1967). 
The data available on the effect of antilymphocyte serum 
on tumour induction by 3-methylcholanthrene are conflicting, 
some authors reporting a slight increase in tumour incidence 
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and shortening of the latency period following ALS treatment 
(Balner and Dersjant, 1969; Cerilli and Treat, 1969; Rabbat 
and Jeejeebhoy, 1970), ethers reporting no effect (Fisher 
et al., 1970; Haran-Ghera and Lurie, 1971). 
~Vagner and Haughton (1971) reinvestigated this problem 
extensively. They induced prolonged immunosuppression with 
ALS in mice and reported that no effect of ALS treatment on 
3-methylcholanthrene induced tumour incidence, latency, inci-
dence of metastases or antigenicity was observed. The immuno-
suppressieve potency of the ALS was assayed by transplanting 
H-2 incompatible tumours and subsequent monitoring of the tu-
meur take in treated and untreated mice. These experiments 
certainly do nat support the concept of immunosurveillance. 
Studies by Stutman (1974; 1975b), showing that tumour inci-
dences in congenitally athymic nude mice, following exposure 
to either 3-methylcholanthrene or urethan were not significant-
ly different from these in the normal heterozygous littermates 
led to the same conclusion. As already mentioned, there is an 
increase in the susceptibility to the development of polyoma 
virus induced tumours in this strain of mice (Allison et al., 
1975; Stutman, 1975a). 
It could be argued that since the chemieals themselves 
are immunosuppressive (Malmgren et al., 1952; Prehn, 1963; 
Stjernswärd, 1967) thereby exerting a dual effect at bath the 
host and tumour level during oncogenesis it is almast impos-
sible to dissect the different processes going on. The fact, 
however, that there is a direct relaticnship between the dose 
of ancogen and the immunogenicity of the tumour resulting from 
it, and its inverse relationship with latency can be explained 
within the framewerk of the immunesurveillance theory. The 
severe immunodepression that results from a high dose of anco-
gen allows the growth of tumours which are highly antigenic. 
At lower doses of the oncogen, however, the immune system is 
less affected and can reeover more r~pidly. Therefore, immune-
surveillance would be more effective so that tumours would 
appear later and be less immunogenic. 
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Bartlett (1972) and Parmiani et al. (1973) provided an 
experimental basis for this hypothesis of immunoselection. If 
mouse cells, placed in diffusion chambers, were exposed to 3-
methylcholanthrene and subsequently transplanted subcutane-
ously so that at least during the early process of oncogenesis 
immuneselection was excluded, the correlation between ancogen 
dose and latency and immunogenicity of the tumour was lost. 
Similar results were obtained with tumours that arose from 
cells spontaneously transformed in diffusion chambers (Bart-
lett, 1972; Parmiani et al., 1973). The tumours that arose 
from cel.ls transformed in v-i..:tAo by 3-methylcholanthrene were 
on the other hand highly immunegenie -in v-ivo. Prehn (1971) 
tested the immunogenicity of cells spontaneously transformed 
-in v-i..:tAo. The tumours resulting from these cells were never 
found to be immunegenie in v-ivo. Therefore, these data might 
favour an alternative explanation of the results obtained by 
Bartlett (1972) and Parmiani et aL (1973), namely that the im-
munogenicity of tumours arising was a function of the preserree 
of the ancogen rather than the result of immunoselection. If 
otherwise, one would expect the cells transformed spontaneous-
ly -in v~o to result in highly immunegenie tumours as well 
since in this system immunoselection plays no role. The argu-
ments regarding the immunesurveillance become even more can-
troversial by the observations of immunostimulation, in v~o 
as well as in v-ivo, of tumour growth (Prehn, 1971; Prehn and 
Lappé, 1971; Fidler, 1973; Medina and Heppner, 1973; Shearer 
et al., 1973; Bray and Keast, 1975; Kall and Hellström, 1975). 
If immunostimulation of tumour growth is real, then its 
role in tumour biology is of an enormous importance. The nude 
mice do not provide an answer to this question. The incidence 
of spontaneous tumours is the same as in the heterozygous 
littermates (Stutman, 1974; Outzen et al., 1975), with the 
exception of lymphoreticular tumours and they are equally 
susceptible to the induction of tumours by the use of carci-
nogens. Therefore, neither immunostimulation nor immunesur-
veillance seems to play a role in these two systems. One has 
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to bear in mind, however, that nude mice have a very effi-
cient B-cell system capable of remarkably effieient responses. 
Moloney sarcoma virus indueed tumours, however, do not re-
gress in nudes as they do in normal mice. The human analogue 
would be the leprosy patient, who has a severely decreased T-
eel! activity and yet no increased tumour incidence. 
Moreover, it should be considered that T-cell independent, 
humoral immunity, rather than cellular immunity may constitu-
te the rnain defence mechanism against the persistance of smal! 
numbers of malignant cells (van Bekkum, 1975) or that small 
numbers of cells evoke a primary humoral immune response, 
whereafter T-cells may lyse the malignant cells in an anti-
body (IgM) dependent way (see Diseussion, chapter· IV). 
The mechanisms of immunostimulation are unknown and may 
involve a number of effector mechanisms such as antibodies, 
T-cells or bath and also non-immunologie mechanisms, depend-
ing on the conditions and systems studied. 
D. Escape from immunosurveillance: Possible mechanisms 
The host-tumeur relationship consists of two dynamic 
systems, bath potentially capable of adapting to selective 
pressures from the internal and external environment. The 
neeplastic cell has an unlimited proliferative capacity. When 
this cell becomes subject to restrictive conditions which at 
times do not lead to its elimination, it may circumvent the 
restrietion by producing variants resistant to the selective 
pressure, maintaining its unlimited proliferative capacity. 
This may lead to a farm of coexistence between the host and 
the tumour or one may become to dominate and ultimately eli-
minate the other. The immune response of the organism against 
the tumour and the escape of the tumour from it are part of 
this multifaceted relationship. There are several mechanisms 
to be encountered such as: 
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1. immunodeficiency of the host, 
2. "sneaking-through", 
3. immunoresistance, lack of recognition and malfunctioning 
of the effector cells, and 
4. shedding of antigen, antigen-antibody complexes and immu-
nostimulation. 
1. 1mmunode6~cieney on the ho4~ 
Numerous experimental and human tumour systems can be 
found in the literature where the development of a tumour is 
attributed to a deficiency of the immune mechanism such as 
the already mentioned ALS treatment and neonatal thymectomy. 
Irradiation is another well documented immunosuppressant re-
sulting in a temporarily generalised depression of the lym-
phoid system and marked lymphopenia (Buckton et al., 1967; 
Thomas et al., 1971). The increased incidence of a number of 
autoimmune diseases (Good and Yunis, 1974) has been associ-
ated with an age-related decline of the immune capacity. The 
impaired capacity of the ageing immune system may therefore 
result in the development of tumours in old age. Makinodan 
has made an extensive study of the reactivity against experi-
mentally given antigens as a tunetion of age (Makinodan and 
Peterson, 1964; 1966a; 1966b; Albright et al., 1969; Nordin 
and Makinodan, 1974). These authors observed an age-related 
decline in the primary as well as the secondary immune re-
sponsiveness. Cell transfer experiments demonstrated the de-
cline of the immune capacity to be mainly due to the cells of 
the irnmunological system itself rather than to changes in the 
environment in which these cells had to function. Brennan and 
Jareslow (1975) showed an age-related reduction of the number 
of theta hearing cells as well as the amount of theta antigeus 
per individual T-cell. The response to phytohaemagglutinin 
stimulation of T-cells in mice (Hori et al., 1973; Gerbase-
DeLima et aL, 1975), in rats (Kruisbeek, 1976) and in man 
(Roberts-Thomson et al., 1974; Weksler and Hütteroth, 1974) 
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has been reported to be impaired. Also the ability of spleno-
cytes to lyse tumour cells and the ability to reject skin allo-
graftsis shown to decline with age (Menon et al., 1974). 
Prolonged immunosuppression also results in an increased 
tumour incidence. Kidney graft recipients which are under pro-
longed immunosuppression show an approximately 80 times high-
er incidence of tumours (Penn and Starzl, 1972; 1973). Lympho-
mas have been prominent and therefore one might argue that 
immunosuppressiv~ agents acted as a carcinogen apart from 
their surveillance inhibiting action. The incidence of solid 
tumours, however, is also reported to be increased. These tu-
mours (about 60 % are skin cancers or carcinoma of the cervix 
or of the lip) are precisely those who are thought to have a 
viral etiology (Schwartz, 1974; Melief and Schwartz, 1975). 
These authors, however, suggested that immunity against an 
infectieus oncogenic virus may be a more relevant question 
than surveillance against a barely immunegenie stimulation 
by the graft. Immunosuppression, adequate to eliminate a 
feed-back regulatory mechanism limiting lymphocytic proliter-
ation could then cause the high incidence of malignant lympho-
mas (Krueger, 1972; Schwartz, 1972). The association of immu-
nocompetence and tumour incidence has been pointed out by 
Melief and Schwartz (1975). The overall incidence of malig-
nacies in certain immune deficiency diseases in young chil-
dren is also highly increased. With one exception (Bruten 
type agammaglobulinaemia, where all malignancies were leukae-
mias), again epithelial tumours do arise in other immune 
deficient states. Again, the prependerance of leukaemias and 
lymphoreticular tumours may be related to the higher sus-
ceptibility to virus infection, if one considers the possi-
bility that these malignancies may be induced by oncogenic 
viruses as known for many animal species. Van Bekkum (1975) 
provides an alternative explanation. He states that "these 
form a high proportion of all malignancies in this age group, 
so that the immune deficient state would merely provide a 
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more favourable environment for carcinogenic factors to which 
all children are exposed". 
2. "SneaiUng :th!tough" 
In numerous experimental systems it has been observed 
that transplantable chemically induced sarcomas did or did 
not progressively grow depending on cell dose: very smal! 
doses of cells growing progressively, relative smal! doses 
were rejected and larger doses again grew progressively {Old 
et al., 1962). Apparently the low dose of tumour cells does 
nat provide an effective antigenie stimulus and the tumour 
reaches an irreversible size befare an immune response is 
mounted. On the other hand there is some evidence that the 
phenomenon is due to a specific, partial tolerance, produced 
by a smal! inoculum (Bonmassar et al., 1974). This observa-
tion resembles that of Stillström (1974), who showed that ex-
posure to a smal! dose of transplantation antigens results 
in a low response to that antigen after subsequent stimula-
tion by that antigen, regardless of the dose. A very smal! 
dose of tumour cells may mimic bath, -Ut ,ö.{;t(L tumour formation 
and the phenomenon described above. The "sneaking through" 
hypothesis was originally proposed by Old et al. (1962), and 
elaborated by Humphreys et al. (1962) and Marcbant (1969). 
The changes in the cell surface antigens as a result of 
malignant transformation are complex and it may be that some 
neo-antigens, although capable of eliciting an immune res-
ponse that can be measured .in v@o, do nat function as tumour 
rejection antigeus -&t v.i_vo. Besides, the degree of integration 
of these antigens in the cell surface may be important. 
Little is known about their molecular organization and their 
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association with the membrane lipid bi-layer remains largely 
to be investigated (Singer and Nicolson, 1972; Robins and 
Nicolson, 1975) . The relative rnahilities of antigeus on un-
transformed as compared to transformed fibroblastic cells are 
different (Edidin and Weiss, 1974). This process of surface 
antigen modulation was first studied by Old et al. (1968). 
The effect that modulation of tumour associated antigeus 
may have on the susceptibility of tumour cells to e.g. com-
plement dependent antibody cytolysis is clear since the cor-
rect aisposition of two IgG molecules is mandatory to fix 
complement. This is illustrated by the observations of Lesley 
and Hijman (1974), who showed that remaval of about 30 % of 
the H2 antigeus from the surface of S 194 myeloma ·cells by 
anti-H2 during a 3-hour incubation at 37° C renders 80 % of 
the tumour cells refractory to complement lysis. Therefore, 
transmembrane control of the dynamics of surface antigeus may 
play an important role in determining the susceptibility to 
immune destruction. Tumour escape may take place by extensive 
lateral redistribution of antigeus into large patches and 
caps, endocytosis ar by antigen shedding (see below). 
Many tumour associated antigeus may be mobile in the 
surface of the membrane, capable of cap formation in such a 
way as described for membrane-bound immunoglobulins on lym-
phocytes (Leonard, 1973) The amount of antigeus and the farm 
in which it is presented may then nat trigger the right cells 
or nat trigger them in the right form, resulting in an inef-
fective immune response: immune serum passively transferred 
to syngeneic animals grafted with the immunizing tumour fails 
to modulate the growth of the chemically induced tumour, al-
though the antiboclies exhibit lymphocyte- and complement-de-
pendent cytotoxicity for this tumour (Baldwin et al., 1973). 
Apparently, a phenotype variant of the tumour cells has been 
selected with antigenie characteristics that makes it resist-
ant against a maybe otherwise effective immune response. 
24 
There is a constant synthesis and degradation of cell 
plasma membranes (Warren and Glick, 1968; Nachbar et al., 
1974; Evans and Gurd, 1971) and one of the mechanisms for 
this membrane turnover which represents also an important 
mechanism for tumour cells to escape from immune destructien 
is the shedding of tumour cell associated antigens (Harris 
et al., 1973). Kapeller et al. (1973) studied the natura! re-
lease of mouse H-2 antigens by kidney cells and Coneet al., 
(1971) found that the shedding of surface proteins from bath 
normal and neeplastic cells occurred at a Pigh rate and is 
dependent on cellular respiration and protein synthesis. This 
loss of cel! surface structures may result from the release 
of pieces of plasma membrane by the process of pinching off 
of microvilli or cell surface projections (Nowotny et al., 
1974) and/or by shedding of antigens at the molecular level 
(Alexander, 1974). Neeplastic cells have been characterized 
by the presence of increased surface proteolytic activity 
which has been implicated as the perpetual stimulus to divide 
and thus increase their invasiveness to surrounding normal 
tissue (Burger, 1973; Nachbar et al., 1974). Currie and 
Alexander (1974), studying the release of antigen in tissue 
culture media supernatants of a number of 3-methylcholanthre-
ne induced rat sarcoma cultures concluded that the rate of 
antigen shedding may actually determine the capacity of a 
tumour to metastasize. Davey et al. (1976). studying a differ-
ent type of tumour, reached the same conclusion. Their hypo-
thesis is supported by the findings of Doljanski (1973) and 
Ben-Sasson et al. (1974) that Rous sarcoma virus transformed 
cells in culture release surface molecules, that bind specifi-
cally to lymphocytes of chickens hearing Rous sarcoma virus 
induced tumours. Pellis and Kahan (1975) provided more direct 
evidence for the retained biologica! activity of tumour anti-
gen released from cultured tumour cells. They showed that ani-
mals could be immunized with exhausted tumour cell culture 
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mediar protecting them against a challenge with viable tumour 
cells. The effects of tumour associated antigens and antigen-
antibody complexes on the abrogation of immune destructien of 
tumour cells has been reviewed by Price and Baldwin (1975) 
and Baldwin and Robins (1975). 
5. Antibody a.nd :the. .óhe.dcUng ofi a.n:t-tge./1..6 
The possible contribution of antibody in inducing shed-
ding of antigen is nat known. There is neverthe1ess consider-
able evidence that tumour cells ~n v~vo are coated with immu-
noglobulin (Witz, 1973). This has been shown for a variety 
of tumours including carcinogen induced hepatomas and sarco-
mas (Witz et al., 1967; Ran et al. 1 1976; Robins, 1975), spon-
taueaus mammary carcinoma (Ran and Witz, 1970} and polyoma 
and SV-40 virus induced tumours (Ran et al., 1976.; Sobczak 
and De Vaux Saint Cyr, 1971). 
The concept that cell-mediated immunity in the tumour 
hearing host may be rendered ineffective by such humoral 
factors was supported by the observations of Hellström and 
Hellström (1974b) showing that ~n vilio lymphocyte cytotoxici-
ty for tumour cells can be abrogated by serum of turnour hear-
ing animals. Blocking factors in the sera of tumour hosts 
preventing the specific recognition of tumour cells by immune 
lymphocytes were shown to be soluble tumour specific immune 
complexes. The specific as wel! as non-specific inhibition of 
effector cell reactivity is due to the interaction of the ef-
fector cells with tumour antigen containing rooieties (Baldwin 
and Robins, 1975; ZÖller et al., 1976). 
E. Conclusions 
The multiple host immune defense mechanisms described 
and the many routes available to make the escape from them 
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possible makes one wonder how these systems cooperate or 
counteract one another ~n v~vo. One has to realize, however, 
that many of the different mechanisms described were studied 
in a variety of systems. The data are clear in the sense that 
there is an overwhelming evidence that an intact immune res-
ponse is effective in modulating and even cantrolling the 
growth of certain farms of virus induced tumours. The amount 
of antigeus to which the animals are exposed is large i.e., 
through the expression of these antigeus on viral envelopes 
or on productively infected cells. Where cells are, however, 
the only souree of tumour associated transplantation antigens, 
as in the case of ancogen induced or spontaneous tumours, no 
effects of immune suppression on the oncogenesis are detected 
although during tumour development immune reactions can be 
monitored and the immune response to these tumours can be 
modified by tumour antigen-antibody complexes either 1n v~vo 
or ~n villa. 
The lack of detectable immunogenicity of spontaneous tu-
mours even in the absence of an immunesurveillance mechanism 
raises questions about the importance of the role of immunity 
in cancer. The fact, however, that the majority of spontane-
ous tumours are not found to be immunegenie does not imply 
that they lack such antigens. We have seen abundant evidence 
for the capability of the immune apparatus to influence tu-
mour growth ranging from restrietion to stimulation of tumour 
growth. It may be that in spontaneous tumour systerns these 
mechanisms are eperating at the same time, one balancing the 
effects of the other and thus preventing the detection of 
either response (Norbury, 1977). If these two effectscan be 
separated making dissectien of the different immune meeha-
nisros feasible, the balance might be tipped towards immunolo-
gical destructien of the tumour. It will evidently depend 
upon the etiology of the tumour (spontaneous, chemically in-
duced or virus induced) which of the immune rnechanisms are 
operating. The developrnent of more sensitive imrnunological 
techniques will ultimately lead to a better understanding of 
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the role of immunity in cancer and give a better insight in 
how the immune response can be made effective in tumour des-
tructien providing the clinician with a hopefully selective 
tool for the early detection and treatment of cancer. 
F. Cellular immune reactions against human bladder cancer 
cells 
Many efforts have been done to show that human tumours 
expressed cell surface antigens which were characteristic for 
that histological type of tumour. This was commonly done by 
showing that lymphocytes of an individual with a given type 
of tumour were cytotoxic only for tumour cells of that parti-
cular tumour type, i.e., that these lymphocytes did nat show 
cytotoxic reactions against histologically unrelated tumour 
cells. Furthermore, it was shown that lymphocytes from healthy 
donors did nat show cytotoxic reactions against the tumour 
cells. 
Bladder cancer camprises about four per cent of all new 
cancers. Three times as many men as wamen develop bladder 
cancer and the incidence for bath sexes is slowly rising. 
Circumstantial evidence has implicated a chemical etio-
logy in human transitional carcinoma of the bladder since 
certain chemieals such as betha-naphthylamine, xenylamine and 
benzidine, are known to cause bladder cancer. 
A host immune response to this type of tumour has been 
observed (Bubenik et al., 1970). The most striking correla-
tion with bath tumour stage and therapy has been reported by 
O'Toole (1972; 1973a; b; 1974) and can be summarized as fel-
lows: patients with transitional cell carcinoma of the uri-
nary bladder were shown to have lymphocytes in their peri-
pheral blood capable of specifically lysing bladder cancer 
cells in vÁ.:tJto. 
several bladder cancer cell lines obtained from indivi-
dual patients were shown to be susceptible to lysis, whereas 
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tumour cells derived from ether types of cancer were net af-
fected. These observations led te the conclusion that the 
antigen on the surface of the different bladder cancer cell 
lines, se called tumour associated antigens, were cross-re-
reactive. Moreover, the tumour-specific immune response could 
be observed irrespective of histocompatibility differences 
between the target cells and effector cells. 
Radiotherapy initially induced suppression of the cellu-
lar immune response of the patients and could be fellewed by 
1. full restoration suggesting a favourable prognosis; 2. a 
weak response that appeared associated with early tumour re-
currence; ar 3. no restoration of the immune response, indi-
cating continued tumour growth after radiotherapy. Successful 
surgical remaval of a localized tumour resulted in a rapid 
loss of reactivity whereas a positive response was maintained 
when residual tumours could be demonstrated. The latter ob-
servation was explained on the basis of the continuous pres-
enee of a small tumour burden. 
Cell fractienation studies indicated that the effector 
cells belonged to a non-T-cell lymphoid cell populaticn. 
Similar results were obtained by ether investigators 
(Bean et al., 1974; Bloem et al., 1974; Bloem and Seeger, 
1976; Hakala et al., 1974), although the relation between the 
immune response and tumour stage and therapy was less pro-
nounced. 
The purpose of our studies was to investigate the cellu-
lar mechanisms of the immune response of bladder cancer pa-
tients against their tumour tissue, the degree of specifici-
ty of the response and the possible clinical significanee of 
the response. A better understanding of the cytotoxic meeha-
nisros and analysis of the effector cells involved should ul-
timately lead to an effective modulation of the immune res-
ponse to cure the tumour hearing individual from his residual 
tumour. In the following chapters it will become clear that 
the patient's reaction against the tumour are complex and 
frequently involve several different types of antigens. 
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Therefore, it has become an important task to analyse the 
complexity and to evaluate the significanee of the microcyto-
toxicity assay as a diagnostic or prognostic tool for moni-
toring the course of the disease. 
Cell-mediated cytotoxicity ~~ v~o reflects the activi-
ties of several different effector cell types and each cell 
type may involve different effects on tumour growth and they 
may each operate during different phases of the disease. 
Therefore many studies have been directed towards iden-
tifying the nature of the cells responsible for the non-spe-
eitic or natural cytotoxicity against human tumour cells. 
Various cell types have been implicated in this role inclu-
ding: Fe-receptor hearing (activated T-) cells (Peter et al., 
1975; Hersey et al., 1975}, mononuc1ear phagocytic cells 
(Holterman et al., 1974), null (non-T, non-B) lymphoid cells 
(Kiuchi and Takasugi, 1976), T-cells (Holterman et al., 1974), 
and non-T-cells (Bakács et al., 1977). 
Many teehuical variations are employed for the fractien-
ation of cell populations. In chapter IV the identification 
of a new cell population of T-lymphocytes is described. In 
Chapters V and VI a number of cell separation procedures are 
used for the identification of the cells exerting non-specific 
ar natural killer cytotoxicity. 
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CHAPTER II 
CELLULAR MICROCYTOTOXICITY IN A HUMAN BLADDER 
CANCER SYSTEM: ANALYSIS OF JN VJTRO LYMPHOCYTE-
MEDIATED CYTOTOXICITY AGAINST CULTURED 
TARGET CELLS 
A. Introduetion 
The recent upsurge in interest in the immune responses 
to human tumours emphasizes the need for monitoring the spe-
eitic and nonspecific immune functions. Experimental synge-
neic animal studies employing ln v4tno techniques for measur-
ing cell-mediated cytotoxicity for tumour cells demonstrated 
the preserree of neoantigens on tumour cells. with specifici-
ties identical to those capable of eliciting tumour immune 
reactions -Ln v.{vo (Hellström and Hellström, 1969; 1974; Bald-
win, 1973). These results provided the rationale for measur-
ing the cell-mediated cytotoxicity of human patient lymphocy-
tes against tumour cells. It was assumed that the -Ut vLtlto cy-
totoxic activity of peripheral blood leukocytes from cancer 
patients was a manifestation of a state of irnmunity to tumour-
associated antigens (TAA). Many investigators, using mostly 
the microcytotoxicity test (MCT) (Takasugi and Klein, 1970), 
have shown that lymphocytes from individual cancer patients 
preferentially destray tumour cells of the same histological 
type rather than normal cells or tumour cells of a different 
type of tumour, regardless of the allogeneic differences 
(Hellström et al., 1971; Hellström and Hellström, 1973; 
Bubenik et al., 1970; 1971; O'Toole et al., 1972; O'Toole et 
al., 1974; de Vries et al., 1972; Fossati et al., 1971; 
Fossati et al., 1972; Heppner et al., 1973; Bean et al., 1974). 
Bubenik et al. (1970) reported on the presence of TAA on 
certain cell lines derived from a human urinary bladder car-
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cinema. O'Toole et al. (1972) extended these studies and 
found a inversed relation between the stage of disease and 
the cytotoxicity of lymphocytes. The further reported alter-
ations of the anti-tumeur immune response with different farms 
of therapy. Bean et al. (1974) using their modified isotopic 
MCT (Bean et al., 1973), confirmed the workof Bubenik and 
O'Toole. 
An increasing number of investigators, however, report-
ed their inability to demonstrate "tumour type specificity" 
(Takasugi et al., 1974; Skurzak et al., 1973; Berkelhamroer 
et al., 1975). However, recently, the occurrence of normal or 
natura! killer cell-mediated cytotoxicity of lymphocytes 
against tumour cells has been described in healthy animals 
(Nunn et al., 1973; Greenberg and Playfair, 1974; Kiessling 
et al., 1975a; Kiessling et al., 1975b; Zarling et al., 1975) 
and man (healthy donors, HD) (Takasugi et al., 1973; Takasugi 
et al., 1974; de Vries et al., 1974; Kay and Sinkovics, 1974; 
Rosenberg et al., 1974; Hersey, 1975a; Hersey et al., 1975b; 
Heppner et al., 1975; Mukherji et al., 1975b). This effector 
lymphocyte has been termeO the natural killer (NK)-cells. 
In the present study, lymphocytes from bladder tumour 
(ET) and tumour control (TC) patients and healthy donor (HD) 
were tested in parallel on bladder tumour cells from a cell 
line (T24) reported to carry TAA (Bubenik et al., 1970; Bube-
nik et al., 1971; O'Toole et al., 1972), melanoma cells 
(Mel-I and NKI-4), also reported to carry TAA (de Vries et 
al., 1972; de Vries and RÜmke, 1976), and normal bladder epi-
thelium (HCV). The influence of the selection of target cells 
and the choice of baseline control on the interpretation of 
MCT results was analyzed. Disease-related cytotoxicity is de-
fined as statistically significant destructien of disease-re-
lated tumour cells by the patient's lymphocytes in camparisen 
with the baseline control. Non-specific cytotoxicity is defin-
ed as destructien of a proportion (selective) or all (non-se-
lective) of histologically unrelated_ target cells by effector 
cells, while no destructien of any target cell signifies no 
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cytotoxicity. Ta investigate whether a disease-related acti-
vity of lymphocytes derived from bladder cancer patients, 
superimposed on the normal cytotoxic effects of HD could be 
demonstrated (De Vries and Rümke, 1976), the overall effects 
of lymphocytes from BT, TC patients and HD (tested in paral-
lel) on the different types of cultured target cells were com-
pared statistically. 
Although several baseline controls were utilized during 
this study, the medium control was used as a camman baseline 
for the purpose of camparing the overall cytotoxic effects of 
the different groups 1 and the groups were compared statisti-
cally by the Wilcoxen test. The value of this analysis is that 
one can determine the frequency distribution of the normal 
and/or nonspecific activity of the control donors (HD and TC 
patients) versus the medium contra!. Utilization of multiple 
lymphocyte donor controls and this methad of calculation elim-
inates the possibility of the inadvertant selection of a 
lymphocyte donor with normal cytotoxicity or growth stimulato-
ry activity for target cells as a control which could result 
in a conclusion of an apparent disease-related cytotoxicity. 
Furthermore, it allows one to pool the data from the differ-
ent experiments, therefore giving an objective answer to the 
question of whether a disease-related response is superimposed 
on the normal and/or nonspecific activity of lymphocytes 
against various target cells. 
B. Materials and Methods 
Blood specimens were obtained through the cooperation of 
the clinical investigators of our institutes. A total of 51 
patients were tested befare (one time) or after (one or more 
times) therapy. Their ages ranged from 55 - 80 with an aver-
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age of 67 years. The clinical staging of the tumour was based 
on the TNM system of the UICC (1963). The patients were dis-
tributed in the various categories as shown in Table I. 
Bladder tumour patients were tested befere therapy, 1 - 3 
weeks after radiotherapy and 8 - 10 weeks after cystectomy to 
reduce the influence of brumunosuppressive effects of radiation 
or surgery. Patients were free of tumour at the time tested 
after therapy. 
Tahle I 
NUMBER AND CLINICAL DISTRIBUTION' * OF URINARY BLADDER CANCER PATIENI'S 
Classification T-category no. of patients 
total male female 
1. Non-palpahle tumour or 
soft mass 
al tumour confined to the Tl 17 12 5 
mucose membrane 
b) tumour with infiltration T2 16 15 
of superficial muscle 
2. l'alpahle tumour wi th in- T3 18 18 0 
filtratien of deep muscle 
* Staging as proposeèl by the UICC {1963) . 
Z. Con.:tJto-U 
Lymphocytes from 37 TC patients (20 fema1es; 17 males) 
were tested, occasiona1ly during but mostly after therapy, 
with residual tumour present. They ranged in age from 31 - 35 
years with an average of 61. A total of 67 HD were tested (37 
fema1es; 30 males). The age of HD varied from 17 - 61 years 
with an average of 31. A surnmary of control donors of lympho-
cytes is given in Table II. 
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diagnosis 
Healthy donors 
Reetal ca. 
Prostate ca. 
Mammary ca. 
Cervix ca. 
Lung ca. 
Larynx ca. 
Lingual ca. 
Stomach ca. 
Cerebral ca. 
Uterus ca. 
Liposarcoma 
Penis ca. 
Table II 
CONTROL LYMPHOCYTE DONORS 
abbreviation 
HD 
TC 
no. of 
individuals 
67 
3 
2 
7 
8 
6 
3 
1 
1 
2 
37 
All blood specimens were coded by ethers befare deliver-
y. After the tests were performed, a clinical farm was ob-
tained descrihing the diagnosis and clinical characteristics 
of the patients, the stage and extent of the disease, previ-
ous therapy and the planning for future therapy. 
3. TMget cefló 
Long-term cell lines were used routinely as target cells. 
Table III surnmarizes the cell lines used in this series of 
tests. The cells were trypsinized for serial passage once a 
week and used in the MCT 6 days after passage, befare the 
cells reached confluency. The medium used for routine tissue 
culture was Parker 199 + 10 % heat inactivated feetal calf 
serum (FCS) with 100 IU penicillin and 100 ug streptomycin/ 
ml and freshly added glutamine (0.3 mg/ml). All cultures were 
checked periodically for the presence of mycoplasma (Vogelen-
zang and Compeer-Dekker, 1969) and determined to be negative. 
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Table III 
TISSUE CULTURE CELLS USED AS TARGETS IN CYTOTOXICITY ASSAYS 
Origin Cel! culture Reference Souree 
dedgnation 
Transitional cel I T24 Bubenik et cl., 1973 
care i noma of the 
) urinory bladder Metastatle cutaneous MEL-1 O'Toole et ol., 1974 c. O'Toole melenoma 
Non-malignant HCV-29 J. Fogh (unpublished) 
bladder epithelium 
Cutaneous melenoma NKI-4 J. de Vries, 1972 J. de Vries 
4. P!t.e.pa~r.aû.on ot) lymphoc.y:tu 
Lymphocytes for a single test were obtained from 20 rnl 
defibrinated blood frorn each donor. All blood samples were 
processed within 2 hours after collection. Defibrination was 
performed in 100 ml bottles containing 1 glass bead per 2 ml 
blood. Leukocytes were obtained by allowing the erythrocytes 
to sediment through plasma-gel (1 part of plasma-gel (Roger 
Bellon, Neuilly, France) mixed with 4 parts of blood) in glass 
tubes with a length of 11 cm and an inner diameter of 23 mm at 
an angle of 45° for 30 minutes at 37° c. The supernatant was 
aspirated and centrifuged (10 min, 350 g) and the pellet con-
sisting of erythrocytes, granulocytes and mononuclear cells 
was resuspended in 1 - 2 ml of the supernatant and placed on-
to a column of unstained spun nylon with a length of 1 cm and 
a diameter of 15 mm, which had been prewashed with 8 ml of 
the supernatant. The nylon column was incubated for 30 min at 
37° C. The lymphocytes were eluted with warm medium RPMI-1640 
+ 5 % FCS to reeover the nonadherent cells. The cells were 
spun down and resuspended in 20 ml isotonic Tris buffered 
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NH4Cl, pH 7.2, and incubated for 5 min at 37° C to lyse the ery-
throcytes (Boyle, 1968). After this incubation, 20 ml of cultu-
re medium were added and the lymphocytes were washed 3 times 
and checked for viability with eosin and trypan blue. Although 
the cell yield is rather low (about 30 % yield compared to 
whole blood lymphocytes count), one obtains an almast pure 
lymphocyte population containing less than 1 % monocytes or 
granulocytes (Bean et al., 1975). In general, the viability 
was over 98 %. The preparatien of effector cells and target 
ce1ls is depicted in figure 1. 
EFFECTORS TARGETS 
PERIPHERAL BLOOD MONOLAYER CULTURE 
î~cubc~e 3-12 h. 
inoubcte 30-40 h. 
I 
wcsh{lcteo 
Fix, >~oîn 
I 
ccunr resîdwal targets 
~ 
m 
~ 
~ 
0 
n 
m 
0 
c 
~ 
Figure 1. Summary chart of lymphocytes and tumour cell processing. 
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Table IV 
CHECKERBOARD DESIGN OF THE ASSAY 
Target cells 
Lymphocyte T24 Mel-I 
donors I effector/target cel! ratio effector/target cell ratio 
400 : 1 200 1 100 : 1 400 : 1 
---
2 
HD -56* -62"' 0 1S' 
TC - 7 -38* 0 45' 
ST-Il 4 
BT-III ,,. 84' 45' 100 * 
ST-I - 2 -24 
BD = healthy donor; TC "' tumour control patients; 
BT = bladder caoeer patients category I, II and III. 
2 per cent reduction in relation to medium control (MC) , 
* significant at p ( 0.05 
200 : 1 100 : 1 
16 5 
". 16° 
86' 
88. 96. 
26. 14 
HCV 
effector/target cell ratio 
400 : 1 200 : 1 100 : 1 
--- --- -
36. 13 13 
42' 34' 16 
... 
36' 24 - 2 
20' 14 
This test was based on the methad described by Takasugi 
and Klein (1970). The target cells were collected from mono-
layer cultUres by treatment with 0.05 % trypsin and 0.02 % 
EDTA (w/v) . The cells were washed with medium containing 10 % 
feetal calf serum and diluted to a concentratien giving 50 -
100 per 20 ~1 medium: 20 ~1 samples were then plated into 
wells of microtest plates (Falcon Plastics, Los Angeles, Cal-
ifornia, USA, no. 3034) by means of a 20 ~1 micropipet 
(Hamilton Company, Reno, Nevada, USA). The plates were incu-
bated overnight at 37° C in humidified air+ 5 % co2 . Cell 
attachment was checked microscopically and, when adequate, 
the medium was removed and 20 ~l lymphocyte samples or medium 
were added to the wells. The lymphocytes were tested in ratios 
of 100, 200 and 400 per target cell and each lymphocyte con-
centration was tested in 8 replicates. After 48 hours of incu-
bation, the lymphocytes were removed by washing the plates 
twice with phosphate-buffered saline. The remairring adherent 
cells were fixed and stained with May-Grünwald Giemsa and 
counted microscopically. The mean nurnber of target cells left 
in 8 replicate wells after incubation with lymphocytes was 
calculated. A checkerboard design of the assay derneustrating 
the minimum nurnber of different types of lymphocyte donors 
used in each test is given in table IV. 
For the evaluation of the influence of the choice of 
baseline control on the interpretation of MCT results, the 
average nurnber of cells in the wells with lymphocytes derived 
from patients with carcinoma of the bladder was compared with 
that found in wells with medium alone (medium control) and 
control effector cells (HD and TC patients with a tumour of 
unrelated histology) by the Student t-test. A "p" value of 
39 
less than 0.05 was considered significant. The percentage cy-
totoxicity was calculated by the following formula: 
% cytotoxicity 
mean number of target cells in control wells -
mean number of target cells with test lymphocytes 
mean number of target cells in control wells x 100 
For comparison of the overall effect of different groups of 
lymphocyte donors the Wilcoxen test was used. A "p" value 
~ 0. ·os was considered significant. 
C. Results 
1. Infiluence o6 ~he exp~entat de4~gn o6 ~he a4~ay on ~he ~nt~p~eta­
tion o6 Jte4u.t.t4 
Table V represents one of multiple experiments where the 
influence of the selection of different types of baselines 
for specificity control of the interpretation of HCT results 
becomes apparent. The number of cells remaining in the wells 
for the different control donors of lymphocytes used as base-
line controls (HO (1); TC (2) ) differ significantly for both 
cell lines. Moreover, the cytotoxic effect of one single lym-
phocyte control donor on the survival of the various types of 
target cells could be different (HD (2) on T24 and Mel-I 
against medium control). For instance, patient BT-II shows a 
disease-related reaction in relation to donor HD (1) and the 
medium control, but this reaction is considered non-specific 
if compared with donor HD (2) and donor TC (table V). It is al-
se clear from these data that, again depending on the baseline 
control selected, the effect of lymphocytes from a control do-
nor on the different cell lines can be reversed. When the cyto-
toxic effects of the TC patients are calculated with lymphocy-
tes from HD (1) as the baseline 1 the effects are interpreted as 
non-specific cytotoxicity against T24 and non-specific stirnula-
tion against Mel-I. It is clear, therefore, that no reliable 
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lymphocy!o 
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6T-1 
BT-11 
HD(l) 
HD(2) 
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Table V 
ROLE OF BASELINE SELECTION ON THE INTERPRETATION OF CTX 
Torgel colli 
T24 (bl~ddor c~ncet) Mei-I (molonomo) 
no, of 
collo/wel I 
In MC 2 
321 !. 473 
150 + 21 
235+41 
147!. 24 
193 + 28 
220 !. 35 
por een! CTX in re lofion fo 
MC ~~TC 
- ,. 
-57"'" -20 
32 .... 36'"' 
-' 
22 ... 
-60'''' 
_" 
33"'' 37"'" 24''" 
" 
18'"" Jl'" 
no, of 
celh/woll 
;" MC 
103!. 19 
122+24 
)19!. 25 
152 + 29 
168!. 27 
143 :!:_ 21 
MC 
28''' 
" 
" 
- . 
_" 
HD ~ heolthy do<>or; TC= lumour control potienl; ST= bladder coneer potienl<, Colegory I ond 11 
MC =medium conlrol 
per een I CTX in relotion fo 
HD(I) !:JE.ill TC 
" 
32'"' 39'''' 
-' ". n•·· 
". 
" 
-28" 
_., 
-W 
number< are meent± S,O, of wrviving cello/well remoining olloçhed to the bollom ofwelhol lh<> ond of the test 
4
, ~;'/{~~.~~d~c~~~o~/!1:~';'( ~e.l6~';'~"~ ~:~ 1 :0!~':. ~~Op:(l~ ,001 _ '0,005; • ... at p( 0 .OOI 
J CTX: cytolo~ldty; STIM,: growth <tlmuloHon; NBg,: no CTX '" STIM, 
inlerp<elollon of >pecifieily in re lotion lo 
""'- !2!:ill ~ .IS_ 
non-spec, Neg, bladder non-<pec, 
crxs lumour <pee, m 
STIM. ond 
non->pec.CTX 
bladder bladder non->pec,CTX non->poc, 
tumour tumour CTX (non-
spec.CTX >pH,CTX <elective) 
Neg, non->poc, normol 
STIM. STIM, 
normol CTX normol CTX 
normol normol CTX Mrmol 
m ond normol STIM, 
SliM, 
Neg, non-<pec, non-spec. 
"' 
SliM. 
non->pec, 
STIM, 
conclusion about specificity can be made, due to the unpre-
dictable effects of lymphocytes of clinical control and 
healthy donors. Therefore, we used the medium control as the 
baseline for the calculation of reductions. 
The selection of the types of target cells appears to 
have a similar influence on the interpretation of results. 
Table VI illustrates the fact that, in this type of assay, 
the effect of the same BT donor (BT-I) would be interpreted 
as disease-specific if only cell lines T24 and HCV would have 
been included in the experiment. When, however, cell lines 
T24 and Mel-I or all cell lines are included in the experi-
ment, the activity of test lymphocytes which was concluded to 
be disease-related becomes nonspecific. This confirms the 
findingsof Mukherji et al. (1975b). This could mean that, if 
more effector cell and/or target cell controls are included 
in one assay, the probability of finding disease-related cy-
totoxicity would be greatly diminished. 
Z. No~pecifi~ ey~o~oxicity ofi tymphocy~~ fiAom ~umoUA cont4ot p~e~ 
and ~ kitteA (NK) eet! cy~o~o~y ofi heatthy dono~ 
The data in tables VII and VIII clearly show that a pro-
portion of HD and TC patients exert non-specific significant 
activity against the different target cell lines. We tested 
67 HD and 37 TC patients and the results are surnmarized in 
Tables VII and VIII. The pattern of reactivity as shown in 
the tables is representative of the pattern that results from 
the evaluation of all data. Although some of the lymphocyte 
preparations of HD and TC patients gave nonselective killing, 
the majority showed selective reduction of the different 
target cel! lines used in this study. From the HD, 20 per 
cent showed cytotoxicity against none, 45 per cent against 1, 
23 per cent against 2 and 2 per cent against all three target 
cell lines. For the TC patients, these percentages were re-
spectively 32, 34, 16 and 18 per cent. The normal reactivity, 
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Table VI 
INFLUENCE OF TARGET CELL CONTROL SELECTION ON THE INTERPRETATION OF CTX 
Target cells 
T24 Expt. Lymphocyte 
Mel-I HCV 
Interpretation of results in relation to 
target cells 
na, donorsl 100 : 12 
----
3 
23 BT-I 90-
HD 20 
TC 44~ 
16 BT-II 90 **** 
HD 17 
TC 0 
11 BT-III 87**** 
HD 14 
TC -13 
100 : 1 100 : 1 
so**" 
15 0 
14 0 
0 32-
3 29~ 
31- 21. 
72- 5 
6 43~ 
13 0 
T24 + Mel 
non-specific CTX 
bladder tumour 
specific CTX 
non-specific CTX 
T24 + HCV 
bladder tumour 
specific CTX4 
non-specific CTX 
bladder tumour 
specific CTX 
HD ~ healthy donor; TC ~ tumour control patient; BT ~ bladder caoeer patients, category I, II and III 
2 effector cell : target cell ratio 
3 per cent reduction in relation to MC. 
**** significant at p ( 0.001; *** significant at p ( 0.005; ** significant at p ( 0.01; 
* significant at p ( 0.05. 
4 CTX ~ cytotoxicity 
Table VII 
SELECT!VITY OF NORMAL CYTOTOXIC ACTIVITY OF HEALTHY DONORS 
Target cells 
T24 Mol HCV 
Exp. 
",, ly/tc2 ly/tc ly/tc 
oo. code na. 200:1 100' 1 200:1 100' 1 200' 1 100:1 
(1) 13 12 3 NT4 10 52. 41 . 
8 17 37 40. -21 18 0 
21 47 60. 2 20 0 0 
23 0 0 NT 60. ". 
21 81 -10 25 34' 0 22. 17 
82 9 57. -75 .. -25 2 35. 
35 159 76. 
"' 
65. NT aa· NT 
38 176 -88 * -50,. - 7 11 
47 (!) 14 - 6 8 -23 ". 8 
(2) 0.9 - 4 2 -17 21 21 
(3) 50. 41. . -15 
-30 
48 (1) -18 -18 5 - 5 - 1 
(2) 
- 4 -36 * -11 37. 49. 
(3) 
- 5 - 4 4 5 49. 5 
(41 -39" -33" -28 * -24 * -21 
- 4 
49 (1) - 9 6 0 50. 30. 
{2) 11 -22 7 56. 33. 
(3) 
-14 -14 -23" 43. 25. 
(4) 
-12 4 0 5 10 18 
HD "' healthy donor 
2 effector cell . target cell ratio 
3 per cent reduction in relation to MC . . significant atp,(O.OS 
• NT "' not tested 
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Table VIII 
SELECTIVITY OF NON-SPECIFIC CXTQTOXICITY OF TUMOUR CONTROL PATIENTS 
T24 
Exp. lymphocyte diagnosis ly/tc
1 
no. donor 200 : 1 100 : 1 
-- ---
7 !5 cervix ca. 242 ". 
!5 52 cervix ca. 
",.. 
16 
25 108 cerebral ca, -33 * 15 
26 114 stomach ca. 30. 16. 
31 139 lung ca. 31. 21 
37 171 larynx ca. -39* -10 
42 195 lung ca. ,.. 36. 
43 202 mamma ca. 16. -10 
204 lung ca. 39. 23. 
206 liposarcoma 7 2 
effector cell ' target cell ratio 
2 per cent reduction in relation to MC. * significant at p ( 0.05. 
3 NT: not tested 
Target cells 
Mel 
ly/tc 
200 1 100 1 
-33 10 
NT - 2 
38 
. 37. 
2 
"' 50. 40. 
-20 -15 
40. 33. 
12 10 
9 7 
6 -29 * 
HCV 
ly/tc 
200 1 100 1 
66. 40 
NT 28. 
26. 48. 
22 26 
40. 28 
8 5 
2 - 4 
9 -22 
69. 18 
4 - 4 
defined as natura! killer (NK)-cell activity of lymphocytes 1 
of HD did nat appear to be sex- ar age-related nor Qid donors 
from the laboratory show an increased reactivity over donors 
from outside the laboratory. 
3. Comp~on on the ov~ ~ytotoxie enne~ on tymphocyt~ n~om blad-
den tumoU4, tumo~ co~ot patie~ and heatthy dono~ g~oup~ on T24, 
HCV, Met-I and NKI-4 cultuAed taAget c~ 
As shown by our data (Tables V and VI) 1 the number and 
type of control donors as well as the number of target cel! 
controls greatly influences the chance of determining disease-
related tumour reactions, due to the normal reactivity of lym-
phocytes from HD and the either normal or nonspecific cyto-
toxicity of TC patients (Tables VII and VIII). Consequently, 
an impractically large checkerboard design would have to be 
utilized to clearly demonstrate disease-related cytotoxicity 
in a single assay. Therefore, we have compared the different 
groups of lymphocyte donors statistically to investigate 
whether putative disease-related responses being superimposed 
on the non-specific or normal cytotoxic responses could be de-
tected, indicating that tumour associated antigens (TAA) are 
present on cultured tumour cells. 
The frequency distribution scatter diagrams illustr.ate 
the cytotoxic effects of peripheral blood lymphocytes from 
the different groups of patients and HD against disease-rela-
ted target cells and appropriate target cells (figs. 2 1 3 and 
4). These figures show that there is a wide range in the 
level of reactivities of lymphocytes from the individuals of 
each lymphocyte donor group. Befare and after therapy, BT 
patients showed reactivity towards all three target cells 
used in parallel :In each assay; this reactivity was strenger 
at higher lymphocyte concentrations. The overall cytotoxic 
effects of lymphocytes from TC patients selected as controls 
for the determination of specificity of the effector cell 
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Figure 2. Scatter diagram depicting the cytotoxic effects of 
lymphocytes from stage I, rr, III, paoled I, rr, III 
BT patients befare and after: therapy. 
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Figure 3. Scatter diagram depicting the cytotoxic effects of 
lymphocytes from stage I, II, III, paoled I, II, III 
BT patients befare and after~ therapy. 
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Figure 4. Scatter diagram depicting the cytotoxic effects of 
lymphocytes from stage I, II, III, paoled I, II, III 
BT patients befare and after* therapy. 
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level did nat differ significantly from those of HO (table 
IX). It should be emphasized that these patients were tested 
during or after therapy. When tested within 8 weeks after 
therapy, the overall cytotoxic effects of lymphocytes from 
BT patients of all three categories were similar, as was to 
be expected on the basis of the results shown in table IX 
(HD versus TC) and hence nat significantly different from 
those of HD and TC patients during or after therapy (Tables 
IX and X) . The overall cytotoxic effects of lymphocytes 
derived from BT patients of different categories differed 
from these of HD and TC patients, if the HCT was carried out 
so 
Table IX 
MEAN PERCENTAGE CTX (~S.O.) OF LYMPHOCYTES FROM BT PATIENTS 
AFTER THERAPY, TC PATIENTS AND HD ON T24, MEL AND HCV 
CULTURED CELLS IN RELATION TO THAT OF HD 
400 lymphocytes/target cel I 
T24 p' MEL p' HCV p' 
BT stage I 
-':':"JJ 8 + ''::l 20:<:183J BT stage 11 23 + 21 13 :!:_ 21 29 + 19 
HD 9 + 38=:J 7 + 28=:J 27 :!:_ 26 J 
TC all stages 18 + 31 22 + 30 14 + 33 
200 lymphocytes/target ce 11 
BT stage 
13 :': "3J ":':"j ":':"j BT stage 11 0 + 23 8 + 27 23 + 17 
HD 
-1 :!:_30=:J -2::26 J 14 :!:_ 25 J 
TC all stages -3 + 41 12 + 20 10 + 27 
100 lymphocytes/target cel! 
BT stage I 
-9 :': 21 3J 
-5 :': "j 23:<:32j 
BT stage 11 10 + 21 9 + 27 7 + 30 
HO 8_:27=:J -4_:17=:J 8 :!:_25 J 
TC oll stages 0 + 34 6 + 21 1 + 26 
Only p values ( 0. 05 are indicated 
Table x 
MEAN PERCENTAGE CTX (± S.D.) OF LYMPHOCYTES FROM BT PATIENTS 
AFTER TBERAPY, TC PATIENTS AND liD ON T24, MEL AND HCV 
CULTURED CELLS IN RELATION TO THAT OF TC PATIENTS 
400 lymphoc:ytes/target c:ell 
T24 p• MEL p• HCV p• 
BT stage I -1!21~ 8+30~ 20 !18~ BT stage 11 23 + 21 13 ~ 21 29 + 19 
BT stage I+ 11 16 + 23 12 + 23 26 + 18 
TC all stages 18 + 31 22 + 30 14 + 33 
200 lymphac:ytes/target c:ell 
BT stage I "!"~ 11! 16 ~ "ê"~ BT stage 11 0 + 23 8 + 27 23 + 17 
BT stage I+ 11 5 + 22 9 + 22 22 + 17 
TC all stages -3 + 41 12 + 20 10 + 27 
100 lymphoc:ytes/target c:ell 
BT stage 
-9! 21 ~ -5! 15~ 23!32~ BT stage 11 10 + 21 9 + 27 7 + 30 
BT stage I+ 11 2 + 23 3 + 24 JO+ 30 
TC all stages 0 + 34 6 + 21 1 + 26 
Only p values ( 0.05 are indicated 
befare therapy (tables XI and XII). However, these reactivi-
ties were nat disease-specific. For example, the lymphocytes 
of stage-I ET patients were significantly cytotoxic to T24 
target cells only in camparisou with TC patients, if tested 
at concentratien of 400 : 1. When compared with HD, this 
apparent specificity is lost, since they are found to be sig-
nificantly cytotoxic against Mel-I and HCV target cells as 
well ( tables XI and XII) • 
In genera!, lymphocytes of BT patients when tested befere 
therapy appeared to be more cytotoxic against the non-disease 
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Table XI 
MEAN PERCENTAGE CTX (+ S.D.) OF LYMPHOCYTES FROM BT PATIENTS 
BEFORE THERAPY, TC-PATIENTS AND HD ON T24, MEL AND HCV 
CULTURED CELLS IN RELATION TO THAT OF HD 
400 lymphocytes/target cel I 
BT stage I 
BTstagell 
BT stage lil 
HO 
TC oll stages 
200 lymphocytes/target cel I 
BT stege 
BT stege 11 
BT stege lil 
HD 
TC all stages 
100 lymphocyres/torget cel I 
BT stage 
BT stage 11 
BT stege 111 
HD 
TC all sloges 
T24 ,. 
28 ~ 26 •025 40 + 28r 
27 + 43 
9 + 38 
·18! 31] 
31 + 36 
11 ~ 24t.0025 
22 + 40 
-1 ~30 .025 
-3:; .,J 
24::: 35~ 
15 + 35 
22 + 35 
8 :': 27] 
0 + 34 
Only p values ( 0. OS are indicated 
MEL ,. HCV ,. 36 + 39f 40 + 15f 
36 :;:- 24 "025 61 :;:- 26 · 025 
- .0005 - .0005 
27 :!: 44 30 :!: 37 
7 + 28 27 + 26 
22 :;:- 30] 14 + 33] 
- -
28 + 31 }2 26 + "iS - .0005 - .025 13+19 31+21 
- .025 - .005 
28+40 31+31 
- .0025 - .005 
-2:26] 14:25] 
12+20 10+27 
- -
26+ 30E 12. "k 23 ~ 23 "0005 37 :;:- 25 
23~33 .000521 ~ 30 .0005 
_4 ~ 17 .ooo5 8 : 25 .ooo5 
6 ~ 21] 1 ~ 26] 
related target cell lines (tables XI and XII) and hence the 
cytotoxic reactions are concluded not to be disease-related. 
This contrasts with the conclusion reached by de Vries et al. 
(1976) on camparing the cytotoxic effects of lymphocytes from 
melanoma patients with these of HD, using NKI-4 rnelanoma 
cells and T24 bladder tumour cells as target cells. We there-
fore studied the effects of BT patients on these cell lines 
befare therapy. The data are presented in table XIII. Al-
though some patients (B.T-1 (a and b) and BT-III (b); table 
XIII) show streng cytotoxic effects against T24 and Mel-I 
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Table XII 
MEAN PERCENTAGE CTX (+ S.D.) OF LYMPHOCYTES FROM BT PATIENTS 
BEFORE THERAPY, TC-PATIENTS AND HD ON T24, MEL AND HCV 
CULTURED CELLS IN REIJ'!.TION TO TEAT OF TC PATIENTS 
400 lymphocytes/ torgel ce 11 
T24 ,. 
BT stoge 
BT stoge 11 
BT stoge 111 
BT stoge I+ 11 + 111 
TC oll stoges 
40. "r - .05 28 :!: 26 
27 + 43 
31 + 32 
18 + 31 
200 lymphocytes/torget cel I 
BT stoge 
BT stoge 11 
BT stoge 111 
BT stoge I+ 11 + 111 
TC oll stoge~ 
31+36[ - .05 
11 :!: 24 
22 + 40 
19 + 34 
-3~41 ·05 
100 lymphocyles/target cell 
BT stoge 24+35l BT stoge 11 15 + 35 
BT stoge 111 22 +35 
BT stoge I+ 11 + 111 21 + 36 
TC o!l sloges 0~34 · 05 
Only p values ( 0. OS are indicated 
MEL 
36 :': 39\ 36 + 24 
27 + 44 
33 + 34 
22 + 30 
,. 
28;: ")n 13 + 19 
28 + 40 
- .05 
22 + 31 
12 + 20 
26+30i1 23 + 23 · 05 
- .05 
23 + 33 
25 + 29 · 05 
6~21 .005 
HCV ,. 
40 + 151: 
61 :!: 26 .005 
30 :!: 37 
46 + 31 
- .05 
14:!: 33 
26 + 13i3 - 05 31 + 21 . 
- .005 
31 + 31 
- 01 
30 + 23 . 
10 ~ 27 •001 
12 :': "t 37 + 25 - OOI 21 + 30 . 
24 + 27 
- .001 
1 + 26 
cells, these effects appear to be even stronger against NKI-
4. The percentage CTX of the lymphocytes from the remaining 
three patients (BT-I (c) and BT-III (a and c) i table XIII} is 
also the highest on NKI-4. From these data, it is clear that 
NKI-4 rnelanoma cells are even more susceptible to the cyto-
toxic effects of lymphocytes from BT patients than T24 and 
Mel-I. This indicates that the cytotoxic effects of lymphocy-
tes from BT patients are significantly different from the 
effects of lymphocytes from HD, also when NKI-4 cells are used 
as target cells. 
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"' ~ Table XIII 
CYTOTOXICITY OF LYMPHOCYTES FROM BT PATIENTS ON T24, MEL-I AND NKI-4 CELLS 
mean numher of cell• per we!l per cent reduction 
Polient ly/tc T24 Mei-I INKI-4 724 ~ 
----
BT-I(o) 1 200 : 12 21.3 13,4 :s 23.5 4.9 2,3+ \,7 64 + 5 ...... 32+ 3"' 
100: 1 47.5 5.3 25.5 7.3 8.3 + 2,8 20 + 5 26 + 3' 
Me' 59,1 16, I 34.5 8.5 34.3~ 5,0 
IIT -Hh) 200 : 1 33,1 6.8 12.5 1.9 3,1 + 1.6 68 + 3'''' 66+ , .... 
100 ' 1 71,3 23,8 23,3 4.7 13,9+ 9.6 31 + 9'' 37 + 2" 
MC 103 17 36,8 5.5 64.5! 12.4 
IIT -l{c} 200 : 1 29,0 6.4 13,1 2. 9 17.9 5.1 1 + 3 23+ 2' 
100 : I 31,6 8. 9 18,1 5.6 28,3 5.7 8 + 4 6> 2 
MC 29,4 5.0 17 ,I 4.0 43. I 4.0 
BT -I! I (o) 200 : I 45,4 12, I 32,3 9.5 6.0 2.5 23 + 7' 2 + 4 
100 : 1 48,5 15,0 33,0 4.2 14,8 11.9 18 + 8 0. 3 
MC 58,8 18,3 33,0 8.2 34,6 5.3 
ST -l!l(b) 200 : 1 34.4 5.4 25,1 6.7 8.1 5.0 42 + 4"' 24+ 3' 
100: 1 49.8 14,\ 28,4 8.8 16.4 6.4 15::;: 7 14+ 4 
MC 58.8 18,3 33.0 8.2 34.6 5,3 
BT-III{c) 200 : 1 153 18 54, 1 18,5 35,0 5.1 -11 + 11 2 + 8 
100 i 1 149 23 49, 1 8,0 45,6 11,6 - a+ 12 11+ 6 
MC 138 22 55,1 15.4 50.0 11.8 
1 IIT: bladder coneer patienh 1 colegarial 1 and Hl, te•led befare theropy. a, band c represenl 3 indivjdual palienls 
far each category 
2 effector cel I: largel cel! ratio 
3 numbers are means:!: S,D, of surviving cel!s/wel! remaining ottoched la the battam af wells atthe end of lhe te•l, 
4 per cent redoeiion in relatian to MC, •••• significant at p (0,001; ••• •ignificanl at p (0,005; 
*" •lgnificant at p (0,01; *significant at p(0,05. 
5 MC: medium contra!, 
NKI-4 
93 + , •••• 
76 + , .... 
95 + , •••• 
78 + 4 .... 
58 + 2' 
34:;: 2' 
83 + , .... 
57 + 4 .... 
77 + 2'"' 
53! 2 
30 + 3'' 
10 + 6 
These results again indicate that determination of speei-
ticity is total1y dependent on the number of controls at both 
the effector cell and target cell level. 
D. Conclusions 
In contrast to the well standardized serological methodS 
used routinely in experimental tumour biology, the variables 
which influence cellular MCT results are only poorly under-
stood, despite the efforts made to analyse the reasans for 
the discrepant results obtained by different researchers 
{Baldwin, 1975; Herherman and 01dham, 1975). 
Variables greatly influencing the MCT results are the 
number and the selection of the various types of target cells 
{table VI, Mukherji et al., 1975a, b; Oldham et al., 1975). 
In this study only long-term cultured target cells were used 
to determine whether disease-related cytotoxic reactions by 
lymphocytes from bladder cancer patients could be detected. 
The use of established cell lines as a souree of target cells 
is subject to a number of criticisms: 1. they do nat resembie 
the original heterogeneaus population of tumour cells ~ 4~U 
due to the selection of specific cells which are rapidly di-
viding; 2. the observation that only a fraction of the at-
tempts to establish cell lines are successful suggests a 
selection for those types of ce1ls that adapt more readily 
to ~n v~o culturing. This may lead to changes 1n the expres-
sion of antigeus on the membrane of these cells; 3. there are 
a number of reports demonstrating a greater susceptibility of 
long-term cultured target cells to destructien by lymphoid 
cells resulting in an increase in the normal ar natura! kil-
ler cell reactivity of lymphocytes from control donors, al-
though others did nat find such differences {Mukherji et al., 
l975a, b; Heppner et al., 1975; de Vries et al., 1974; Oldham 
et al., 1975; Takasugi et al., 1973; Takasugi et al., 1974). 
ss 
It has been argued, therefore, that the use of establis-
hed cell lines is one of the factors explaining the inability 
of several investigators to detect disease-related antitumour 
reactions (Oldham et al., 1973; de Vries et al., 1974; de 
Vries et al., 1975; Heppner et al., 1975; Takasugi et al., 
1973; Takasugi et al., 1974). Short-term cultured target 
cells would be less subject to the above criticism and are 
reported to be less vulnerable to the killing effects of the 
lymphoid effector cells of HD (Mukherji et al., 1975b; 
Heppner et al., 1975); in addition, a number of investigators 
have demonstratea disease-related cell-mediated cytotoxicity 
in human tumour systems employing short-term cultured target 
cells (Hellström et al., 1971; Bubenik et al., 1970a; Bubenik 
et al., 1970b; Fossati et al., 1971; Fossati et al., 1972; 
Baldwin et al., 1973). However, other investigators found 
long- and short-term target cells of different histologie 
origin to be equally affected by normal lymphoid effector 
cells from HD (Oldham et al., 1975; Takasugi et al., 1973; 
1974). The use of short-term target cells involves several 
problems: 1) they are composed of malignant and nonmalignant 
cells. This greatly complicates the discriminatien between 
nonspecific, normal and disease-related cytotoxicity, sirree 
bath malignant and nonmalignant cells may serve as target 
cells, while they cannot always be distinguished morphologi-
cally; 2) they are nat readily available for cytotoxicity 
testing, which is a prerequisite for large scale testing of 
lymphocytes for clinical investigations. For these reasonsand 
on the basis of the observations mentioned above, long-term 
cultured target cells were used as target cells in this study. 
A second factor which proved to be a crucial variable in 
the determination of the level of cytotoxicity and the speci-
ficity of the antitumour reactions is the choice of the type 
of baseline control for the calculations. Unpredictable ef-
fects of control lymphocytes from HD and TC patients can be 
seen ( tables VII and VIII). Similar observations have been 
reported by other researchers (Mukherji et al., 1975a; 1975b; 
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Oldham et al., 1975; Takasugi et al., 1973). Oldham et al., 
{1975) used the "least active normal donor" in a single assay 
as the baseline control; however, as has been shown (table V), 
one individual donor may exert opposite effects on different 
types of cell lines (Mukherji et al., 197Sb) and this would 
mean that, for each cell line, a different "least active nor-
mal donor" should be selected. Moreover, the selection of the 
"least active normal donor" in one particular assay is depen-
dent on the number of normal donors included in that test and 
hence makes it incumbent on the investigator to include a 
large number of normal donors in each test. Repeated use of 
the same lymphocyte donor whose lymphocytes are proven to be 
unreactive at one occasion is unreliable, since there is a 
large fluctuation in the cytotoxic effects of the lymphocytes 
of one individual donor if tested repeatedly at different 
time intervals (chapter II, Heppner et al., 1975; Pierce and 
Devald, 1975; Oldham et al., 1973; Oldham et al., 1975). The 
repeated use of cryopreserved unreactive 1ymphocytes is also 
unreliable (chapter III). Therefore, the medium control was 
used as a common baseline in this study. Although this type 
of baseline does not control for the growth stimulating or 
cytotoxic effects of control lymphocytes from HD and/or TC 
patients, it is this feature that allows an objective campari-
sen of the overall cytotoxic effects of lymphocytes from the 
different donor groups in order to investigate whether di-
sease-specific effects of lymphocytes from BT patients are 
superimposed on the observed normal and nonspecific reactivi-
ties. For this purpose, the lymphocytes were always tested on 
the same set of target cells to reduce the influence of fluc-
tuations in susceptibility to cell lysis by ly.mphoid effector 
cells for one particular target cell throughout prolonged cul-
turing (chapter III). Since the patients themselves represent 
a major variable, the BT patients were divided into three 
categories on the basis of tumour stage (table I) to maintain 
each group as homogeneaus as possible. 
The results obtained indicate that lymphocytes of BT pa-
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tients tested befare therapy are significantly more reactive 
against the different types of target cells as compared to 
those of HO and TC patients (tested during or shortly after 
therapy) at various lymphocyte : target cell ratios (tables 
XI and XII). When 1 however, the same BT patients were tested 
after therapy, their overall cytotoxic effects against the 
same set of target cells were similar to those of HO or TC 
patients ( tables IX and X). From these data, it can be con-
cluded that the strenger reactivity is nat tumour-specific. 
This is in contrast to the conclusion drawn by de Vries and 
Rümke (1976) . These authors compared the overall cytotoxic ef-
fects of lymphocytes from HO and melanoma patients using T24 
bladder and NKI-4 melanoma cells as target cells and found the 
cytotoxic effect of lymphocytes from roelauoma patients t~ be 
significantly strenger in camparisen to that of HD. Such a 
difference in cytotoxic effect was nat detected on T24 target 
cells. Therefore, it was ooncluded that a tumour-related res-
ponse was superimposed on the nonspecific cytotoxic effects 
of lymphocytes from melanoma patients if the effects were 
compared with those of lymphocytes from HD. Table XI shows 
the frequency of cytotoxic reactions of BT patients against 
T24 target cells to be smaller as compared to that on Mel-I 
cells; moreover, the NKI-4 cells appeared to be even more 
susceptible to the cytolytic activity of lymphocytes from BT 
patients when their lymphocytes were tested befare therapy 
(table XIII). 
It is noteworthy that the three cell lines used through-
out this study showed no statistically significant difference 
in susceptibility to cell lysis by lymphocytes from HO (data 
nat shown). 
This latter observation confirms the conclusion that the 
cytotoxic effects of lymphocytes from BT patients, and possi-
bly of other groups of cancer patients tested befare therapy 1 
are significantly strenger against tumour cells, if compared 
with HO and TC patients during or shortly after therapy. The 
cytolytic effects were also observed on HCV cultured cells 
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which are of nonmalignant origin. This susceptibility to cel! 
lysis was also observed by de Vries (personal communication). 
It is unlikely that the lack of specificity must be at-
tributed to the lytic activity of monocytes which are repor-
ted to give nonspecific cytotoxic effects (O'Toole et al., 
1973; Riethmüller et al., 1975), since these cells are present 
only in low numbers in our lymphocyte preparations. Moreover, 
the procedure by which effector lymphocytes are isolated 
seems not to account for the nonspecific reaction observed, 
since the isolation procedures yield reversed effects on the 
different types of target cells (Mukherji et al., 1975b; 
Oldham et al., 1975). Several studies have indicated various 
subpopulations of lymphoid cells to be responsible for the 
non-specific and NK-cell reactivity of lymphocytes of HD and 
TC patients, including C3/Fc-receptor carrying cells, Fc-
positive (T-)cells (chapters V and VI; Hersey et al., 1975b; 
Jondal and Pross, 1975; O'Toole et al., 1973; O'Toole et al., 
1974). These different candidates for the cytotoxic effects 
observed might be present in different concentrations in the 
peripheral blood of individual donors or in general in dif-
ferent donor groups. The cytotoxicity observed for a single 
cancer patient may therefore be the result of a combination 
of disease-related, non-specific and normal or natura! 
killer cell reactivities of the effector cell subpopulations. 
Since cytotoxicity is merely defined as strenger cytolytic 
reactivity by test lymphocytes over control, e.g. control lym-
phocytes or medium control, this complicates the evaluation 
of disease-related cytotoxic reactions. The observation of in-
creased overall non-specific cytotoxicity of lymphocytes 
from BT patients befare therapy might be due to the presence 
ofcross-reactive embryonic antigeus present on tumour cells 
as described in well-defined animal tumour roodels (Baldwin 
et al., 1973; Baldwin and Embleton, 1974). 
The discriminatien among the different cytotoxic effects 
will depend on the possibility of separating normal, non-spe-
cific or NK- and disease-related reactive effector cells 
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frorn each ether, assuming there is no overlap in these react-
ivities. This, however, does not mean only the development 
of refined cell separation techniques but also modification 
and more rigarous standardization of the MCT and molecular 
characterization of the cell surface antigens. We have found 
that effector cells of the same individual donor have differ-
ent effects on long term cultured target cells from a parti-
cular cell line if these target cells are from different pas-
sages. The effector cells used were obtained from one batch 
of frezen cells and tested in the same experiment on target 
cells from different passage numbers {chapter III). The fluc-
tuations in the results are probably due to the complexities 
inherent in the present methodology. 
Finally, few studies have been performed on the necessi-
ty of histocompatibility between effector cells and target 
cells as suggested by Doherty et al. (1976) in virus studies. 
This would make testing of autologous lymphocytes on tumour 
cells mandatory. The ~ v~o sensitization of lymphocytes 
from HLA identical sibs are from HLA-matched donors might 
offer an alternative approach. 
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CHAPTER III 
CRITICAL EVALUATION OF THE MICROCYTOTOXICITY 
TEST (MCT) : ATTEMPTS TO STANDARDIZE THE MCT 
A. Introduetion 
In the previous chapter it was shown that lymphocytes 
from healthy donors may exert streng normal ar natura! cyto-
toxic effects against tumour cells and that the level of the 
cytotoxic effect was donor dependent. It was for that parti-
cular reasen that the medium-control was used as the base-
line for the calculation of the per cent cytotoxicity. To 
further study the nature of the NK-cells (see Chapters V and 
VI) it is of importance to establish whether a standardized 
MCT measures the cytotoxic capacity of the NK-cells in a re-
producible and quantitative fashion. It already has been 
shown that fresh lymphocytes from the same individual, taken 
at time intervals and tested in the MCT in separate experi-
ments, show fluctuations in their cytotoxic effect and also 
that with serial passage of cell lines the target cells 
change in their susceptibility to lysis by lymphocytes (Levy, 
1973; Oldham et al., 1973; Heppner et al., 1975). The observ-
ed day-to-day variations seriously compromised the monitor-
ing of the cytotoxic capacity of donor lymphocytes in longi-
tudinal studies. These variations might be reduced by using 
cryopreserved lymphocytes and target cells. This would allow 
for the colleetien of lymphocyte samples from one individual 
over a long time period followed by testing of these samples 
ar of samples of a number of donors in a single experiment. 
The variatien in this single experiment would then result 
only from variations in the patients' material tagether with 
these due to the freezing procedure of these individual sam-
6\ 
ples. Furthermore, the cryopreserving technique would then 
allow to repeat the testing of: 
a) aliquots of a large sample of lymphocytes from one indivi-
dual, providing a standard base-line for evaluation of 
the level of cytotoxicity of patients' lymphocytes in in-
dependent experiments, and 
b} lymphocytes isolated from blood taken at time intervals of 
individual donors on a pool of target cells with known sus-
ceptibility to lysis and antigenie content, which then 
bath could be used in different experiments. 
The use of a standard base-line and aliquots of one pool 
of target cells would also allow one to compute the assay va-
riation and the variatien in the cytotoxic capacity of the 
various subpopulations of lymphoid cells. 
The successful cryopreservation of a number of functio-
nal properties of lymphocytes such as mitogenic stimulation, 
for histo-compatibility testing and the preservation of a num-
ber of cell surface markers (Weiner et al., 1973; Eysvooge1 
et al., 1973; Streng et al., 1975; Birkeland, 1975} provided 
the basis for testing the effect of cryopreservation on the 
cytolytic capacity of lymphocytes. We have asked ourselves 
the following questions: 
1. Is there an effect of the freezing procedure on the cyto-
toxic capacity of lymphocytes and on target cell lysibili-
ey? 
2. Is there an effect of serial subculturing of the target 
cel1s on the lysibility of these cells by lymphocytes? 
3. Does a maximally standardized MCT i.e., using cryopreser-
ved effector and target cells, yield reproducible results 
when several microcytotoxicity experiments are performed 
with time intervals. 
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B. Materials and rnethods 
1. The. m-i..c.Jtoey.t.a.:toUci..:t!J .:tu.:t 
The lymphocyte preparations were tested for their cyto-
toxic capacity in the MCT as described befare (chapter II). 
Target cells were plated 3 hours befare addition of the ef-
fector cells since pilot studies had shown that this procedure 
considerably reduced the variatien in plating efficiency. 
2. Tu:tótg o6 .:the -Ln6fue.n.ce. o6 -the. C!L!JOpJtUeJt.va...ü.on p!toce.dwte on .the. c.y.:to-
f.ytic. e.66e.ct o6 f.ymphoc.y-tu a..nd on -the. f.y.ó-Lbili..ty o6 .ta!r.ge;t c.ei..t6 a..nd. 
zhe eóó<à oó óe!Uo.t p<Wóage oó UV!.gà ceeL~ on ZhWr. lqûb.i.Utq. 
The Experimental design is shown in table I. 
Target cells: T24, a bladder cancer cell line (see chapter II) 
and Colon-1, were used as target cells. Culturing and harvest-
ing of the cells was performed as described in chapter II 
(Materials and methods). Cryopreserved target cells were cul-
tured for 1 week befare they were used as targets in the MCT. 
Lymphoc.y.:te ~of.atlon 
Lymphocytes from peripheral blood, anticoagulated with EDTA, 
(Merck, Darmstadt, Germany) were obtained by gradient eentri-
fugatien using the Isopaque-Ficoll technique (Böyum, 1968). 
Blood was diluted 1 : 1 with Hanks' Balanced Salt Salution 
(BSS), layered over the gradient and centrifuged for 13 min 
at 1400 g. Cells at the interface were aspirated and washed 
twice with RPMI-1640 medium supplemented with 5 % foetal calf 
serum. 
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Table I 
EXPERIMENTAL DESIGN 
f'"''"'"'"'''''"'"""'"""''''"''"'""""'"'''''"'""'''''"'"'"'""i target cel Is ( T 24 and colon- 1) 
Ë fresh r, 
Ê 
! 
I 
fresh 
lymphocyle< 
frezen/ slored :::=====-----J lymphocytes 
exp,l 
................................................................... 
frezen/ slored -~--
lymphocytes ----
frezen/ slored 
lymphocyles -----
frezen/ slored - -
Jymphocytes 
frezen/ stared - __ _ 
lymphocyle< 
frezen / stared 
target eells 
A 
I 
J 
exp,2 
Frezen / slored 
torgel cello 
t 
I 
I 
I 
I 
exp.3 
frezen / slored 
torgel ce lls 
i 
I 
I 
I 
I 
I 
I 
I 
I 
I 
--' 
Hp,4 
frezen / slo..ed 
target cel Is 
i 
I 
I 
I 
I 
_ __ _j 
exp.5 
3. P4og~med 6heez~ng oQ !ymphoeyt~ 
Cells were suspended in RPMI-1640 medium supplemented 
with 20 % foetal calf serum and 10 % dimethylsulfoxide (mlSO) 
in freezing tubes (2 ml ampoules Greiner 238 S). The DMSO was 
added within 1S min befare treezing of the cells. The lympho-
cyte samples were frozen at present cooling rates by use of a 
Cryson BV-4 liquid nitrogen controlled freezer. The cell sus-
pensions were caoled at a rate of -1° C/min to -20° C and 
then rapidly caoled to -120° c by rapid addition of liquid 
nitrogen (freezing rate 6° C/min). Vials were then trans-
ferred to a liquid nitrogen starage tank where they were kept 
in the vapour phase until use. Cell suspensions were thawed 
by rapidly transferring individual tubes from the liquid ni-
trogen tank into a stream of warm water (approximately 40° C) 
and agitating the tubes until no ice was present. Subsequent-
ly, RPMI-1640 with 20 % feetal calf serum was added stepwise 
up to 10-fold dilution of the frezen suspension and the cells 
were washed twice with the medium with 10 % feetal calf se-
rum. 
4. MecLinm 
Parker 199 medium supplemented with 10 % feetal calf se-
rum was used. For this study one large batch of medium was 
prepared, aliquoted and used tbraughout the experiments so 
that variations in the results could not be ascribed to varia-
tions in the reagents. 
The experiments described in this chapter were designed 
in a factorial fashion. The data were treated pertaining to 
as for a completely randomized block design, although with 
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the effector/target cell ratio variable a split level was in-
troduced. This may have led to an underestimate of the effec-
tor/target cell ratio effect because the residual error vari-
ance, used as the denomin~tor for the calculation of the 
Fischer F-value, is characteristically larger than the error 
variance, associated with the within donor effect. 
C. Results 
1. E66e.W o6 fiJte.e.zi.ng a.n.d :thaw/..n.g on :the.. IU...Wn.g c.a.pa.c{;ty ofi e..fi6e..c.:t0Jl. 
.tymphoc.y:tu and 011. :the.. I.JUóc.e.p:UbJ...U.tq ÓO!!. .ty.ö-W on :the. :ta.Jtge.:t ceV:-6 
The analysis of varianee of the data presented in II and 
III are given in Table IV. 
The fresh and cryopreserved lymphocytes were tested in 
fresh and cryopreserved target cells in a reciprocally way 
(Materials and methods, table I). The data of the MCT are 
given in tables II and III and the analysis of varianee of 
these data are presented in table IV. 
a) the lymphocytes of the various individual donors tested in 
this experiment display a significantly different lytic ef-
fect against the target cells, confirming the data discussed 
in chapter II. The donor effect interacts significantly with 
the ether variables studied, viz. D x R; D x L; D x T and 
D x Q interaeticus (table IV) and hence the factors are sta-
tistically nat independent. 
b) The effector/target cell ratio, being significant pelt .óe.., 
yields a significant interaction with the type of target 
cell (R x Q; table IV) besides the D x R interaction mentierr-
ed earlier. 
cl The mean lytic capacity of fresh lymphocytes is signifi-
cantly larger than that of cryopreserved lymphocytes. Inter-
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TABLE II 
INFLUENCE OF THE CRYOPRESERVATION OF LYMPHOCYTES AND TARGET CELLS 
ON THE CYTOTOXIC CAPACITY OF LYMPHOCYTES AND THE LYSIBILITY OF 
TARGET CELLS 
per cent reduction of T24 target cells 
. 
effector/ fresh frezen 
donor target cell _____.i._________" lymphocyt~ 
number ratio fresh frezen fresh frezen 
250 200 53 23 73 39 
100 29 1B 50 39 
251 200 10 -17 2 0 
100 19 B 21 - 3 
253 200 4 10 -15 B 
100 3 6 4 0 
259 200 0 -16 11 -13 
100 0 - 3 20 9 
260 200 6 - 9 4 0 
100 0 5 -19 - 3 
261 200 9 - 2 
100 2 - 9 10 -11 
• passage number of T24: BB. 
estingly no interaction of the cryopreservation of lymphocy-
tes with that of the target cells were observed, indicating 
that these effects represent two independent variables (L x T 
interaction; table IV) . 
d) The susceptibility to lysis of the two target cells in-
creases as a result of cryopreservation (T effect). 
e} The most significant variable in this experiment appeared 
to be the type of cell used as a target in the MCT. Therefore, 
the reproducibility of the MCT was separately analysed for 
each cell line (see below) . 
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Table III 
INFLUENCE OF THE CRYOPRESERVATION OF LYMPHOCYTES AND TARGET CELLS 
ON THE CYTOTOXIC CAPACITY OF LYMPHOCYTES AND LYSIBILITY OF 
TARGET CELLS 
per cent reduction of Colon-1 target cells 
effector/ fresh frezen ---~ ~---
donor target cell lymphocytes 
number ratio fresh frezen fresh frezen 
250 200 33 25 60 28 
100 20 15 46 21 
251 200 47 15 79 47 
100 38 19 75 47 
258 200 43 72 61 79 
100 39 51 33 40 
259 200 10 39 40 53 
100 19 34 31 44 
260 200 33 22 61 47 
100 21 8 41 26 
261 200 - 4 29 34 39 
100 7 29 12 21 
• passage number of Colon-1: 19 
. 
It was of interest to investigate whether the suscepti-
bility to lysis of target cells varied with subculturing of 
these target cells. Therefore, aliquots of cryopreserved lym-
phocytes from individual donors were tested on serially pas-
saged target cells in order to minimize variations in the as-
say due to variations at the level of the effector cells. The 
results are presented in tables V and VI, and they show that 
the per cent cytotoxicity fluctuates considerably. The analy-
sis of varianee reveals a significant effect of passage num-
ber. The effect of passage number of the target cells proba-
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TABLE IV 
ANALYSIS OF VARIANCE OF THE INFLUENCE OF THE CRYOPRESERVATION OF LYMPHO-
CYTES AND TARGET CELLS ON TBE CYTOTOXIC CAPACITY OF LYMPHOCYTES AND 
LYSIBILITY OF TARGET CELLS 
Effect Degrees of Sum of squares Varianee F-value 
freedom estimate 
D 5 61732.3 12346.5 30.54** 
R 5073.8 id. 12.55 ** 
L 6780.6 id. 16.77** 
T 15859.5 id. 39.24 ** 
Q 170885.3 id. 422. 76'** 
D x R 5 10287.7 2057.5 5.09** 
D x L 5 23521.5 4704.3 11.64 ** 
D x Q 5 83130.5 16626. 1 41.13 ** 
D x T 5 15640.7 3128.1 7. 74 ** 
R x L 140.1 id. 0.35 
R x T 1150.5 id. 2.85 
R x Q 6176.7 id. 15.28** 
L x T 75.0 id. 0.19 
L x Q 1604.3 id. 3.97* 
T x Q 6521.7 id. 16.13** 
Error 672 271632.0 404.2 
*: denotes a probability between 1 and 5 % that the H0 is valid 
**: probability of less than 1 %. 
D: donor effect 
R: effector/target cell ratio effect 
L: fresh or cryopreservation effect of lymphocytes 
T: fresh or cryopreservation effect of target cells 
Q: target cell type effect 
bly account for the significant interaction with the effector/ 
target cell ratio (R x P interaction; table VI). However, an 
alternative explanation cannot be excluded i.e., that the 
fluctuations are the result of the lack of reproducibility of 
the MCT. 
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Table V 
EFFECT OF SERlAL PASSAGE IN VITRO OF TARGET CELLS ON THE LYSIBILITY OF 
THE TARGET CELLS 
per cent reduction of fresh T24 target cells 
donor effector/ 
number target cell passage number 
ratio'* 88 89 90 91 92 
250 200 23 3 - 7 13 
100 18 15 -21 2 
251 200 -17 5 
100 8 17 - 1 
258 200 10 8 -29 -19 - 1 
100 6 21 -20 -12 2 
259 200 -16 - 7 5 -10 2 
100 - 3 - 3 5 -15 0 
260 200 - 9 3 -22 -12 9 
100 5 - 6 - 5 12 7 
261 200 - 2 -15 -13 -27 18 
100 - 9 -10 - 8 6 
*frezen stared lymphocytes 
ANALYSIS OF VARIANCE ** 
Effect negrees of Sum of squares Varianee F-value 
freedom estimate 
D 3 1106 368.7 0.90 
R 1 3852.8 3852.8 9.40*** 
E 3 8150.1 2716.7 6.63*** 
D x R 3 771.3 257.1 0.63 
D x E 9 19805.1 2200.6 5.63"'** 
R x E 1117.4 372.5 0.91 
D x R xE 9 27077.4 3008.6 7.34*** 
Error 224 91812.9 409.8 
** Only the complete data from donors 258 through 261 were used. 
D: donor effect 
R: ratio effect 
E: experiment effect 
***: probability of less than 1% 
Table VI 
EFFECT OF SERIAL PASSAGE IN VITRO OF TARGET CELLS ON THE LYSIBILITY OF 
THE TARGET CELLS 
effector"/ per cent reduction of Colon-1 target cells 
donor target cell passage number 
number ratio 18 19 
250 200 - 5 25 
100 37 15 
251 200 -67 15 
!DO -58 19 
258 200 32 72 
100 31 51 
259 200 22 39 
100 12 34 
260 200 12 22 
100 12 8 
261 200 33 29 
!00 13 29 
frezen-stared lymphocytes 
Effect Degrees of 
freedom 
D 3 
R 
•• ANALYSIS OF VARIANCE 
Surn of squares 
10207.4 
3227.7 
20 
14 
- 6 
9 
16 
7 
48 
15 
35 
34 
44 
16 
21 
Varianee 
estimate 
3402.5 
3227.7 
21 22 
25 
15 
17 
6 
0 58 
6 33 
-73 38 
26 26 
6 28 
- 9 39 
1 33 
25 26 
F-value 
1.88 
1. 79 
p 3 59256.1 19752.0 10.93*** 
D x R 3 8270.8 2756.9 
D x p 9 26253.5 2917.1 
R x p 3 19772.5 6590.8 
D x R x p 9 28267.5 3140.8 
Error 224 406565.5 1807.0 
** Only the complete data from donors 258 through 261 were used. 
D donor effect 
R ratio effect 
P passage effect 
1.53 
1.61 
3.64" 
1. 74 
* denotes a probability between 1 and 5 % that the H0 is valid ~: prob~ility of less than 1 %. 
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3. Ano.l..yl>ÁÁ o ü :the. JLe.p!Wduc,Lb,Lü.;ty o 6 :the. miCJLoc.y:to:to Uc-U:y :tu:t 
For this purpose two types of experiments were perform-
ed. a) Aliquots of frozen-stored target cells from different 
passage numbers were tested in a single experiment (table 
VII) . b) Target cells with the same passage number were tested 
at weekly time intervals using aliquots of frozen-stored lym-
phocytes of individual donors as effector cells in order to e-
liminate the variables at the level of the effector cells. The 
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Table VII 
INFLUENCE OF PASSAGE NUMBER OF THE TARGET CELL ON THE LYSIBILITY OF 
THE TARGET CELLS AND THE REPRODUCIBILITY OF THE MCT 
per cent reduction of T24 target cells 
Experiment number 
donor effector*; 2 3 4 5 
number target cell passage number 
ratio 61 S4 ss ss ss ss ss 
250 200 -26 7 -11 39 -1S -13 
100 -30 0 - s 39 - 2 -16 
251 200 -35 -17 -52 -17 
100 -26 s -23 - 9 
25S 200 16 10 - 6 s 0 -23 -10 
100 15 2 0 - 2 -17 
- s 
259 200 -21 - 6 2 -13 -41 -16 -1S 
100 -2S -14 0 9 -12 -12 - 4 
260 200 -14 -24 1 0 -40 - 5 9 
100 -27 - 6 9 - 3 2 5 9 
261 200 2 - 9 - s 13 -30 -15 
100 - 6 - 1 2 -11 - 1 - 3 7 
* frozen-stored lymphocytes 
analysis of varianee is presented in table VIII A 
analysis of varianee is presented in table VIII 8 
data for T24 and Colon-1 cells are presented in tables VII and 
IX, respectively, and the analysis of varianee of the data 
given in tables VII and IX are presented in tables VIII A, B 
and IX, respectively. 1v1oreover, the donor and ratio effects 
described earlier were again significant (D, R effects; table 
VIII A) . It should be rnentioned that the significanee of the 
second order interaction complicates the interpretation. 
Unfortunately, it must be concluded that there are a num-
ber of intrinsic variables of the MCT that cannot be control-
led, resulting in large fluctuations ranging from reduction 
to enhancernent of target cell growth and hence influencing 
the level of cytotoxicity, although always the sarne combina-
tions of frozen-stored effector and target cells were tested. 
Table VIII A shows also that the susceptibility of the T-24 
target cells with different passage numbers, when tested in a 
single experiment, does fluctuate significantly (P effect}. 
This can also be seen from the data presented in table VI, 
and hence indicates that the fluctuations in the lysibility 
of target cells with different passage numbers tested in dif-
ferent experiments indeed is likely to be due to the subcul-
turing of these target cells and can also be ascribed to the 
lack of reproducibili ty of the NCT because 1 when target cells 
of the same passage are tested in different experiments, sig-
nificant fluctuations are observed (see above). Aliquots of 
target cells of the same passage were tested at weekly inter-
vals to monitor the reproducibility of the MCT. From the ana-
lysis of varianee (table VIII B) it may be concluded that the 
NCT is nat reproducible since the effect of cytotoxicity test-
ing from week to week is significant (E effect} . 
D. Conclusions 
The aim of this study was a systematic analysis of the 
effect of cryopreservation on human lymphocytes and target 
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Table VIII A 
ANALYSIS OF VARLANCE**OF THE INFLUENCE OF PASSAGE NUMBER OF 
OF THE TARGET CELL ON THE LYSIBILITY OF THE TARGET CELL 
Effect Degrees of Sum of squares Varianee F-value 
freedom estimate 
D 3 3575.6 1191.8 4.19xx 
R 2737.9 7300.3 25.66xx 
p 2 2047.5 1023.7 3.60x 
D x R 3 2146.9 715.6 2.52 
D x p 6 14530.5 2421.7 8.51xx 
R x p 2 627.5 313.8 1.10 
D x R x p 6 4455.4 742.6 2.61x 
Error 169 48071.5 284.4 
Table VIII B 
** ANALYSIS OF VARIANCE OF THE INFLUENCE OF REPEATED TESTING OF THE SAME 
PASSAGE NUMBER OF THE TARGET CELL ON THE REPRODUCIBILITY OF THE MCT 
Effect Degrees of Sum of squares Varianee F-value 
freedom estimate 
D 3 3128.3 1042.8 1 :94 
R 8590.5 8590.5 16.00 *** 
E 4 14093.3 3523.3 6.56*** 
D x R 3 915.9 305.3 0.57 
D x E 12 8478.2 706.5 1.32 
R x E 4 5866.9 1466.7 2. 73 * 
D x R x E 12 7264.6 605.4 1.12 
Error 280 150339.3 536.9 
** Only the data from donors 258 through 261 were used. 
D donor effect 
R : ratio effect 
E : experiment effect 
:denotes a probability between 1 and 5 % that the HO is valid 
~: probability of less than 1 %. 
Table IX 
REPRODUCIBILITY OF THE MCT 
per cent reduction of Colon-1 target cells 
effector* I experiment number 
donor target cell 2 
number ratio passage number 
19 19 19 
250 200 28 31 9 
100 21 28 9 
251 200 46 35 28 
100 47 30 44 
258 200 79 10 32 
100 40 33 16 
259 200 53 - 3 8 
100 44 16 30 
260 200 47 31 4 
100 26 24 18 
261 200 39 14 10 
100 21 11 27 
* frozen-stored lymphocytes 
-ANALYSIS OF VARIANCE 
Effect Degrees of Sum of squares Varianee 
freedom estimate 
D 3 1719.0 573.0 
R 1 125.2 125.2 
E 3 34577.3 11525.8 
D x R 3 1454.5 484.8 
D x E 9 21302.3 2J66.9 
Rx E 3 7931.1 2643.7 
D x R x E 9 8539.9 948.9 
Error 224 331629.7 1480.5 
** Only the data from donors 250 through 261 were used. 
D donor effect 
R ratio effect 
E experiment effect 
***: probability of less than 1 %. 
4 
19 
- 7 
- 7 
20 
13 
15 
31 
23 
13 
F-value 
0.39 
0.08 
7.79*** 
0.33 
1.60 
1. 79 
0.64 
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cells and the reproducibility of the MCT. Under the optimal-
ly standardized conditions i.e., using cryopreserved effect-
or and target cells, the level of cytotoxicity observed might 
nat be influenced by day to day variations (see later) . Sev-
eral authors have reported that cryopreserved lymphocytes and 
target cells gave similar results in a long term cytotoxicity 
assay as compared to fresh cells. This was demonstrated in a 
rat model system (Ortaldo et al., 1976) and in a human model 
system (Jeejeebhoy and Lawler, 1976). In the rat system, how-
ever, the target cell tumour associated antigens are well de-
fined and hence the specificity of the reactions are well de-
fined likewise. In the human system, mentioned above, the 
fresh and cryopreserved lymphocytes and target cells were 
never tested simultaneously and only a limited number of ex-
periments was performed. This study indicates that cryopre-
served lymphocytes are less cytotoxic than fresh lymphocytes, 
extending and confirming previous observations by others 
(Pavie-Fischer et al., 1975). 
Cryopreserved target cells are more susceptible to lysis 
than fresh target cells, although the cryopreserved cells 
after thawing were cultured for 1 week befare they were used 
as target cells in the MCT, viz. an irreversible damage of 
the target cells is nat a plausible explanation since these 
cells would have died off befare testing. The factor dis-
playing the most significant effect is the type of tumour 
cell used as the target, i.e., a large difference in target 
cell lysibility is noted (table IV; Q effect). The same is 
true for the passage numbers of a particular target cells 
i.e., the susceptibility to lysis of target cells fluctuates 
with subculturing. 
When the cytotoxic effects of different donors are com-
pared by testing thern in a single experiment a significant 
donor effect is observed (table IV and VIII A). Such a donor 
effect, however, is lost when the donors are repeatedly test-
ed in independent experiments {table VIII B and IX) . This 
confirms our previous conclusion, already mentioned in chap-
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ter II, that lymphocytes of normal donors do nat provide a 
proper base-line for the calculation of the cytotoxic capa-
city of cancer patients lymphocytes due to the fact that in a 
single experiment different donors appear to exert signifi-
cantly different cytotoxic effects. 
Furthermore, this observation implicates that in order 
to campare the cytotoxic effects of lymphocyte samples taken 
from one individual at different times or to campare the cy-
totoxic capacity of lymphocyte samples taken from different 
individuals, it is mandatory to test these samples in a 
single experiment since neither cryopreserved lyrnphocytes, 
when tested at different occasions, provide a standard base-
line nor do aliquots of target cells of the same passage 
tested at different occasions show comparable lysibility to 
the lytic effects of the effector cells. 
The most crucial finding is that the MCT cannot be used 
for longitudinal monitoring of cell mediated cytotoxic capa-
city of patients in experirnents perforrned at different times 
(table VIII and IX). Technically, the MCT is complex and 
there are variables such as experimentator errors, cell count-
ing, pipetting, incubator temperature, humidity and co2 con-
centration {Jewett et al., 1976) and these variations are 
not due to biologica! phenomena. One of the major drawbacks in 
the MCT is the long incubation time required, allowing a num-
ber of factors to influence the results, factors that appa-
rently cannot be controlled. The development of an assay that 
measures the cytotoxic effects of lymphocytes in a much short-
er time period, limiting the variances in the test, is requir-
ed. One approach may be the 51cr-release cytotoxicity assay. 
This test allows the monitoring of target cell lysis by lympho-
cytes after 18 h incubation of effector and target cells. 
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CHAPTER IV 
THE IDENTIFICATION OF A NEW SUBPOPULATION OF 
T-LYMPHOCYTES 
A. Introduetion 
In the study aiming at the testing of the efficacy of 
lymphocyte subpopulation isolation procedures in order to 
test the various subpopulations for NK- and K-cell activity, 
one of the cell surface markers i.e., the complement receptor, 
was used for fractienation of lyrnphocytes. Rosettes were made 
by using IgM coated sheep red blood cells (E
5
h) plus comple-
ment. No IgG was used for sensitization of the E
5
h to prevent 
rosette formation by cornplexing of the IgG-Fc receptor (IgG-
FcR) with IgG antibody coated E
8
h. As controls for the roset-
tes formed with the E
8
h-IgM-complement complex in order to 
show that rosettes were formed via the complement receptor on 
the surface .of the lymphocytes: a. Esh' b. Esh coated with IgM, 
and c. Esh plus IgM and inactivated complement were each add-
ed to lymphocytes in separate tubes. The observation was made 
that rosettes were formed in the tubes containing lymphocytes 
and IgM coated Esh. 
Receptars for aggregated IgG and antigen-IgG type anti-
body complexes have been detected on human T-cells (Yoshida 
and Anderson, 1972}. Moretta et al. (1975} recently demon-
strated a new receptor on T-cells which is capable of binding 
antigen-IgM type antibody complexes after culturing the lym-
phocytes. Our studies indicate that na culturing of fresh-
ly drawn peripheral blood lymphocytes is necessary for the 
expression of this receptor. Furthermore, we have studied the 
effect of feetal calf serum concentratien of the incubation 
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medium as well as the effect of controlled freezing and thaw-
ing of lymphocytes on the capacity of lyrnphocytes to form 
rosettes with EA-IgM. 
B. Materials and methods 
1. Lymphoeyte ~o~on and e~e 
Lymphocytes from peripheral blood were obtained by gra-
dient centrifugation using the Isapaque Ficoll technique 
(BÖyum, 1968) as described befare (chapter III, Materials 
and me thods ) . 
Overnight incubation of purified 1ymphacytes: cells were 
stared at 37° C far 18 h at a concentratien of 2 x 10 6 /ml by 
placing the tubes with 2 ml cell suspension in a horizontal 
pasition in a 37° C incubator. 
2. PJtepMa.Û.on ofi an.ü.-E.óh-af'l.tÁ..óeJtWn and the IgM an..Ubody c..o/U:a.-i.vU.ng 
t\Jt.ae.tion 
Rabbits were immunized with stroma of sheep red blood 
cells (E
5
h) to raise an antiserum rich in IgM type antibodies 
as described by Rabat and Mayer (1961). IgH was isolated by 
DEAE chromatography, starting buffer 0.1 M phosphate, pH 7.5. 
The linear gradient was made by admixing· 0.3 M phosphate buf-
fer to the starting buffer. IgM fractions were tested, pool-
ed, concentrated and subjected to Sephadex G-200 gel filtra-
tien. The elution buffer was phosphate buffered saline plus 
0.15 M NaCl, pH 7.5. The IgM containing fractions were col-
lected and tested for complement dependent haemolytic activi-
ty of E
5
h. Fractions not containing IgG as determined by im-
muno-electrophoresis were pooled. Partial cleavage products 
of IgM pentamers were induced by treating the IgM antibody 
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fraction with dithioerythritol (DTE) (final concentration 
0.1 mM) (Chapuis and Koshland, 1974). 
Blood of sheep was mixed 1 : 1 wi th Alsever' s fluid and 
kept at 4° C until use. Esh were wasbed 4 times with phos-
phate buffered saline (PBS) and resuspended at a concentra-
tien of 1 x 10 8 /ml in RPMI-1640. The E
8
h were sensitized with 
a diluted IgM containing antiserum fraction (l step beyond 
the agglutination titre) by incubating the mixture at 37° C 
on a roller bank. The complex formed will be abbreviated as 
EA-IgM. For the rosette formation equal volumes (250 ~1) of 
EA-IgM and purified lymphocytes (2 x 10 6/ml) suspended in 
RPMI-1640 supplemented with 5 % foetal calf serum (unless in-
dicated otherwise) were mixed and spun down for 5 min at 
250 g, resuspended and incubated at 37° C for 5 min to disrupt 
possible E
8
h-cell rosettes. The percentage RFC was deterrnined 
in a haemocytorneter after supravital staining of the lympho-
cytes with brilliant cresyl blue (0.1 per cent in PBS). 
To investigate whether non-complexed IgM-type antiboclies 
could bind to the IgM-receptor on lymphocytes, lymphocyte 
suspensions (2 x 10 6 /ml) were incubated at 37° C with the 
IgM containing fraction of the antiserurn and subsequently 
washed twice with RPMI-1640 supplemented with 2.5 % foetal 
calf serum to remave free IgM. The complex formed -will be 
abbreviated as Ly-IgM. Ly-IgM was then incubated at 37° C or 
4° C with an equal volurne (250 ~l) of a 1 % E
8
hsolution. 
For inhibition studies we used purified IgM isolated 
from sera of patients with macroglobulinaemia. The IgM was a 
gift from Dr. F.W. Putnam (University of Indiana, Bloomington, 
Indiana, U.S.A.), who also isolated Fe fragments from IgM. 
These preparations were made available to us by Dr. F. Gmelig-
Meyling {University Hospita!, University of Utrecht, The 
Netherlands). A 0.5 ml volume of purified lymphocytes 
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(l x 106 /ml) were incubated for 2 h at 0° C (on melting ice) 
with 0.125 mg of the inhibitor followed by incubation with EA-
IgM and the percentage of rosettes formed was counted. 
4. Lymphocy:te. mM.kVL :tv.:.:tö 
Th.e. .&-imu.U.a.ne.oM E and EA-1gM Jto.&e;tte. 6oM1a..ti.on 
In order to study the nature of the cell binding the EA-
IgM complex double marker experiments were performed. Thus, 
since binding of E
5
h to lymphocytes is an accepted T-cell 
marker the ability of lymphocytes to form double rosettes 
was examined (Wybran et al., 1972). 
E
5
h-rosettes and mixed E
5
h-E11.-IgM rosettes were formed by 
incubating the lymphocytes at 22° C for 20 min with a mixture 
of E
5
h and IgM sensitized fluorescein isothiocyanate-labelled 
Esh (Möller, 1974) abbreviated as EAFITC_IgM. Uncoated E
5
h 
and/or E
5
h treated with normal rabbit serum were used as con-
trols throughout this study. The double rosette were counted 
using a Litz-Dialux microscope. 
The technique used has been described previously (Knapp 
et al., 1973}. Anti-T-cell antiserum was prepared from a 
horse anti-human-thymocyte IgG fraction (Upjohn Comp., Kala-
mazoo, Michigan, u.s.A.) and made specific for human T-cells 
by exhaustive absorption with insolubilized normal human se-
rum, ABO erythrocytes, B-cells from chronic lymphatic leu-
kaemia cells and cells of the myeloid lines. It was prepared 
and supplied to us by Dr. Gré Asma from the Institute for 
Experimental Gerontology TNO, Rijswijk, The Netherlands 
(Asma et al., l977a, b}. 
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C. Results 
1. EA-IgM JtMefte!.J: &Jte.qu.e.nc..y, pJtope.JI.tie!.J and :the. e.fióe.ct6 ot) di...66e.Jte.nt 
:type!.l ofi t.Jt.e.atme.n:t ot) lymphoc..!f:te!.l on :the. peJLc..e.n:ta.ge. ofi EA- IgM-RFC 
As can beseen in fig. 1, a considerable nurnber of blood 
lymphocytes are capable of rosette formation with EA-IgM anti-
body complexes. However, a wide range of reactivities is ob-
served. This confirms the finding of Gmelig-Meyling et al. 
(1976). 
Table 
ments where 
1 shows the results of two representative experi-
the effect of pre-incubatien of lymphocytes for 
60 
50 
~ 40 ; 
~ 30 
~ 
i 20 
10 
0 
fresh frozen-slored lympho.:ytes 
lympho.:yles lymphocytes ~~nh.:"a~"j~&c 
& 
.. 
! 
.. 
.:. 
.:. 
= ~ !!Ïi -;:;-
... 
i" 
SD"' 9.8 so "'8.6 so "' 16.8 
n"' 35 n "' 34 n" 35 
-- = me on pereenloge of rosettes 
Eoeh dot repre•ents one ·tndiv·oduol donor 
EA-IgM-RFC"' rosette forming cells with complex 
of sheep red blood eefls ond lgM 
antiserum froction 
Figure 1: Percentage of EA-IgM-RFC of purified 
peripheral blood lymphocytes. 
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18 h at 37° C and progra~med treezing and thawing of lympho-
cytes on their rosette forming capacity of fresh lymphocytes 
with EA-Ig!'>1 complexes was studied. Although a decrease or in-
crease in the percentage EA-IgM-RFC after incubation of the 
lymphocytes for 18 h at 37° C (donors 2 1 5 and 7, respective-
ly) and programmed freezing and thawing (donor 1) is seen, 
the mean percentages of EA-IgH-RFC are approximately the same, 
regardless of the type of pretreatment (table 1, fig. 1). It 
was found, howevèr, that pronounced fluctuations in the per-
centage of rosettes are observed more frequently after 18 h 
preincubation of lymphocytes at 37° C prior to EA-IgM rosette 
formation in camparisen with fresh lymphocytes than after 
freezing and thawing of lymphocytes; e.g. after freezing/ 
thawing, the percentage of EA-IgM-RFC was always equal to 
that of fresh lymphocytes or slightly lower, whereas the per-
centage of EA-IgM-RFC of lymphocytes after pre-incubatien at 
37° C was mostly either increased or decreased in camparisen 
to fresh lymphocytes. As can be seen in table I, there is a 
consistent drop (50 % or more) in the percentage of EA-IgM-
RFC after 18 h of incubation of programmed frozen-thawed lym-
phocytes at 37° c. We have no explanation for the latter 
phenomenon at present. 
It should be emphasized that prolonged incubation of lym-
phocytes at either 4 or 37° c should be done by placing the 
tube containing the lymphocyte suspension in a horizontal 
position (Zeylemaker, personal communication). This results 
in a 100 % recovery of over 98 % viable lymphocytes (data not 
shown) . Investigation of the effect of different temperatures 
of incubation and incubation times of lymphocytes with EA-IgM 
complexes in order to determine the optima! conditions for 
rosette formation (i.e., 22, 37° C and different incubation 
times: 0 - 30 min) showed that the procedure described in 
Materials and methods (this chapter) yielded stable rosettes 
and reproducible data. No significant difference was found 
if rosette formation was induced by centrifuging the incuba-
tion mixture, supplemented with either 2.5 % or 20 % feetal 
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Table I 
PERCENTAGE OF EA-lgM"-RFC**OF LYMPHOCYTES WITHAND WITHOUT DIFFERENT TYPES OF TREATMENT 
Percentage of EA-lg M:R FC ** 
Experiment I Experiment 2 
donor number 1 2 3 4 5 6 7 
- - - - - - -
Fresh lymphocytes 24 40 27 18 20 37 23 
frozen/thawed 12 46 29 16 22 39 20 
lymphocytes 
lymphocytes pre- 14 18 23 17 35 29 35 
incubated at 37°C, 
18 h 
frozen/thawed NT NT NT NT 6 l3 9 
lymphacyte~:l incu-
batedat 37 C, 18 h 
* EA-IgM =complex of sheep red blood ce!ls with lgM containing antiserum froction 
** RFC = rosette forming ce!ls 
NT = not tested 
8 9 
- -
41 21 
38 18 
25 NT 
14 0 
calf serum, at 250 g followed by resuspension and incubation 
at 37° c for 5 min and incubation of the pellet (20 % foetal 
calf serum) at 22° C for 20 min prior to resuspension and in-
cubation at 37° c for 5 min (table II} . The latter procedure 
was necessary when double marker experiments were performed 
FITC for the simultaneous detection of EA -IgM-RFC and E
8
h-RFC 
(rosettes of T-cells with E
5
h} to facilitate E
8
h-rosette 
formation. 
2. Tempe/f..a.t:Wte dependenee o6 EA-IgM-Jt0.6eti:U 
Prolonged incubation of EA-IgM-rosettes at 3.7° c re sul ts 
in a decrease in the percentage of rosettes. After incubation 
of the rosettes at 37° C for 18 h virtually no rosettes are 
observed (table III}. In order to investigate whether the 
rosette-forming cell !oases its capacity to farm EA-IgM roset-
tes, we repeated the rosetting procedure after incubation of 
the rosettes for 18 h at 37° C. As can be seen (table III, 
donors c, D, E and F), the cells are no langer capable of 
forming rosettes with the EA-IgM. In pilot studies, the ratio 
of Esh to lymphocytes (50 : 1) used in this test was found to 
be optima!. Thus a proportion of the EA-IgM might no langer 
be available for combining with the IgM receptars on the sur-
face of the lymphocytes because the antibody of the EA-IgM 
has formed a complex with the IgM receptor after dissociation 
of the (EA-IgM)-lymphocyte comp1exes ar because IgM receptars 
shed from the surface of the lymphocytes are bound to EA-IgM. 
Addition of fresh EA-Ig.M to the rosettes incubated at 37° C 
for 18 h, however, does nat result in rosette formation. 
Therefore, saturation of the IgH on the Esh by IgM-receptors 
of lymphocytes seems nat a likely explanation for the lack of 
rosette-formation. When frozen-stored lymphocytes from the 
same donor were added to the overnight incubated rosettes, 
rosettes were formed. This indicates that indeed there were 
still EA-IgM complexes present after incubation for 18 h at 
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Table II 
THE INFLUENCE OF SERUM CONCENTRATION AND TYPE OF INCUBATION FOR ROSETTE FORMAT ION· 
ON THE PERCENTAGE OF EA-IgM•-RFC*" 
Exp. 
oo. 
3 
donor 
number 
5 
12 
13 
26 
27 
28 
5 min, 250 g; resuspend 
2.5% foetol colf •erum 
39 
41 
45 
" 
34 
75 
62 
52 
Percentage of EA-IgM-RFC 
Rosetting procedure 
5 min, 250 g; incubated 
20 min, 22° C; resuspend 
2.5% foetol calf serum 
36 
" 
45 
28 
" 
78 
75 
57 
EA-IgM "'complex af •heep red blood cells with lgM contoining onti•erum fraction 
RFC "'roselte forming cell• 
5 min, 250 g; reouspend 
20% foetol calf serum 
38 
42 
42 
27 
40 
76 
65 
53 
"' 
"' 
Table III 
TEMPERATURf SENSIT!VITY OF EA-IgM• ROSETTES AT 37° C 
Percentage of EA-IgM-RFC** at different timesofter incubotion of !he resetles al 37° C 
donor 
number 
A 
c 
D 
0 min 
39 
57 
30 
17 
35 
20 
10 min 20 min 
30 26 
33 24 
23 
35 min 2 hour 18 hour 
--
21 16 11 
19 5 
24 17 1 
0 
3 
1 
EA-IgM =complex of sheep red blood cel Is with lgM conloining antiserum froction 
RFC = rose_tte forming cells 
*** re-rosetling = repeet of the EA-IgM rosette procedure (see Moterioh ond methods) 
18 h, oeidition 
of "fresh" EA~ 
1 f! hour 
re-rosetting*** 
lgM, re-rosetling 
----
1 2 
0 3 
0 0 
0 0 
18 h, oeidition of 
same number frezen 
lymphocytes of some 
donor, re-roselting 
--
16 
9 
17 
10 
37° C capable of combining with the IgM receptor on lymphocy-
tes and hence IgM receptars were no langer present on the 
surface of the lymphocytes forming rosettes and incubated for 
18 h at 37° C. If one corrects for the fact that twice as ma-
ny lymphocytes are present after addition of frozen lymphocy-
tes of which 50 % do not farm rosettes (table III, donors C, 
D, E and F), the corrected percentages of EA-IgM-RFC after 
addition of frozen-stored lymphocytes are the same as befare 
incubation. This could be expected on the basis of data pres-
ented in ta~le I which show that programmed freezing of lym-
phocytes does nat significantly alter the percentage of cells 
capable of forming EA-IgM rosettes. 
3. Intu.b.-i.U.on ofi EA-IgM JtoJ.>e.:tte ijoJtma.U.on 
To show that indeed the IgM coat of Esh was responsible 
for the rosette formation, we stuclied the inhibition of roset-
te formation by adding human IgM and its Fc-fragments and rab-
bit IgG as described in Materials and methods (this chapter). 
The data shown in table IV indicate that the rosette form-
ation can be inhibited only by IgM or its Fc-fragments. The 
latter observation indicates that the binding of the receptor 
to IgH needs only the presence of the Fe part of the IgM mole-
cule. 
We therefore investigated whether the IgM antibody of the 
IgH antiserum fraction could bind to the IgM receptor of lym-
phocytes, by pre-incubatien of lymphocytes with the antiserum 
and subsequent washing of the incubated lymphocytes to remove 
excess of free IgM, since free IgG antiboclies do not bind to 
the IgG-FcR ln vi.XJI..o (data not shown). The complex to be form-
ed is designated as Ly-IgM. The results are shown in table V 
and demonstrate that no prior antigen-antibody complex form-
ation is required for binding of IgM type antiboclies to the 
IgM receptor on the lymphocytes. When this experiment was 
carried out at 37° C the percentage KFC for the lymphocytes 
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Table IV 
ROSETTE FORMATION OF LYMPHOCYTES WITH EA-IgM* AND Ly-lgM** WITH Esh 
Percentage EA-IgM-RFC *** 
donor• EA-IgM + Ly-lgM E - RFC **** 
•h 
KE 
RB 
PO 
LD 
EG 
lymphocytes + Esh 
27 18 0 
18 9 0 
17 12 0 
13 11 0 
16 19***** 0 
EA-IgM "'complex of sheep red blood celh with lgM containing 
antiserum froction 
lgM "'complex of lymphocytes wîth lgM containing antiserum 
fractîon 
RFC "'rosette forming cel Is 
Esh- RFC "'cel Is forming rosettes wîth sheep red blood cel Is 
Ly-lgM + E
5
h were încuboted at 4° C 
from donors KE and RB that results from mixing EA-IgM and lym-
phocytes is much higher compared to that after mixing Ly-IgM 
and E 5 h. 
However, as mentioned earlier, EA-IgM-RFC dissociate 
slowly at 37° C (table III). The same seems to be true for 
the Ly-IgM complex. The incubation of Ly-IgM with E
5
h was 
performed at 4° c for 30 min, since the rosettes were found 
to be stable at that temperature for a prolonged time (data 
not shown) . Indeed, the percentage of EA-IgM + lymphocytes 
are similar to that of Ly-IgM + E
5
h (table V, donors PD, LD, 
EG). 
To determine which subpopulation of lymphocytes formed 
the EA-IgM rosette, we carried out double marker experiments 
by incubating lymphocytes with a mixture of fluorescein iso-
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Table V 
INHIB!TION OF EA-IgM* ROSETTE FORMATION BY lgG, lgM AND lgM-Fc FRAGMENT$ 
Percentage EA-IgM-RFC** 
percentage lnhîbitîan of rosette formation between broekets 
donors 
ER 
Wl 
RE 
KE 
pre-încubatîon 
of lymphocytes 
with medî<Jm 
35 
35 
27 
33 
pre-incubotion 
of lymphocytes 
wlth lgG 
32 ( 6) 
31 (11) 
24 (11) 
30 ( 9) 
pre-înc<Jbotion 
of lymphocytes 
wlth lgM 
6 (77) 
19 (49) 
16 (40) 
11 (70) 
• EA-IgM =complex of sheep red blood cells with lgM 
contalning antiser<Jm froctlon 
* *RFC "'rosette formîng cel Is 
pre-înc<Jbotlon 
of Fc-frogment 
of lgM 
9 {74) 
14 {60) 
16 (60) 
12 (64) 
thiocyanate (FITC)-labelled Esh' sensitized with IgM contain-
ing antiserum and E
5
h. After centrifugation, the mixture was 
incubated for 20 min at 22° C and the medium was supplemented 
with 20 % foetal calf serum in order to facilitate E-rosette 
formation 1 which is used here as a T-cell marker. As shown in 
table II 1 there is no influence of the serum percentage and 
time of incubation used on the percentage of EA-IgM-RFC. Table 
VI shows the results of the mixed rosetting assay and it can 
be concluded from these data that the majority of the EA-IgM-
RFC (87 - 96 %) are T-cells. One objection that can be made 
is that the high percentage of mixed rosettes (E
5
h-rosettes 
and EA-IgM-rosettes) is due to cross-linkage of IgM bound to 
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N Table VI 
SIMULTANEDUS EXPOSURE OF MEMBRA NE RECEPTOR$ FOR lgM AND E~h * BY LYMPHOCYTES 
absolute number of RFC 
donor 
number 
2 
3 
4 
E,h 
{EAFITC_I Mu"+ E ) RFC 
g •h 
90 
45 
SB 
35 
= sheep red blood celh 
RFC = rosette forming celh 
EAFITC -lgM-RFC 
4 
3 
9 
3 
E
5
h-RFC percentage EA-IgM-RFC 
showing E,h binding 
-
I 96 
12 94 
14 87 
27 92 
*** EAF ITC -lgM = complex of fluorescein isothiocyonote-lobelled sheep erythrocyles with lgM 
contoining ontiser•lm froction 
E
8
h-FITC and E
8
h. Indeed, it was occasionally observed that 
the mixed rosettes were not totally disrupted after 5 min in-
cubation at 37° C, a temperature at which the E -rosettes 
sh 
are known to dissociate, whereas the EA-IgM rosettes are still 
stabile (table III). Therefore, we incubated the lymphocytes 
with a tetrarnethylrhodamine (TRITC) conjugated anti-hurnan-T-
cell antiserum. After washing the lymphocytes to remave ex-
cess antiserum, they were mixed with EA-IgM and rosette for-
mation was induced as described. The results shown in table 
VII lead to the same conclusion: the EA-IgM-RFC belang to the 
T-cell population of lymphocytes. 
4. The. de.pende.nc_e. oû EA-IgM Jr..o-6e;tte ûoJuna..tion. on ;the. p11.u.e.nc..e. o6 IgM 
pe.n.ta.me/1..6 
We have mixed the IgM containing fraction of the anti-
serum with a salution of dithioerythritol (DTE) (final con-
centration 0.1 ~~ DTE) to reduce intersubunit disulfides. 
This results in reduction products, leaving approxirnately 60 
% of the IgM in its pentameric structure (Chapuis and Kosh-
land, 1974). E
8
h were subsequently coated with the partially 
DTE cleaved and the noncleaved IgM containing antiserum frac-
tion as described in Materials and methods (this chapter). 
Thus the percentage of EA-IgM-RFC formed with Esh coated with 
partially cleaved IgM (with 60 % of the IgM left in a penta-
meric farm) is expected to be approximately the same as the 
percentage formed with a twofold further dilution of uncleav-
ed Ig1'1 antiserum fraction if: a) the dilution of the antise-
rum is so chosen that the percentage of rosettes formed is 
dependent upon the antiserum dilution; b) the rosette forma-
tion is dependent upon the presence of IgM pentamers. 
Therefore, the dilution of the antiserura for the sensi-
tization of Esh was so chosen that the percentage of EA-IgM-
RFC decreased about 50 % upon a twofold further dilution of 
the antiserum. 
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~ Table VII 
THE IDENTIFICATION OF EA-lgM*-RFC** AST CELLS WITH ANT!-HUMAN-T-CELL ANTISERUM 
Donors 
KRI 
RD 2 
AM 3 
PO 4 
LD 5 
EG 6 
pereenloge membrone positive lym-
phocytes with onti-T cel! antiserum 
+ 
pereenloge T-cells os per cent of 
toto I lymphocyte number 
82 
78 
86 
70 
84 
67 
pereenloge membrone positive 
EA-IgM-RFC and anti- r+ 
cel Is os per cent of toto! 
lymphocyte number 
41 
29 
24 
17 (17)*** 
13 (13) 
16 (21) 
EA-IgM ~complex of sheep red blood cel Is wilh lgM contoining antiserum froction 
RFC = rosette forming cells 
pereenloge EA-IgM-RFC, 
T-as per cent of toto! 
lymphocyte nvmber 
3 
0 
0 
0 
** * percentage of EA-IgM-RFC of I ymphocytes without prior anti -humon T -ce 11 on tiserum incubo ti on 
is indicoted between broekets 
T+ ond EA-IgM-RFC 
os a per cent of toto I 
EA-IgM-RFC number 
94 
100 
92 
100 
100 
From the results (table VIII) it can be concluded that 
the percentage of EA-IgM-RFC indeed decreases 40 % which is 
expected on the basis of the fact that 40 % of the pentamers 
are cleaved. This experiment does nat entirely exclude the 
possibility of EA-IgM rosette formation with Esh coated with 
cleavage products of IgM pentamers, but if such rosettes are 
formed they are not stable under the conditions employed. 
D. Conclusions 
The present studies have shown that receptars for Ig~ 
and antigen-IgM antibody complexes can be detected on human 
T-cells. The possibility of a double recognition reaction be-
tween receptars for Esh and IgM-Fc is an attractive one but 
unlikely, however, since the procedure for EA-IgM rosette 
formation does nat favour the E
5
h-rosette formation (see 
Materials and methods, this chapter). In fact, in the control 
tubes incubated in all tests (mixture of lymphocytes and non-
sensitized E
5
h) we have never found rosettes. This binding 
seems to be mediated by the Fe portion of the IgM antibody 
as indicated by the inhibition studies with IgM and the Fe 
fragments of IgH. Our finding that no prior hl. v.{;t;to incuba-
tion of lymphocytes is necessary for the expression of IgM-Fc 
receptor disagrees with the results obtained by Moretta et 
al. (1975) and McConnell and Hurd (1976) 1 but confirm those 
of Gmelig-Heyling et al. (1976). The difference in results 
may be due to the fact that we wash the purified lymphocytes 
at room temperature, which might permit the release of cyto-
philic Ig.H antibody that blocked the IgM-FcR. The results 
of the controlled freezing/thawing experiments indicate that 
there is no significant change in the percentage of Ea-IgM-
RFC. This is not true for lymphocytes incubated at 37° C for 
18 h, where we have observed either an increase or decrease 
in the percentage of RFC. Furthermore, neither the serum con-
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Table VIII 
DEPENDENCE OF EA-IgM~ ROSETTE FORMATION ON THE PRESENCE OF 
PENTAMERIC lgM TYPE ANTIBODlES 
Exp. 
00. 
,. 
,. 
donor 
nvmber 
" 
25 
26 
27 
28 
36 
37 
38 
39 
40 
EA-IgM-RFC"'* os percent<;!ge of tot<;~llymphocytes nvmber 
stondord roselting pretreetment of lgM-ontiservm 
procedure with DTE**t.nd rosette formation 
in the presence 0.1 mM DTE 3 
17 
22 11 
19 11 
34 14 
40 24 
27 7 
40 23 
32 15 
28 13 
43 32 
EA-IgM =complex of sheep red blood cells with lgM contoining ontiservm froction 
RFC = rosette forming cel Is 
DTE :: dithioerythritol 
lymphocytes have been frozen-stored 
2 Fresh lymphocytes 
3 Pretreotment with DTE of lymphocytes ond E
5
h had no effect on the percent<;! ge EA-IgM-RFC 
centration of the supporting medium nor the procedures des-
cribed for incubation of lymphocytes with EA-IgM are found 
to influence the percentage of rosettes formed. 
However, incubation of the EA-IgM rosettes at 37° C 
leads to dissociation of the rosettes. This is shown to be 
due to loss of the receptars on the surface of the lymphocy-
tes rather than saturation of Fe portions of the IgM on the 
EA-IgM complexes by Fe receptars shed from the surface of 
lymphocytes, as shown by the experiments where rosettes are 
obtained after addition of frozen-stored lymphocytes from the 
same donor to the rosettes incubated at 37° C for 18 h. It is 
shown that the receptars for IgM can be blocked after pre-
incubatien of the lymphocyte with human IgM or its Fe frag-
ments, indicating that binding occurs via the Fe portion of 
the IgM. This is also suggested by the experiments that show 
rosette formation upon incubation of Ly-IgM (IgH fraction of 
anti-E
5
h) with non-sensitized Esh' demonstrating that the 
receptor for IgM on lymphocytes can bind to non-complexed 
IgM. Antigen 
IgM antibody 
binding through passively adsorbed cytophilic 
bas been 
1973) and mice (Lamon 
reported in chickeus 
et al., 1975). 
(Webb and Cooper, 
The formation of a high percentage of "double rosettes" 
by lymphocytes upon incubation of lymphocytes with a mixture 
of E
5
h- and EAFITC_IgM complexes have dernonstrated that the 
IgM-receptor carrying cells belang to the T-cell subset. This 
was further illustrated by the immunofluorescence studies 
which revealed that virtually all cells forming an EA-IgM 
rosette are also membrane positive after incubation with TRITe-
labelled anti-human-T-cell antiserum. Finally, we have demon-
strated that the pentarneric structure of the IgM-molecule 
needs to be preserved for binding of the EA-IgM complex to the 
T-cell IgM receptor. 
The exact role of the IgM receptor and of the IgM cyto-
phylic antiboclies remains to be established. Recently, Larnon 
et al. (1975) described an IgM antibody-dependent cell-nediat-
ed cytotoxicity against cells of Moloney sarcoma virus infect-
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ed mice. They showed that the IgM fraction of antisera could 
induce normal lymphocytes to kill MSV-infected cells by normal 
lymphocytes. In an experimental situation, using rabbit IgM 
sensitized mouse mastocytoma cells, no IgM antibody dependent 
cytotoxicity was observed (Van Oerset al., submitted for 
publication). 
The IgH antibody induced target cell lysis by lymphocy-
tes may play an important role in tumour immunology. In the 
sera from congenitally athymic (nu/nu) mice and from normal 
mice, natura! antibodies with specificity for spontaneous and 
carcinogen-induced tumours have been detected. The antibodies 
are predorninantly of the IgM class (Martin and Martin, 1974; 
1975). This suggests a possible tumour rejection mechanisrn 
which is thymus independent in terros of antitumour-antibody 
production and can induce non-sensitized T-cells to become 
killer cells. Moreover, the natura! killer cell activity ob-
served rnay be IgM and IgG antibody dependent. The verification 
whether such mechanisms are indeed operational during tumour 
development may have important hearing for cancer immunology 
and irnmunotherapy. 
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CHAPTER V 
CHARACTERIZATION OF NATORAL KILLER (NK)-CELLS 
AND KILLER (K)-CELLS IN HUMAN BLOOD: DISCRI-
MINATION BETWEEN NK- AND K-CELL ACTlVITIES 
A. Introduetion 
As we discussed in chapter II, many reports have appeared 
in the literature demonstrating disease-related anti-tumeur 
cytotoxic activity of lymphocytes of tumour patients (Hell-
ström et al., 1971; Bubenik et al., 1970; O'Toole et al., 
1974; Fossati et al., 1972). Documentation of NK cytotoxicity 
of lymphocytes derived from bath normal donors and cancer 
patients against a wide variety of cel! lines seriously 
questioned the validity of determination of cytotoxicity of 
tumour patients' lymphocytes (Takasugi et al., 1973; Oldham 
et al., 1975; Bolhuis, 1977). It is, therefore, evident that 
in the field of tumour immunology characterization of the na-
ture and specificity of the NK-cell is of paramount importan-
ce. Subsequent remaval of these cells may imprave the chance 
of detection of disease-related cellular anti-tumour immune 
reactions in cancer patients. 
Antibody dependent and/Or antibody independent cell-rne-
diated cytotoxicity may operate in cancer patients. The far-
mer effector cells, which are involved in IgG antibody depend-
ent cell-rnediated cytotoxicity against IgG-coated mouse masto-
cytorna cells (K-cell cytotoxicity), bear surface receptars 
for the Fe portion of IgG (IgG-FcR) . Granulocytes and monocy-
tes have al.so been shown to bear these Fe receptars. A number 
of cell types have been deterrnined to exert the "spontaneous" 
cytotoxicity in man, such as IgG-FcR bearing cells (Peter et 
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al., 1975; Kiuchi and Takasugi, 1976), complement receptor 
hearing cells (De Vries et al., 1974) or cells carrying both 
Fe recepters as well as complement recepters (Jondal and 
Pross, 1975}, and activated T-cells (Hersey et al., 1975}. 
Hence, there are indications in the literature that 
1. IgG-FcR are present on both NK-cells cytotoxic against mo-
nolayer target cells (Peter et al., 1975; Hersey et al., 1975) 
ar K-562 cells (West et al., 1976} and K-cells (Peter et al., 
1975; MacLennan, 1972; Perlmann et al., 1972; Dickler, 1974; 
Papeet al., 1977}, 2. that soluble factors ar antibodies 
(Saal et al., 1977; Akira and Takasugi, 1977) are involved in 
NK cytotoxicity and 3. that at least a proportion of these 
cells belong to the T-cell subpopulation of lymphocytes (West 
et al., 1976, Saal et al., 1977, Eiberfield et al.,1975; Kay 
et al., 1977}. The involvement of antibodies, suggested some 
of these authors, would indicate that the NK cytotoxic cell 
mechanism is of an ADCC type. 
The present study was initiated to answer the following 
questions: 
1} are the cells exerting NK cytotoxicity against the K-562 
myeloid cell line, growing in suspension (as measured in a 
short term 51chromium release assay), the same as those 
active against human tumour derived cell lines growing in 
monolayers (as measured in a longterm cytotoxic assay)?; 
2) do the cells derived from different individuals, showing 
NK- and/or K-cell activity bear the same cell surface charact-
eristics (T-cell markers, FcR, surface inununoglobulins (Sig))? 
Ba Materials and.methods 
P-815-X2, a mouse mastocytoma line, was originally ob-
tained from Dr. R.H. MacDonald, Swiss Institute for Experi-
mental Cancer Research, Lausanne, and supplied to us by Dr. 
100 
w. Zeylemaker, Central Labaratory of the Netherlands Red 
Cross Blood transfusion Service, Amsterdam, and K-562, the 
myeloid cell line, was obtained from Dr. Grace Cannon, Litton 
Bionetics, Kensington, Md., USA. The cell lines were main-
tained in suspension culture in modified MEM supplemented 
with 10 % feetal calf serum and 0.3 mg/ml glutamine and in 
RMPI-1640 supplemented with 20 % feetal calf serum and 0.3 
mgjml glutamine without antibiotics. 
Colon carcinoma cells and two melanoma lines (Mel-I and 
NKI-4} were cultured as monolayers. These cells were grown in 
modified MEM supplemented with 10 % feetal calf serum and 
0.3 mg/ml glutamine, trypsinized for serial passage once a 
week and used in the MCT 6 days after culturing, befere the 
cells reached confluency. 
For labelling, 2 x 10 6 target cells in 0.2 ml medium were 
. b d . . f 51 . lncu ate Wlth 100 ~Cl o Na2 Cr04 solutlon, specific acti-
vity 50 - 400 mCi/mgCr (The Radiochemical Center, Amersham, 
UK), for 1 h at 37° C and during the last 15 minutes antisera 
were added to the target cells forADCC (i.e., P-815 mouse 
mastocytoma cells). Target cells were washed three times there-
after, the last wash being performed irnmediately befere use 
in order to minimize the extent of spontaneous 51cr release. 
The NK-cell cytotoxic capacity was tested using the mi-
crocytotoxicity test and was performed as described in chap-
ters II and III. The NK-cell active against monolayer tumour 
target cells in this system will be designated as NK1t. 
3. NK-Qq~o~oxicitq and K-eyXoto~q {AVCC) 
51 One tenth ml of Cr-labelled IgG sensitized P-815-masto-
cytoma cells (10 4 ) and K-562 myeloid cells in Parker 199 + 
10 % feetal calf serum buffered with NaHco3 were added to 
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round-bottomed smal! culture tubes (Falcon 2058) tagether 
with 0.1 ml of a lymphocyte suspension in RPMI-1640 + 10 % 
feetal calf serum (0.5 x 10 6 ). The tubes were incubated for 
4 hours at 37° C in an atmosphere of 5 % co2 in air. Each 
combination was tested in triplicate. Control incubations, in 
the absence of effector cells always gave less than 15 % 
spontaneous 51cr-release. Maximal release in the presence of 
5 % saponine was. ::::-95 %. After the 4 h incubation the tubes 
were centrifuged at 400 g for 5 min and 100 ~ of the super-
natant was transferred to a counting via! and the radioacti-
vity measured in a Packard gamma spectrometer. The percentage 
of specific 51cr-release was calculated as R = (E-S)/(M-S) x 100, 
where E = counts per minute in the experimental tube, 
S = spontaneous release and M = maximal release in the pres-
enee of saponin. 
It has been shown that only lymphocytes exert K-cell 
activity in the ADCC system when IgG-coated mastocytorna cells 
are used as target cells (McDonald et al., 1975; Zeylemaker 
et al., 1975). Monocytes have no lytic effect in this system. 
The NK-cell active in the 51cr-release assay against K-562 
cells wil! be designated as NK
5
t. 
Mononuclear cells were obtained from healthy donors by 
Ficoll-Isopaque centrifugal sedimentation of heparinized 
blood. Contaminating phagocytic cells in the isolated lympho-
id cells were removed by treating the cells with carbonyl 
iron plus rnagnetism. Table I shows the percentage cel! yield of 
the cel! separations. 
a. Separation of T- and non-T-cells by E-rosette sedimentation 
T-lymphocytes possess receptars for E
5
h and this was 
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used to separate these cells. Therefore 5 ml of lymphocytes 
(4 x 10 6 /ml) in RPMI-1640 were mixed with 10 ml of feetal 
calf serum and 10 ml of Esh at 1 x 10 8 /ml in RPMI-1640 in 
disposable Palcon 2070 tubes. The cell suspensions were cen-
trifuged for 30 min at 150 g, and incubated for at least 1 h 
at 4° C. Three ml of the supernatant was left on the pellet 
and the cell pellet was carefully resuspended, 8 ml of cold 
medium was added, and the cell suspension was layered onto 
10 ml of Ficoll-Isopaque and centrifuged at 400 x g for 40 
min at 22° c. After centrifugation the cells from the E-RFC 
enriched pellet fraction and E-RFC depleted interface trac-
tion were collected and tested for NK- and K-eel! activity, 
and for the presence of cell surface markers. No ammonium 
chloride buffer was used tor lysis of the red blood cells 
since this abrogates the NK-cell activity as measured in short-
term cytotoxicity assays (Kay et al., 1977). 
b. Separation of cells lacking FcR 
The technique described by Kedar et al. (1974) with some 
modifications {Van oerset al., 1977) was used. Culture 
flasks (25 sq. cm, Palcon 3013) were treated with 5 ml of a 
salution of 0.05 mg/ml poly-L-lysine (mol. weight 85,000, 
Sigma Chemica! Co., St. Louis, Mo., USA), for 45 min at 22°C. 
After repeated washing (2x) with PBS 2 ml of a suspension of 
Esh (1 x 10 8/ml) was added to the culture flasks and was 
allowed to adhere for 30 min at 22° C. After remaval of non-
adherent cells by repeated washing with PBS (2x) the then 
confluent monolayer of Esh was lysed with H20, and wasbed 
three times with PBS. The erythrocyte ghost monolayer was 
now incubated with 5 ml of a 1 : 64 dilution of rabbit anti-
Esh serum (IgG fraction) for 30 min at 37° C and washed with 
RPMI-1640 5 times thereafter. Four ml of a lymphocyte suspen-
sion (10 x 10 6 /ml) in RPMI-1640 + 10% feetal calf serum was 
then added to the culture flasks and incubated at 37° C for 
10 min. The flasks were centrifuged horizontally in a swing-
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TABLE I 
CELL YIELD EXPRESSED AS PERCENTAGE OF THE INITIAL LYMPHOCYTE NUMBER 
{% total yield) + SE AND PERCENTAGE OF THE LYMPHOCYTE NUMBER USED FOR 
A PARTICULAR SEPARATION STEP (% step-wise yield) ~ SE 
. 
Lymphocyte fractions 
Ficoll-Isopaque purified 
lymphocytes 
Lymphocytes plus iron 
and magnetism treatment 
T-cell fraction {E-RFC 
enriched fraction) 
Non T-cell fraction 
{E-RFC depleted fraction) 
EA-RFC deplected fraction 
EA-RFC reeavered fraction 
Unfractionated lympho-
cytes cul tured for 1 week 
EA-RFC depleted fraction 
cultured for 1 week 
% tot al yie ld 
+ SE 
100 
80 + 3. 1 
ss ~ 7.0 
7 ::. 1. 3 
63 + 6.3 
21 :!::. 4. 3 
60 + 1.9 
43 ~ 4.8 
% step-wise yield number of 
+ SE experiments 
100 7 
80 :!:. 3. 1 10 
68 :!:. 4.8 6 
8 + 1.4 6 
64 + 9.3 12 
23 + 6.8 11 
69 ~ 4.5 3 
60 .:!:. 5.8 9 
* Lymphocyte isolation and fraction separations were performed as des-
cribed in Materials and methods. 
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out bucket at 400 g for 5 min and incubated for a further 10 
min at 22°C. Subsequently, the nonadherent cells were reeaver-
ed by collecting the medium covering the monolayer and gently 
washing the flasks 3 times with medium. For preparatien of 
the EA-RFC depleted fraction this procedure was repeated. The 
procedure is depicted in figure 1. 
Ficoll-Isopaque separated lymphocytes were further puri-
fied by passing the cells over a nylon column. The procedure 
used has been described (Bolhuis, 1977). In short, the cells 
were placed onto a column of unstained spun nylon with a 
length of 5 cm and a diameter of 15 mm, which had been pre-
wasbed with medium supplemented with 5 % foetal calf serum. 
The column was then incubated for 30 min at 37° c. The lympho-
cytes were eluted with RPMI-1640 plus 5 % foetal calf serum, 
and the eluted cells were wasbed in medium. 
7. P~epanatlon ori monocyte enAiched rika~on 
Monocytes were prepared from Ficoll-Isopaque purified 
mononuclear cells. One milliliter leukocyte suspension (30 x 
10 6 /ml) in RPMI-1640 plus 20% foetal calf serum was added to 
a Palcon petri dish (60 x 15 mm) and cells were allowed to ad-
bere to the surface by incubating the cells for 1 h at 37°C. 
After washing the plates thoroughly to remave non-adherent 
cells, the adherent cells were collected by gently seraping 
the plates with a rubber policeman. The percentage monocytes 
present in this reeavered fraction was 50 - 60 % as judged by 
morphologic criteria and size of the cells, as determined 
electronically. 
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Figure 1. Schematic picture of the separation of EA-RFC depleted 
and reeavered fractions and their cytotoxic activity, their 
target cell and the cytotoxicity assay used to monitor 
the cytotoxic activity of the cell populations. 
-
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Esh were stared at 4° C in Alsever's salution and used 
between 1 and 3 weeks after collection. E h were treated with 
8 ' neuraminidase by incubating 1 x 10 E
5
h/ml PBS and 2 units/rol 
of neuraminidase for 30 min at 37° C on a rollerbank (Behring-
werke AG, Marburg, Germany). Forthetest 0.1 ml of a lympho-
cyte suspension (2 x 10 6/ml) was mixed with 0.1 ml of E 
8 sh 
suspension in foetal calf serum (1 x 10 cells/ml). After 
centrifugation for 5 min at 200 g and incubation for 1 h at 
4° C the cell pellet was gently resuspended and the percenta-
ge E-RFC scored by counting 200 cells in a haemocytometer af-
ter staining the lymphocytes with 1 % brilliant cresyl blue. 
Cells binding 3 or more Esh were counted as rosettes. 
9. EA-JWóeftu IEA-RFC) 
A suspension of washed E (1 x 10 8 cells/ml) was incu-
sh 
bated with an equal volume of 1 : 32 diluted rabbit anti-E 
0 oh 
serum for 30 min at 37 C on a roller bank. The EA-complexes 
were washed twice with cold PBS and resuspended in RPMI-1640 
(1 x 10 8 /ml) and 0.1 ml of the suspension was mixed with an 
equal volume of a lymphocyte suspension (2 x 106 /ml), the 
mixture was then centrifuged at 200 g for 5 min and incubated 
for 20 min at 22° C. After careful resuspension of the cell 
pellet the cell mixture was incubated at 37° C for 5 min to 
disrupt possible E-RFC. The percentage of EA-RFC was deter-
mined as described above. 
1 0. MembJtane.. -Unmuno t}.fuo)(_e.h c.e.n.c.e 
This was done as described befare (Knapp et al., 1973; 
Asma et al., 1977). In short, isolated lymphocytes were fixed 
for 10 rninutes in 0.04 % formol salution in PBS and washed 
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with PBS plus 1 % bovine serum alburnin (BSA). Fixed cells 
were vitally stained by mixing equal volumes of cell sus-
pension (20 ~, 2 x 10 6 cells) and the appropriate dilution 
of TRITC-conjugated anti-T-eel! antiserum (T) and incubat-
ion for 30 rninutes at 22° C, gently shaking the mixture ever-
y 10 minutes. The preparatien and specificity testing of the 
T serum is published elsewhere (Asma et al., 1977). After 
washing with PBS plus 1 % BSA, the cells were then stained 
with FITC-labelled goat anti-human Fab (GaHu/Fab, Nordic, 
Tilburg, The Netherlands). After washing the cells, 20 ~1 of 
the stained cells were mixed with 20 ~1 of buffered glycerol 
(1 part PBS, pH 7.8, plus 9 partsof redistilled glycerol 
(Merck)), placed on a cover glass (24 x 32 mm) and covered 
with an objective glass. The cover glass is then sealed with 
paraffin. 
Two hundred mononuclear cells were identified in phase-
contrast and exarnined for the possession of T-cell specific 
antigen and Sig employing the two wave-length methad (Faulk 
and Hijmans, 1972). The Leitz-Dialux microscope with phase-
contrast (transmitted-light) was equiped with a Ploem illumi-
nator with the following filter combination a) 2 x KP 490, 
1 mm GG 455 or 475, 4 mm BG 38 and K 515, KP 560 for FITC 
excitation and emission respectively, b) K 515, KP 560, 1 mm 
BG 36 and K 580 for TRITC excitation and emission, respective-
ly. 
11. C~ng o& tymphacy~eó 
Lymphocytes were cultured for 7 days in RPMI-1640 + 20 % 
toetal calf serum by placing the culture tubes (Falcon 2058) 
containing 2 ml lymphocyte suspension (2 x 10 6 /ml) in a hori-
zontal position at 37° C in an atmosphere of 5 % co2 in air 
in an incubator (Bolhuis and Nooyen, 1977). 
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The optimal approach for the characterization of the ef-
fector cells in experimental roodels is a combination of cell 
separation techniques with simultaneous assessment of cell 
surface markers and reactivity in various assays (Bonnard et 
al., 1977). This requires large numbers (500 x 10 6 ) of pu-
rified lymphocytes. In order to perfarm all assays described 
simultaneously, cryopreserved lymphocytes were used through-
out this study. 
The cryopreservation was performed as described befare 
(Bolhuis and Nooyen, 1977 and chapter III). 
c. Results 
1. P1te..6e11c.e. oó Fc.R on NK- and K-c..ell.ó 
The myeloid cell line K-562 has been shown to be extreme-
ly susceptible to natura! (or "spontaneous") cytotoxicity 
(Jondal and Pross, 1975) in a 4 h 51 chromium release assay 
and indeed unfractionated lymphocytes (fractions A, table II, 
column NK
5
t) of all normal donors tested in our study exhibit-
ed NK-cytotoxicity against this cell line. Furthermore, we 
employed cells from established cell lines as targets to mo-
nitor NK-cell cytotoxicity in an MCT, yielding similar re-
sults {fractions A, table II, column NK1t). P-815 coated with 
IgG was used for monitoring the K-cell activity. It should be 
noted that all fractions of lymphocytes shown in tables II 
and III of one individual donor were examined simultaneously 
in the same experiment for NK-, K-cell activity and the pres-
enee of cell surface markers. This ensures optima! intarmat-
ion regarding the composition of subpopulations of lymphocy-
tes present in the various effector cell preparations, and 
the results obtained by simultaneous testing are nat subject 
to the criticism of possible experiment to experiment variat-
ions. 
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TABLE n 
PER CENT CYTOTOXICITY OF VARIOUS LYMPHOCYTE FRACTIONS 
per cent reduction of target 
NKl~ 
lymphocyte donor NKI-4 Mel-1 colon 
QO!!_OE_ 2.11_ 
A) unfractionated lymphocytes 37. 2S. 
B) T-cell fraction: E-RFC 15 * - s 
C) E-RFC depleted fraction 43. 38. 
Dl EA-RFC depleted fraction 33. 11 
R_O!:_OE_l_li_ 
A) unfractionated lymphocytes 64. 44 
BI T-cell fraction: E-RFC 15 9 
C) E-RFC depleted fraction ss. 33. 
D) EA-RFC depleted fraction 18 28 
QO!:_OE_l_l~ 
A) unfractionated lymphocytes ". 44 
. 
BI T-cell fraction: E-RFC 20. 19. 
C) E-RFC depleted fraction 
. 
13 40. 
D) EA-RFC depleted fraction 19 
QO!:_OE.1.17._ 
A) unfractionated lymphocytes 3S. 31. 
B) T-cell fraction: E-RFC 17. oo• 
Cl E-RFC depleted fraction - 9 38. 
D) EA-RFC depleted fraction 3S. 
P,O!:_OE.1.2.2_ 
A) unfractionated lymphocytes 1S 48. 
D) EA-RFC depleted fraction 
-
3 4 
NK cell cytotoxicity against monolayer cultures (48 h MCT) 
NK cell cytotoxicity against K-562 (4 h 51cr-release assay) 
cells 
NK2 
;t 
K-562 
20 
. 
34. 
32. 
4 
. 
3S 
. 
46 
35'* 
4 
24. 
13. 
24. 
2 
". 
". 34. 
0 
14. 
4 
NKlt 
2 NKst 
3 K K cell cytotoxicity against lgG-coated P-815 (4 h 51cr-release assay) 
*pvalue ~0.05 
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K3 
P-815 
. 
14 
0 
39. 
2S. 
19. 
s 
0 
0 
23. 
0 
TABLE III 
CCMPOSITION OF THE MONONUCLFAR CELL POPULATIONS PRESENT IN THE ISOLATED FRACTIONS 
immunofluorescence 
lymphocyte donor \ E-RFC ' T+ . ,, + \ T+/Ig 
+ \ T-/Ig - % EA-RFC 
Donor 313 
Al-uilf:ra~tionated lymphocytes 
" 
73 18 
" ,, T-cell fraction: E-RFC eg 93 1 6 7 
C) E-RFC depleted fraction 5 16 30 
" 
39 
D) EA-RFC depleted fraction 76 89 1 5 5 
Donor 314 
Al -u'Uii:a'ëtionated lymphocytes 82 22 
" 
T-cell fraction: E-RFC 95 90 1 9 
" C) E-RFC depleted fraction 3 6 30 62 61 
D) EA-RFC depleted fraction 87 93 1 0 
Donor 316 
Al-~f:ra~tionated lymphocytes 76 20 
,, T-cell. fraction: E-RFC 85 96 0 0 4 
C) E-RFC depleted fraction 3 19 45 36 50 
D) EA-RFC depleted fraction 93 1 
Donor 317 
Al-Wîf:ra~tionated lymphocytes 74 80 8 2 10 17 ,, T-cell fraction: E-RFC 
" 
97 2 0 1 3 
0) E-RFC depleted fraction 3 17 36 0 47 73 
O) EA-RFC depleted fraction 77 98 0 0 
Donor 320 
Al-.miraëtionated lymphocytes 80 87 6 20 
D) EA-RFC depleted fraction 96 96 0 
Lymphocytes were not treated. The average yield of 8 ss % of A 
c 7 % of A 
D 43 % of A 
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As shown in table II {fractions D, column NK
5
t} depletion 
for EA-RFC resulted in a complete loss of cytotoxicity against 
the K-562. That the depletion procedure used for EA-RFC was 
indeed efficient is shown in table III {fractions D, column 
% EA-RFC}. Furthermore, these EA-RFC depleted fractions showed 
no langer K-cell activity in a cytotoxic test {table II, 
fractions D, column IgG sensitized P-815}. This suggests that 
the cytotoxic cells bear FcR on their surface {NK
5
t cells}. 
The same fraction of lymphocytes were simultaneously tested 
for NK1t activity on the established cell lines {NKI-4, Mel-1, 
Colon), and varying results were obtained. For instance, the 
EA-RFC depleted lymphocytes from donor 313 {table II, fraction 
D) were still cytotoxic against NKI-4 melanoma but nat against 
Mel-1 melanoma target cells. The identical fractions of donors 
314 and 320 showed no cytotoxicity when tested against NKI-4 
and Colon-1 target cells, and the same fraction of donor 317 
was cytotoxic against Colon-!. These results uggest that in 
this long-term MTC assay, with established cell lines as tar-
get cells, another. subpopulation of cells i.e., cells without 
FcR on their surface, are also involved in the NK-cell lytic 
process {NK1t-cells). These observations imply that the NK 
cytotoxic mechanism of a proportion of the effector cells, is 
nat likely to be of an antibody-dependent type of reaction, 
since this fraction is virtually devoid of EA-RFC {table III, 
fractions D, column % EA-RFC), and since the ADCC against IgG-
coated P-815 is negative {table II, fractions D, column K-cell 
cytotoxicity) . That FcR hearing cells are also cytotoxic a-
gainst the monolayer cell lines can be concluded from the ob-
servations that the EA-RFC depleted fractions are nat cyto-
toxic, whereas the unfractionated lymphocytes of that donor 
show cytotoxicity {table II, fractions A and D). That the cell 
population in fractions A are the most heterogeneaus can be 
concluded from the analysis of cell surface markers {table 
III, fractions A). From these data it can be concluded that at 
least two cell populations are showing NK-activity in the dif-
ferent cytotoxic assay systems employed i.e., bath IgG-FcR ne-
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gative and IgG-FcR hearing cells are cytotoxic against esta-
hlished cel! lines as tested in a long-term cytotoxicity as-
say (NK1t cells), but only FcR hearing cells are cytotoxic 
against K-562 myeloid leukaemia cells as tested in a short-
term cytotoxicity assay (NK
5
t cells). 
West et al. (1976) recently reported that human E-RFC 
fractions, obtained under optima! experimental conditions 
i.e., containing hoth high-avidity and low-avidity E-RFC 
(West et al., 1977), showed NK cytotoxicity against the K-
562 cel! line. The E-RFC depleted fractions, however, were 
never devoid of NK-cell activity. 
We repeated these experiments using both the K-562 cell 
line and the NKI-4, Mel-1 and colon monolayer cell lines as 
target cells. Therefore, T-cell fractions (E-RFC cells) and 
non-T-cell fractions {E-RFC-depleted cells), obtained hy 
rosette formation and separation under optima! conditions 
were tested for NK cytotoxicity. Both T- and non-T-eel! frac-
tions are shown to be almest equally cytotoxic against K-562 
target cells, and the extent of reactivity is more or less 
comparable to the unfractionated lymphocytes (table II, frac-
tions B and C, columns NK1t and NK 5 t). From the cel! surface 
marker analysis of the T-eel! fraction (table III fractions 
B, columns % E-RFC and % T) it can be concluded that the T-
eel! fractions are extremely pure, i.e. pure lymphocytes con-
taining less than 1 % Sig positive cells, and virtually no 
cells lacking T-cell specific antigen. Furthermore, it can 
be concluded that a proportion of T-cells hear FcR (table 
III, fractions B, column % EA-RFC) and show K-eel! activity 
against IgG sensitized P-815 cells (table II, fractions B, 
column NK
5
t). The results from the cytotoxicity experiments 
with the NKI-4, Mel-1 and colon cells as targets are compara-
ble to those with the K-562 cells. Attention should be given 
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to the fact that T-cells, fractionated by E-rosette formation 
and subsequent separation of the E
5
h-RFC on Ficoll-Isopaque 
are less capable of re-rosetting with E
5
h. The percentage T+-
cells indicates, however, that this fraction contained pure 
T-cells. The importance of the latter observation became even 
more apparent when the non-T-cell fractions were examined. 
The interpretation of cytotoxicity data obtained with the 
non-T-cell fractions (Fraction C) is even more complex. 
As can be seen from our data (tahle II, fractions c, 
column NK cytotoxicity) this fraction is also cytotoxic a-
gainst all types of target cells used. The efficiency of E-
RFC depletion is checked by E-rosette formation of the non-T-
cell fraction and this fraction appears to contain virtually 
no T-cells, i.e. 3 - 5 % (tahle III, fractions C, column % 
E-RFC). Analysis of the T-cell markers hy means of the anti-
T-cell serum, however, indicates that 6 - 17 % of the cells 
in the non-T-cell fraction can he identified as T-cells. The 
Sig hearing cells are nat likely to contrihute to the cyto-
toxic effects, since the increase of Sig hearing cells from 
~ 8 % in population A to + 40 % in the interface (tahle III, 
fractions c, column % Sig) did nat increase the percentage 
cytotoxicity (tahle II, fractions c, column NK cytotoxicity). 
Recent experiments showed that lymphocyte fractions, after 
depletion of E-RFC and EA-RFC, thereby increasing the percent-
age of Sig hearing cells up to 80 %, yielded na significant 
cytotoxicity against K-562 (data nat shown}. 
It is unlikely that monocytes are involved in the NK 
cytotoxic process against K-562 since a) purified lymphocyte 
fractions (see Materials and methods1 this chapter) are equal-
ly ar more cytotoxic as compared to the unfractionated cells 
(Ficoll-Isopaque isolated, without iron treatment of the 
cells), excluding a direct NK cytotoxic capacity of monocytes; 
b) fractions of lymphoid cells enriched for monocytes (table 
IV) show significantly decreased cytotoxicity; c) adding mono-
cytes to the pure lymphocyte fractian· does nat influence the 
per cent NK cytotoxicity, suggesting that monocytes do nat 
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TABLE IV 
PER CENT NK-CELL ACTIVITY OF PURE LYMPHOCYTES WITHAND WITHOUT THE ADDITION OF MONOCYTES, AND/OR A 
MONOCYTE ENRICHED FRACTION AGAINST NKI-4, Mel-I, K-562 AND THE COMPOSITION OF THE MONONUCLEAR CELL 
POPULATIONS OF THE ISOLATED FRACTIONS 
Target cells 
effector cells NKI-4 1 Mel-1 I K-562 2 % E-RFC 
--- ---
Nylon purified 39. 
. . 
83 47 
lymphocytes 
Nylon purified 49'* 78 • 50 • 
lymphocytes + 1 % 
monocytes 
Nylon purified ss· 83. 4s 
lymphocytes + 5 % 
monocytes 
monocytes enriched3 ". 69. 19. 29 
fraction 
1 NK1 t: NK cel! cytotoxicity against monolayer cultures (48 h MCT) 
2 NK5t: NK cell cytotoxicity against K-562 (4 h 
51
cr-release assay) 
3 the monocyte enriched fraction contained 60 % monocytes 
* p value ~ 0.05 
% T+ 
24 
Cell surface markers 
+ % Ig 
9 
% T-/Ig 
67 
% EA-RFC 
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play an indirect (helper) effect in NK cell killing; d) all 
lymphocyte fractions were tested in an ADCC against IgG-
coated Esh (a monocyte dependent antibody cytolysis assay) 
and no cytotoxicity was observed. A representative experiment 
is shown in table IV. 
D. Conclusions 
In various experiments, using frozen-stored lymphocytes 
of normal donors, these cells exhibited NK- activity against 
monolayer cell lines and K-562 cells growing in suspension, 
and showed K-cell activity (ADCC) activity against IgG sensi-
tized P-815 cells. A proportion of the NK-cells i.e., those 
showing cytotoxicity against K-562 (NKst-cells), have similar 
cell surface characteristics as K-cells. One of the character-
istics is the presence of IgG-FcR on a proportion of the NK-
and on all K-cells as demonstrated by the abrogation of NK-cell 
and K-cell activity against K-562 and IgG sensitized P-815 
cells, respectively, after EA-RFC depletion of the purified 
lymphocytes by adsorption of the EA-RFC onto IgG-E
5
h ghost 
monolayers. This conclusion is confirming other studies in-
volving the characterization of NK- and/or K-cells (Peter et 
al., 1975; Kiuchi and Takasugi, 1976; Jondal and Pross, 1975; 
Papeet al., 1977; Pross and Baines, 1976; Kay et al., 1977). 
Recently, Bakács et al. (1977) showed, that remaval of IgG-
FcR hearing cells did not result in a complete loss of NK-cell 
activity. These investigators, however, employed monolayer 
cell lines as target cells in a longterm cytotoxicity assay. 
Our cytotoxicity experiments, including bath monolayer cultu-
res (NK -assay) and suspension cultures (NK - 51cr-release 
st st 
assay) also showed, that still another, IgG-FcR negative, lym-
phocyte exerted NK-cell activity against exclusively the mono-
layer cultures (table III, column NKlt cytotoxicity). Our data 
also show that this NK-cell activity was selective i.e., kill-
ed only a proportion of the cell lines, and that bath FcR po-
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sitive (NK
5
t)- and negative (NK1t)-cells may have different 
targets, since the remaval of FcR hearing cells sametimes 
resulted in the loss of cytotoxicity against one, but nat 
against the other type of monolayer target cells. The fracti-
enation of lymphocytes into T- and non-T-subpopulation by 
means of E-rosette formation and separation, yielding T-
cells in the pellet fraction and "non-T-cells" in the inter-
face fraction provided some interesting results. Bath T- and 
non-T cel! fractions appeared to be cytotoxic against bath 
monolayer cell lines as wel! as K-562 cells (our data, West 
et al., 1976). Analysis of the lymphocyte subpopulations by 
means of E-rosette formation indicated that the T-eel! trac-
tion was highly enriched in T-cells and the non-T cell trac-
tion contained virtually no T-cells. When, however, an a/T-
eel! serum {Asma et al., 1977a, b) was used for the identi-
fication of T-cells the following results were obtained: 
1) the T-eel! fraction contained pure T-cells; 2) the so-
called non-T-eel! fraction contained a significant percentage 
of T-cells as shown by the anti T-eel! antiserum. That this 
is nat due to non-specific binding of TRITC labelled a/T-eel! 
serum to the cells is illustrated by the two wavelength ana-
lysis of Sig hearing cells and T-cell specific antigen hear-
ing cells. The two wavelength methad allows the detection of 
both markers on the membrane of individual lymphocytes. Such 
analysis revealed that in the unfractionated lymphocytes, con-
taining T-cells and B-cells (Sig hearing cells) and the non-
T-eel! fraction, containing a high percentage of B-cells, 
virtually no double staining is observed {table III, column 
% T+/Ig+, fractions A and C). Furthermore 1 we have nat observ-
ed positive staining of monocytes, hearing FcR 1 indicating 
that the membrane fluorescence is nat due to binding of the 
labelled antisera to IgG-FcR. This argues against the fact 
that the detection of T-cells with serum is due to nonspecific 
membrane staining and indicates our observation that T-cells, 
after rosette formation and separation, do nat farm E-rosettes 
as readily as befare the E-RFC depletion. This conclusion 
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is supported by the good correlation between % T-cells as 
determined by E-rosette formation and by antiserum, when per-
formed befare fractienation of these cells on Ficoll. The 
implications of this finding are important and may explain a 
number of the apparent contradicting results in the litera-
ture. West et al. {1976; 1977) concluded that the T-cells showing 
the NK-cell activity belang to a subpopulation of T-cells 
hearing low affinity receptars for E
5
h. Apparently the opti-
mal conditions empl~Dyed for E-rosette formation and separation 
do nat completely prevent the dissociation of low-avidity 
E-RFC, resulting in the appearance of T-cells with low affini-
ty receptars for Esh after this separation procedure in the 
interface. Since these low-affinity E-RFC have been shown to 
exhibit the strengest NK-cell activity {West et al., 1976) 
this would explain the fact that lymphocytes in the non-T-cell 
fraction, containing only 6 - 17 % T-cells, show a similar 
level of NK-cell activity as the T-cell fraction {containing 
100 % T-cells, see above) at the same lymphocyte target cell 
ratio, since the latter is relatively depleted and the farmer 
relatively enriched for T-cells bearing low-affinity receptars 
with Esh" 
Hersey et al. (1975) showed T-cells, hearing FcR, to be 
cytotoxic. Kiuchi and Takasugi {1976) defined the NK-cell as 
a null cell, i.e. without T- and/or B-cell characteristics 
except the presence of IgG-Fc-receptors. These authors used 
E-rosette formation and separation and subsequently checked 
the purity of the separated fractions by E-rosette formation. 
Our data clearly demonstrate that for testing of the purity of 
the cell fraction after purification other assays for the 
characterization of a cell subpopulation should be employed 
than the one used for the separation of the cell subpopula-
tion i.e. 1 it was demonstrated that nat all T-cells farm E-
rosettes after E-RFC-separation on Ficoll. 
Most likely, a proportion of the E-rosettes, apparently 
the low-avidity E-RFC {West et al., 1977) 1 dissociate during 
the E-RFC fractienation procedure on Ficoll, and will be found 
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in the interface i, e, , the so-called non-T-cell fraction, and 
a proportion of these T-cells may bear FcR {Samarut et al., 
1976). Thus, the cells from the interface, showing NK-cell 
activity would be characterized as non-T, non-B, IgG-FcR hear-
ing cells on the basis of their E-, EA- and Sig markers. Ana-
lysis of the cells is the interface fraction with the a/T-eel! 
antiserum, however, indeed showed the preserree of T-cells. 
West et al. {1976) reported that the E-RFC depleted fractions 
were seldomly depleted of NK-cell reactivity. Our data are in 
accordance and the simultaneous analysis of cel! surface mar-
kers performed strongly suggest that indeed T-cells are pres-
ent in this E-RFC depleted fraction. The analysis of cel! sur-
face markers also showed that pure T-cells (E-RFC, anti-T-
eel! serum positive) can farm EA-rosettes and exert K-eel! 
activity {ADCC) confirming other data (Van Oerset al., 1977; 
Samarut et al., 1976; Dickler et al., 1974). 
Bakács et al. {1977) state on the basis of their experi-
ments that non-T-cells are responsible for NK-cell activity 
against monolayer cultures, They, however, found that the 
E-RFC enriched {T-eel! enriched) fraction was always cyto-
toxic, unless passed over a nylon column befare cytotoxicity 
testing. Saksela et al. {1977) recently showed that cells 
showing "spontaneous" activity were retained on nylon and 
this may explain the loss of NK-cell activity, which Bakács 
et al. (1977) observed. Our observations and those of others 
that B-cell enriched fractions (West et al., 1976; Bakács et 
al., 1977) and monocyte enriched fractions (our data) had no 
direct NK-cell activity strengthens the conclusion that the 
"contaminating" T-cells in the E-RFC depleted {i.e., "non-T-
eel!" fraction) are responsible for NK-cell cytotoxici ty. 
From the data discussed so far it can be concluded that at 
least two populations of NK cells exist: 
1) NK-cells showing NK cytotoxicity against all types of 
target cells tested in long-term and short-term cyto-
toxicity experiments and with IgG-FcR on their cell 
surface {NKlt and NKst' IgG-FcR positive); 
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2) NK-cells showing NK cytotoxicity against monolayer 
cultured target cells tested in MCT, with no demon-
strabie IgG-FcR on their cell surface as demonstratea 
with EA-RFC and ADCC. 
Recently, the generation of Fe receptars and hence NK
5
t- and K-
cell activity after prolonged culturing of EA-RFC depleted 
cells has been demonstrated (Chapter VI, Ortaldo et al., in 
the press). One might argue that these cells are generated 
during the 48-hour incubation period required for the MCT and 
hence the same type of effector cells was responsible for the 
NK-cell killing as in the short-term 51cr release assay using 
K-562 as target ce1ls. Our observations that EA-RFC dep1eted 
cell fractions, cu1tured for 48 hours did not show any cyto-
toxicity against T-24 cells in a 4 hour 51cr-cytotoxicity 
test, whereas the cells showed cytotoxicity in a 48 h MCT ar-
gues against this possibility (data not shown) . 
K-cell cytotoxicity is known to be antibody-dependent, 
and the presence of IgG-FcR on NK-cells of antibodies may in-
dicate that the NK cytotoxicity could be of an ADCC type for 
the following reasons: 
1) lymphocytes already have Ig with specificity for cer-
tain target cells bound to their surface -in v-ivo (Akira 
and Takasugi, 1977; Kay et al., 1977; Pross and Jon-
dal, 1975); 
2) antibody is released by lymphocytes and binds to FcR 
hearing cells during the cytotoxic assay {Blair and 
Lane, 1975; Pape et al., 1977). 
The first possibility would then explain our observation that 
EA-RFC negative cells showed NK cytotoxicity against mono-
layer cultures, since their IgG-FcR were already saturated 
with IgG. The second type of reaction would require function-
ally intact FcR on the membrane of lymphocytes. 
The question whether the FcR is functionally involved in 
the NK cytotoxic mechanism will be the subject of chapter VI. 
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CHAPTER VI 
ANALYSIS OF THE INVOLVEMENT OF THE IgG-Fc 
RECEPTORS ON LYMPHOCYTES IN THE NK-CELL 
CYTOTOXICITY 
A. Introduetion 
In the previous chapter it was shown that there exist at 
least three populations NK-cells: 1. a NK1t-cell belonging to 
a subset of lymphocytes with an IgG-FcR, e.g., exerting NK-
cell activity against monolayer target cells, as monitored in 
a 48 h MCT, and showing antibody dependent lysis of P-815 
cells; 2) a NK1t-cell without detectable IgG-FcR, e.g. exert-
ing NK-cell activity against rnonolayer target cells, as mani-
tared in a 48 h MCT, but nat showing antibody dependent lysis 
of P-815 cells; and 3) a NK
5
t-cell with an IgG-FcR, e.g., 
exerting NK-cell activity against 51chromium labelled K-562 
cells as monitored in a 4 h isotape release cytotoxicity as-
say and showing antibody dependent lysis of P-815 cells. 
For the NK 1t-cell without an FcR on its surface, it is 
clear that its cytotoxic mechanism is nat antibody dependent. 
The author contends that the characterization and puri-
fication of the effector cells, particularly in human systems, 
is of crucial importance for a better analysis of their cyto-
toxic mechanism, the immunologie specificity of their action 
and their possible role as an irnmunosurveillance mechanism. 
The analysis of cytotoxicity in various combinations of 
effector cells and target cells has presented evidence that 
target cells may be lysed nat only by lymphocytes, but by a 
number of cell types (see Introduction, chapter V). Further-
more, it can be concluded from the data presented in chapter 
V that target cells can be killed by more than one type of 
lymphocyte. In the past much attention was devoted to the 
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lysibility of various target cells (chapters II, III and 
Herherman and Oldham, 1975). With the identification of so 
many types of effector cells and new subsets of lymphocytes 
(chapters IV and V) attention should now be given to the phe-
nomenon of discrete "selective susceptibility to lysis" 
(chapter V) i.e., the lysibility of a particular cell will 
depend on the number of types of potential effector cells for 
which it may serve as a target. In the previous chapter it 
was shown that the various types of NK-cells, FcR positive 
and negative, are likely to belang to the T-cell subset which 
also bear low-affinity receptars for E
5
h (West et al., 1977). 
West reported that this low-affinity E
5
h-RFC are proba-
bly pre-T-cells. On the basis of our cell surface marker ana-
lysis of the lymphoid cells in each fraction (chapter V) it 
was concluded that these cells most likely accounted for non-
T-, non-B-cells, as defined earlier by Takasugi as null cells 
(see discussion chapter V). The important question remains 
whether the FcR for IgG present on the surface of the other 
two types of NK-cells is functionally involved in the lytic 
process. The experiments described in this chapter will focus 
on this question. 
B. Materials and methods 
The cel! isolation, cryopreservation, separation, type 
classification, isotape labelling techniques and the cyto-
toxicity assays for monitoring the NK and K-cell activities 
are described in chapters II, III and V (Materials and meth-
ods). 
1. 1~o~on oü the FeR b~ng eetlA 
All procedures for the separation of cells lacking FcR 
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were performed as described in Materials and methods in 
chapter V. The adherent cel! fraction was collected by incu-
bating the monolayers plus the adherent cells for 18 h at 
37° C and then collecting the medium with the cells that had 
detached spontaneously. 
Z. C~ng ofi lymphocyteJ 
Lymphocytes were cultured for 7 days in RPMI-1640 + 20 % 
foetal calf serum by placing culture flasks (Costar 3075} 
containing 10 ml lymphocyte suspension (2 x 10 6 /ml} in a hori-
zontal position at 37° C in an atmosphere of 5 % co2 in air 
in an incubator. 
c. Results 
1. The efiflect o6 p~otonged c~g ofi tymphocyZeö on NK- and K-eelt 
a~v~y 
We designed an experiment to study whether the various 
fractions showing NK- cel! activity and containing FcR hearing 
cells needed the presence and/or functional activity of these 
FcR. 
From table I A it can be seen that prolonged culturing of 
population A lymphocytes increased the NK-cell activity 
against the monolayer cel! lines tested (table I A, fractions 
A and Ac, column NK1t cytotoxicity). The NK cel! cytotoxicity 
against K-562 of the cultured fractions (A) from donor 321 
was decreased, but there was also a drastic decrease in the 
percentage EA-RFC (table II A, donor 321, column EA-RFC). 
In order to see whether the cytoxicity observed was me-
diated through the IgG-FcR, the EA-RFC depleted lymphocyte 
fraction was cultured. As shown earlier, EA-RFC depleted 
cells, although occasionally remairring cytotoxic against tar-
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Table I A 
PER CENT CYTOTOXOCITY OF VARIOUS LYMPBOCYTE FRACTIONS AFTER SEPARATION 
EA-RFC DEPLETED FRACTIONS, EA-RFC RECOVERED FRACTION AND THE EFFECT OF 
PROLONGED CULTURING ON NK CELL CYTGrOXICITY 
target cells 
lymphocyte donor 
Donor 313 
AJ-lliiira'ët.ionated lymphocytes 
Ac) unfract.ionated lymphocytes * * 
cultured for 1 week 
D) EA-RFC depleted fraction 
Dc)EA-RFC depleted fraction 
cultured for 1 week 
E) EA-RFC reeavered fraction 
Donor 314 
Al-@iraCt.ionated lymphocytes 
A0 )unfractionated lymphocytes 
cultured for 1 week 
DJ EA-RFC depleted fract.ion 
D c) :~ ~~e~e~!=t~d w!~~ction 
El EA-RFC reeavered fract.ion 
Donor 316 
Al-untraCtionated lymphocytes 
A0 )unfractionated lymphocytes 
cultured for 1 week 
Dl EA-RFC depleted fraction 
D c) :~:~e~e~!~t~d w!:ction 
E) EA-RFC recovered fract.ion 
NKI-4 1 Mel-I 1 colon 1 
". 
99. 
23 
n• 
16 
". 
... 
59. 
1 lymphocyte target cell ratio: 200 : 1; 
2 lymphocyte target cell ratio: 50 : 1: P-815 is sensit.ized w.ith 
(see Mater.ials and methods). 
""" 
K-562 2 
20. 
4 
". 
35. 
". 
9. 
53. 
9. 
38. 
2 
23. 
19. 
lgG 
* P-value ~0.05 
** lymphocytes fract.ion were EA-RFC depleted after cultur.ing for 1 week 
.immediately befere cytotox.ic.ity testing. 
=c:!:~!: A0 , D, D0 and E were isolated and descr.ibed .in Mater.ials 
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K 
P-815 2 
0 
5 
46. 
10. 
9. 
". 
0 
get cells growing in monolayerS (i.e., NKI-4, Mel-I and/or 
Colon-I), lost their NK-cell activity against K-562. When 
these cells (fraction De) were cultured for 1 week (fraction 
De) they became extremely cytotoxic against K-562 and the 
cytotoxicity against the monolayer cultures was increased as 
well: against NKI-4 (donors 314, 316 and 320), against Colon 
(donors 314 and 320) and against K-562 (donors 316 and 321) 
as can beseen in tables 1 A and I B, fractions D and De' co-
lumn NK cytotoxicity. The K-cell activity against IgG-sensi-
tized p-815, however, was very low, and so was the number of 
EA-RFC. Since these two assays require functionally intact FcR 
the latter two observations again support the conclusion that 
IgG-FcR, although they may be present on a proportion of the 
NK-cells, are not involved in the NK-cell cytotoxic mechanism. 
Lymphocytes of donor 314 (table I A), however, showed the 
opposite effect and lymphocytes of donor 320 showed an in-
creased cytotoxic activity as monitored in bath the NK- and K-
cell assays. 
whether the NK-cell activity of these EA-RFC depleted 
and cultured cells (table II B, fractions De), which showed 
no NK cytotoxicity befare culturing (table II B, fractions D) 
represent the induction of new subpopulation of NK-cells, 
which so far remairred undetected has to be elucidated. The 
per cent EA-RFC was always increased slightly after culturing 
of the EA-RFC depleted cell population. These results do nat 
clearly demonstrate that the IgG-FcR is nat involved in the 
NK-cell lytic mechanism, although it is clear that the in-
crease in NK-cell activity upon prolonged culturing of the 
lymphocytes does nat necessarily coincide with an increase in 
antibody dependent K-cell killing and vice versa. Moreover, 
the effect of culturing of lymphocytes on NK- and K-cell kill-
ing seems donor dependent. 
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TABLE I B 
PER CENT CYTOTOXOCITY OF VARIOUS LYMPHOCYTE FRACTIONS AFTER SEPARATION 
EA-RFC DEPLETED FRACTIONS, E/1.-RFC RECOVERED FRACTION AND THE EFFECT OF 
PROLONGED CULTDRING ON NK CELL CYTOTOXICITY 
lymphocyte donor 
donor 320 
Al -",;;'iraë"tionated l.ymphocytes 
Ac)unfractionated l.ymphocytes ** 
cultured for 1 week 
D) EA-RFC depleted fraction 
D c) :~~~e~e~~=t~d w=:ction 
E) EA-RFC reeavered fraction 
donor 321 
Ä) -",;;"t"raë"tionated lymphocytes 
Ac)unfractionated lymphocytes 
cultured for 1 week 
Ac):i~::~o;~~e~ ~:~~o~~=;;c 
depleted 
D) EA-RFC depleted fraction 
cultured for 1 week 
D ) EA-RFC depleted fraction 
" cultured for 1 week, 
EA-RFC depleted 
E) E/1.-RFC reeavered fraction 
""" 
NKI-4 1 Mel-I 1 
IS 
- 3 
.,. 
30' 
,,. 63. 
,,. 
1: lymphocyte target cell ratio: 200: 1; 
target cells 
' colon 
". 
' SB • 
". 
NK ,, 
K-562 2 
". 
' IB' 
". 
S9. 
!8' 
!7' 
". 
!6' 
31. 
2: lymphocyte target cell ratio: 50 : 1; P-815 is sensitized with IgG 
(see Materials and methods). 
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P-val.ue ~ 0. OS 
lymphocytes fraction were EA-RFC depleted after culturing for 1 week, 
immediately -before cytotoxicity testing. 
:~c:;~~~:: A0 , D, De and E were isolatedas described in Material.s 
K 
P-815 2 
" 
0 
". 
". 
73. 
0 
0 
. 
" 
~ 
~ 
~ 
Table II A 
COMPOSITION OF THE MONONUCLEATED CELL POPULATIONS OF THE DIFFERENT FRACTIONS 
OF THE ISOLATED FRACTIONS 
immunofluore seenee 
~
lyroph'?eyte donor 
+ + + + ~ 
% E~RFC % T ~ Ig '1. T /Ig % T /Ig % EA~RFC 
Donor 313 
AJ- Unfräetionated lymphoeytes n 73 
' 
I 
" " Ac) ~:~~:~=~o;:~e~ ~:~hocytes 
D) EA-RFC depleted fraetion 
" " ' 
D c) :~:~e~e~!;t~d w!~:etion " " D I 
D 
,, EA-RFC reeavered fraetion 
" 
Donor 314 
J\)- Mfräctionated lymphocytes 
" " Ac) unfractionated lymphocytes en 
cultured for 1 week 
D) EA-RFC depleted fraetion 
" " 
0 D 
D
0
) EA-RFC depleted fraetion 
" cultured for 1 week 
" 
EA-RFC reeavered fraction 
" " 
Donor 316 
AJ- -;;nfractionated lymphocytes 
" " 
A0 ) ~=~~:~=~o;~=e~ !~:~hoeytes 65 9 
D) EA-RFC depleted fraction 93 
De) EA-RFC depleted fraction 
" eultured for 1 week ,, EA-RFC reeavered fraction 
" 
Fractions A, A0 , D, D0 and E were isolated as described in Materials and methods. 
~ 
N 
ro 
Table II B 
COMPOSITION OF THE ~!ONONUCLEATED CELL POPULATIONS OF THE DIFFERENT FRACTIONS 
OF THE ISOLATED FRACTIONS 
irnmwlofluorescence 
~
lymphocyte donor % E-RFC 
'" 
+ + % T+ /Ig + 't T-/Ig - % EA-RFC ' ,, 
---
donor 320 
A)- Unfractionated lymphocytes 80 87 
' 
I 6 
" Ac) unfractionated lymphocytes 
" cultured for 1 week 
D) EA-RFC depleted fraction 96 96 0 0 
' 
0 
De) EA-RFC depleted fraction 
" cultured for 1 week 
" 
EA-RFC reeavered fraction eo 95 
' 
0 
' 
11 
Donor 321 
ÄJ- Unfräctionated lymphocytes 
"' 
95 0 I 
' 
D 
A0 ) unfractionated lymphocytes 
cultured for 1 week 
" 
EA-RFC depleted fraction ,, EA-RFC reeavered fraction es 
" 
6 0 
Praetiens A, A , D, D and E were isolated as described in Materials and methods. 
0 0 
2. The NK- and K-c..ett o.cüv.d:.y o6 EA-RFC Jt..e.c..oveJr.e.d f..ymphoc..y:telJ: 
6unctionat ~nvolverne.nt o6 :the. FcR? 
We already have shown that EA-RFC when incubated on EA-
monolayers, remain attached to the IgG coated Esh ghost mono-
layer. These cells, overlayered with medium, were incubated 
for 18 h at 37° c. After incubation the cells that had spon-
taneously detached from the monolayers were reeavered (total 
yield 21 %, table I, chapter V) and tested for their NK- and 
K-cell activity against K-562, NKI-4, Colon-1 and against IgG-
sensitized P-815 (tables I A and I B, fractions E). Cell sur-
face marker monitoring revealed that, although theoretically 
100 % of these cells are expected to bear PeR, only a very 
smal! percentage (4 - 12 %) of these "FcR hearing" cells still 
bear IgG-Fc receptars capable of binding to IgG sensitized Esh 
and fresh EA-monolayers (table I B and II B, fractions E, co-
lumn % EA-RFC) , If one compares the NK-and K-cell activity 
(ADCC) against K-562 and IgG sensitized P-315 of the EA-RFC 
reeavered fraction to that of the unfractionated cells, one 
can see that the lymphocytes of 3 out of 5 donors (donor 313, 
314, 316, tables I A and I B, fractions A and E, column NK1t 
and K) showed an increased NK- but a decreased K-cell activity. 
Por 2 out of 5 donors the level of NK- and K-cell activi-
ty remained the same as befare EA-RFC recovery (donors 320 
and 321, tables I A and I B, fractions A and E, columns NKst 
and K) . The NK-cells of all donors showed an increased lytic 
activity against the monolayer target cells (tables I A and 
I B, column NK1t). When the EA-RE'C reeavered fractions were de-
pleted for residual EA-RFC directly befare cytotoxicity test-
ing, the results became more clear. As can be seen in fig. 1, 
the levels of cytotoxicity against K-562 and P-815 befere 
fractienation were equal and the influence of the effector 
target cell ratio was monitored. 
when the EA-RFC reecvered fraction was depleted for resi-
dual EA-RFC directly befare the cytotoxicity testing, one can 
see that the level of NK-cell activity remained unchanged or 
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Figure 1. Separation of NK- and K-cell activity by means of EA-RFC 
recovery fellewed by EA-RFC depletion. 
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was even somewhat- higher as compared to the unfractionated 
lymphocytes, whereas the level of K-cell activity was de-
creased. Furthermore, at an effector target cell ratio of 
3 : 1 the NK-cell per cent cytotoxicity against K-562 is still 
significant whereas the K-cell activity is completely abolis-
hed. Moreover, the decrease in K-cell activity coincided with 
a decrease in the per cent EA-RFC. 
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3. The. -Ut6.fue.nce. o6 M.tu.b.te. c.omp.te.xu on .the. NK- and K-c.e..U a.ct.-[v.u..<_u 
Complexes were expected to reduce the lytic activity of 
K-cells by "plugging" of the IgG-FcR on the surface of the 
effector lymphocytes. That this is indeed the case can be 
seen in fig. 2. The maximally per cent reduction of K-cell 
cytotoxicity was 100 % for lymphocytes of two of the three 
donors and 60 % for 1 donor, depending on the effector/target 
cell ratio. The reduction in per cent NK-cell cytotoxicity, 
however, is much less, ranging from 40 to 65 per cent, sug-
gesting that at least a subset of the NK
5
t-cells do not need 
the functional involvement of the IgG-FcR for NK killing of 
K-562 target cells. 
0 
. 
0 
. 
. 
0 
0 
0 
' ~ 
. 
> 
0 
~ 
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0 
~ 
~ 
100 
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0 
lympho~yt,e 
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12 25 
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Complexe•·= Robbit- onti- OVA, 1 : 4 diluted 
OVA 17~g/ml 
Figure 2. Per cent reduction by immune-comp1exes of the cytotoxic 
capacity of NK- and K-cells-
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This stronger inhibition of K-cell cytotoxicity is illu-
strated by a complete inhibition of EA-RFC formation (fig. 2). 
Figures 3 and 4 show the data obtained from an experiment com-
bining the monitoring of the NK- and K-eel! activity of EA-
RFC recovered, EA-RFC depleted fraction (described earlier) 
with inhibition of the NK- and K-eel! cytotoxicity by immune 
complexes. Since the total level of NK-cell cytotoxicity of 
unfractionated lymphocytes is reduced by the immune complexes, 
this experiment allows the interesting conclusion that the 
cytotoxic capacity of a proportion of the NKst-cells can be 
inhibited by cornplexes. These NKst-cells thus probably bear 
FcR on their surface. 
The K-cell activity, however, is reduced even strenger. 
Again, from figs. 3 and 4 it can be seen that addition of 
immune complexes completely inhibit EA-RFC formation and that 
no EA-RFC are present in the EA-RFC reeavered fraction after 
I~G-Esh short monolayer incubation. When the influence of the 
addition of immune complexes on the NK- and K-cell activity 
of the EA-RFC reeavered cel! population, after depletion of 
residual EA-RFC, is monitored one can see that the NK-cell 
aetivity is only slightly reduced. This observation allows 
the conclusion that two subsets of NK -cells exist: 1. NK 
st st 
cells bearing IgG-FcR on the cel! surface since this NK-acti-
vity can be blocked by immune complexes and hence may require 
the functional involvement of FcR for its lytic activity; and 
2. NKst-cells of which the lytic activity cannot be blocked by 
immune complexes. The latter cel! population expressed IgG-FcR 
on its surface befare fractionation. Thus this IgG-FcR seems 
nat to be functionally involved in the lytic NK process. 
An alternative explanation is that the inhibition of NK-
eell cytotoxicity by immune complexes was caused by steric 
hindrence rather than by blocking of a functionally required 
FcR. 
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Figure 3. The influence of immune complexes on the NK- and K-cell 
activities of unfractionated and EA-RFC reecvered lym-
phocytes separation of NK- and K-cell actlvities 
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Figure 4. The influence of immune complexes on the NK- and K-cell 
activities of unfractionated and EA-RFC reeavered lym-
phocytes separation of NK- and K-cell activities 
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o. Conclusions 
As stated in the previous chapter NK-cell killing may 
require FcR and hence display an antibody dependency for its 
lytic activity. The antibody may already be present on the 
cell surface of the purified lymphocytes (~ vlva coating of 
lymphocytes by antibodies) or be produced during the 4 h 
period required for cytotoxicity testing. 
Jondal and Pross (1975) showed that the NK-cells sepa-
rated with the complement receptor hearing cells and nat with 
E-RFC and stated that these effector cells were non-T-cells. 
Earlier work of these researchers suggested these non-T-, com-
plement receptor hearing cells to bear FcR on their surface 
(Jondal, 1974). When, however, complement receptor hearing 
cells were isolated with pure IgM antibodies the NK activity 
did not separate with the complement hearing cells. Use of 
78 IgG, however, yielded similar data as reported by Jondal 
(West et al., 1977). Most likely the separation of NK-cell 
activity was mediated through the IgG-FcR. Other investigators 
confirmed the presence of IgG-FcR on the surface of NK-cells 
(Peter et al., 1975; West et al., 1977; Kay et al., in the 
press) . Bath, NK cells as well as K-cells are reported to 
bear FcR. The data presented in the previous chapter suggest 
that another, FcR negative, cell population shows NK-cell ac-
tivity, but exclusively against monolayer tumour target cells. 
It was shown in this chapter that prolonged culturing of 
lymphocytes, without IgG-FcR, induces IgG-FcR formation or ex-
pression and induces NK-cell activity. These observations are 
in accordance with the data of Ortaldo et al. (submitted for 
publication). These investigators also showed that this NK-
activity is only induced when the culture medium is supple-
mented with feetal calf serum. Human serum has no such an 
effect. The MCT, using monolayer cells as target cells, re-
quires 48 h. Thus one may argue that NK-cells are generated 
during the cytotoxicity assay. Lymphocytes, cultured for 48 h 
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and subseguently tested for NK-cell activity against monolayer 
target cells in a 4 h 51 chromium-release assay of monolayer 
target cells have, however, no lytic effect {unpublished 
data). Thus, the cytotoxicity observed seems indeed to be 
effected by a newly detected subset of IgG-FcR negative lym-
phocytes. Stejskal et al. {1973) reported on induced cytotoxi-
city after culturing of lymphocytes in foetal bovine serum 
and others confirmed their observation (Zielske and Golub, 
1976; Levin et al., 1976; Bolhuis et al., submitted for pu-
blication; Ortaldo et al., submitted for publication; this 
chapter). The susceptibility of K-562 and P-815 cells to ly-
sis as a result of ·the induced cytotoxicity after culturing 
in medium supplemented with foetal calf serum make it proba-
ble that their observations represent the induction of NK-
activity. 
One of the main efforts in the field of tumour immuno-
logy has been the direct cytotoxicity testing of lymphoid 
cells of cancer patients. The aim was to demonstrate that the 
isolated cells were educated in v~vo to mediate tumour speci-
fic cytotoxic reactions {chapter I) . 
That this expectation was nat satisfied is discussed 
earlier {chapters I and II). Recently 1 much attention is given 
to the indirect cytotoxicity testing. This involves the cul-
turing of lymphocytes with {allogeneic) tt.umour cells with sub-
seguent rnanotaring of cell mediated cytolysis of the tumour 
cells. If one chooses such an approach it has to be realized 
that foetal calf serum in the culture medium rather than the 
tumour cells would induce the cytotoxicity observed later 
during the cell mediated cytotoxicity phase of the experiment 
and thus foetal calf serum is nat recommended for this type 
of experiment. 
The issue remains whether the NK-cells with IgG-FcR on 
their surface can be functionally eguated with the IgG-FcR 
hearing K-cells. This would implicate the functional invalve-
rneut of the IgG-FcR in the NK lytic process. The results ob-
tained from the cytotoxicity testing of fractionated lympho-
136 
cytes cultured for 1 week already indicated that the NK-cell 
activity did usually not separate with the K-cell activity. 
The EA-RFC reeavered lymphocyte population of 3 out of 5 do-
nors showed increased NK-cell activity without a concomitant 
increase in K-cell activity. No trypsin was used for the re-
covery of the EA-RFC cells since this might lead to inactiv-
ation of NK-cells (Jondal and Pross, 1975; Faulk and Hijmans, 
1972). Moreover, these cells beared IgG-FcR on their surface 
befare fractionation, since they were repeated on the basis 
of that quality, After 18 h incubating, however, low numbers 
of FcR hearing cells were detected, probably because the 
cells had shed off their FcR. Again this observation suggests 
that NK- and K-cells are distinct cell types or when there is 
an overlap between these cell types (K-cells and NK1t- or 
NKst-cells, PeR positive) the NK- and K-cell lytic capacity 
are distinct functions of the individual lymphocyte. 
The immune complex inhibition experiments of NK- and K-
cell cytotoxicity and the combination of NK or K cytotoxic 
tests of EA-RFC reeavered cells with immune complex inhibition 
provides experimental basis for the hypothesis presented here 
i.e., that several types of NK-cells exist. Whether the lytic 
mechanism of a subset of these NK-cells is antibody dependent 
as suggested by others (Saal et al., 1977; Akira and Takasugi, 
1977; Blair and Lane, 1975) needs further experimentation, 
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GENERAL DISCUSSION 
The importance of the immune system as a defense mecha-
nism against the proliferation of cancer cells has been con-
sidered during the past 20 years ranging from having no role 
at all to it is the major de-fense mechanism. Others now say 
that it might be a mechanism of questionable importance. Many 
clinicians and researchers took the newly formulated theory of 
immunesurveillance on the status of a dogma and nurnerous ex-
amples could be found in the literature where the unique anti-
genicity of tumour cells was demonstrated in experimental ani-
mal systems. The enthusiasm about these reports, however, ob-
scured the boundaries between expectations and facts once the 
search for such tumour associated antigens was initiated in 
hurnan turnour systems. Transformation from normalto neeplastic 
cells involves a number of changes such as alterations of the 
composition and arrangement of cell surface components and 
any such variations were thought to lead to the appearance of 
new antigenie structures at the surface of these cells. 
we have been able to demonstrate that there is no clear 
evidence at present for the existence of tumour associated an-
tigens in the sense that these are specific for tumours of a 
certain histologie origin. The inability to demonstrate the 
preserree of tumour associated antigeus was due to heterogene-
ity of the material (chapter II), the fact that the inter-
pretation of results was compromised by the selection of lym-
phocyte control and/or target cell control, the changes in 
susceptibility to lysis of the target cells as a result of 
subculturing and the lack of reproducibility of the assay. 
Furthermore, the NK-cell activity may obscure the detection 
of tumour-specific reactions. Hence, our findings do not 
implicate that there are no such antigeus or that there is 
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no role for the immune response in modulating malignant di-
sease in a profitable sense for the tumour hearing individual. 
Many if not all naturally occurring immunegenie tumours 
of animals may turn out to have a viral etiology resulting in 
the neo-antigenicity of the malignant cells. There are indi-
eations that also viruses play a role in a variety of sponta-
neous cancers in man (Nooter et al., 1975). However, the 
tumours of laboratory animals naturally infeeted with enea-
genie viruses express antigens of whieh the antigenieity is 
several orders of magnitude higher than those found on human 
tumours with a suspected viral etiology. Hence human tumours 
may have only a marginal expression of these antigens which 
are below the threshold of active irnmunogenieity. 
The partial development of speeific irnmunological toler-
anee to viral assoeiated tumour antigeus in a long infeeted 
host must be considered as another possibility. 
Little is known about the antigenicity of spontaneous 
tumours in wild mice and rats which probably have a viral e-
tiology. It would be of great importance to study the anti-
genieity of these tumours. In the introduetion the assumption 
has already been discussed that frequent natura! exposure of 
animals to viruses has selected the host for high immune re-
sponsiveness and therefore one could envisage in the human 
situation that there may be an imperfect genetic selection 
for resistance against tumours developing early at life due 
to the fact that the infrequent oceurrenee does nat result in 
sueh a seleetive pressure. For the majority of spontaueaus 
tumours in a_dult man it is known that they appear late in or 
after the reproductive period. Therefore, a selective evolu-
tionary pressure for the development of high responsive tu-
mour specific immune recognition systems seem unlikely. 
Clear evidenee was given in ehapters V and VI for the 
presenee in human peripheral blood of natura! killer eells a-
gainst monolayer cultures. Preliminary experiments suggest 
that this natural activity exhibits immunologie seleetivity. 
It was further shown that the natural killer cytotoxicity is 
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exerted by various cell populations, i.e., T-cells withor 
without IgG-Fc recepters and furthermore that T-cells without 
IgG-Fc receptars exhibited their cytotoxic effect against 
monolayer target cells but not against myelogenous leukaemia 
cells growing in suspension. Although this natural killer 
cell phenomenon has obscured the detection of tumour specific 
immune responses in human systems we have to recognize the 
possible important .-i.11 v.-i.vo surveillance function of these cells. 
The ma in question is whether i t will be possible to roodu-
late the immune response in such a way that it can effect 
spontaneously arising tumours in man, tumours which only 
slightly differ from analogous normal cells in antigenie sur-
face structure and which are only weakly immunegenie in the 
tumour hearing individual. This question may prudently answer-
ed positively and although highly speculative, without firm 
experimental evidence, there are several approaches to tumour 
prophylaxis and immunotherapy which are open for experiment-
ation. 
Immunotherapy of human cancer has become an important 
modality in clinical oncology. A wide variety of microbial 
substances has been investigated for their capacity to affect 
immunological responsiveness at various stages. They can ele-
vate the immune response against otherwise very weak antigens 
by combining with the antigen or altering its antigenicity. 
Weiss (1972; 1976) has studied in detail the behaviour of 
such an adjuvant or bet~ immune modulator, the methanol ex-
traetion residu fraction of tuberele bacilli. This study in-
dicated the multifaceted applicability of sueh reagents to the 
prevention and treatrnent of malignant disease. It was shown 
that this immunemodulator enables an organism to respond to 
otherwise non-immunegenie substances or even prevent or break 
a state of specific immunological tolerance. If one takes in-
to account the lack of strong immunegenie antigens on the 
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surface of tumour cells and the possibility of toleranee for 
tumour associated antigens it is obvious that these immune 
modulators can be of crucial importance in developing resistance 
of the tumour host against progressive neoplasia. The import-
ance for chemica! and physical characterization of immunemo-
dulators and the association of the immunological activity 
with structure and physical state cannot be emphasized enough. 
There are a number of ways in which immunegenie modifi-
cations of antigen can be brought about, for instance, by che-
mica! and enzymatic treatment ar by cellfusion techniques. 
Such modifications have been shown to provake new immunegenie 
qualities ar immunogenicity and to break states of specific 
irrununological unresponsiveness (Prager, 1973). It. will be 
of great interest to investigate whether animals irrununized 
with tumour cells with new or altered antigenie structures 
induced either by chemica! compounds, viruses or cell fusion 
can then recognize the non-immunegenie structures present on 
the surface of the urumodified tumour cells. Previous experi-
ments have shown that ..i.n. villa education of human lymphocytes 
on monolayers of tumour cells results in the generation of 
nonspecific killer cells. This may be explained by the induc-
tion of natural killer cells af ter cul turing the cells as de·s-
cribed in chapter VI. If tumour cells with an altered anti-
genie structure as described above may become immunegenie one 
could envisage the possibility of in v~o education of auto-
geneus and allogeneic effector cells for passive adoptive 
immunization. 
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SUMMARY 
In chapter I the pro's and con's regarding immunesur-
veillance were discussed and it is clear that no conclusive 
evidence can be given to either approve or disapprove the 
validity of the concept. 
Each tumour-host system will have to be analysed on its 
own merit, and the importance of the immune system as a de-
fense mechanism against cancer will depend on the etiology of 
the various farms of malignancies. 
The care question of tumour-irnmunologists today is 
whether the hope can be entertairred for a successful immuno-
logie approach in the control or cure of cancer in man, espec-
ially since these tumour cells seem to differ only slightly 
in antigenie surface structure from analegeus normal counter 
parts. 
The author contends that this question can prudently 
answered in the affirmative when in spite of all the justi-
fied hurry, serieus assessment wil! be allowed for the mole-
cular characterization of tumour antigens and a profound in-
vestigation of the host capacity to respond to these antigens, 
so that more than faith alone will be the basis of future at-
tempts at immunotherapy. 
In chapter II the use of the microcytotoxicity test is 
described to determine the cytotoxic effect of purified peri-
pheral blood lymphocytes from patients with carcinoma of the 
urinary bladder, tumour control patients and healthy donors 
against cultured bladder cancer, melanoma and "normal" blad-
der epithelial cells. Disease specific cytotoxicity is de-
fined as statistically significant and selective destructien 
of disease-related tumour target cells. Within the different 
donor groups, an enormous variatien in non-specific cyto-
toxic effects of the lymphocytes against the various cel! 
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lines was seen. It appeared that the selection of the base-
line control and of type of target cell control influences 
the level of cytotoxicity and interpretation regarding the 
specificity of the reactions observed. In order to determine 
whether a tumour-specific reaction was superimposed on the 
non-specific natural killer cell activity, the overall cyto-
toxic effects from the three lymphocyte donor groups were com-
pared statistically. The analysis of results revealed that 
effector cells from bladder cancer patients and tumour control 
patients, when tested after therapy showed the same pattern 
of reactivity of healthy donors. The cytotoxicity of lympho-
cytes from bladder cancer patients, when tested befare the 
initiatien of therapy, was strenger in camparisen with the 
ether two groups of donors, but this strenger cytotoxic re-
activity against tumour cells was nat tumour-specific. 
In chapter III the statistica! analysis of the reprodu-
cibility of the microcytotoxicity test is described. It was 
concluded that the experiment-ta-experiment variation, using 
the sam~ cryopreserved effector and target cells repeatedly, 
is large and hence does nat allow longitudinal monitoring of 
the cytotoxic capacity of patients lymphocytes in independent 
experiments. Moreover, it was concluded that cryopreservation 
in general decreases the lytic capacity of lymphocytes and 
increases the lysibility of target cells. 
In chapter IV the identification of a new subpopulation 
of human T-cells, carrying a receptor for the Fc-portion of 
IgM type antibodies is described. It was shown that either 
free IgM antibodies or IgM-antibody-antigens complexes can 
be bound to the receptor on the surface of the lymphocytes. 
The specificity of the binding was demonstrated by the 
fact that either IgM or Fc-fragments of IgM antibodies could 
block the binding capacity of the receptor, but not IgG. 
Moreover, the pentameric structure of IgM needs to be 
preserved for binding, since cleavage products do notbind 
to the receptor. 
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In chapter V the nature of the natura! killer cells was 
investigated. Analysis of cell surface markers resulted in 
the following conclusions: 1. NK-cell beleng to the T-cell 
subset of lymphocytes; 2. B-cells are not involved in the NK 
cytotoxic mechanisms as studied in the assays described; 
3. monocytes are not involved in the cytolytic process of 
NK-eells. 
In chapter VI the analysis of the functional involvement 
of the IgG-Fc receptor was explored. When IgG-FcR hearing 
eells, absorbed onto plastic surfaces covered with IgG coated 
Esh membranes, were reecvered from these monolayers by 18 h 
incubation at 37° C, almest no FeR eould be detected by means 
of rosetting techniques. Furthermore, these eells showed a 
significantly reduced K-eel! aetivity (ADCC). On the contrary, 
the level of NK activity remained equal or was increased. 
These results indicate that although both NK-cells and K-cells 
bear FcR, FcR are not functionally aetive in NK-cell killing 
as opposed to the antibody-dependent-eellular cytolysis, il-
lustrating that ADCC and NK-eell killing most likely involve 
distinct mechanisms. The conclusion was confirmed by the 
results of another experiment, showing that immune complexes 
inhibited K-cell activity to a significantly larger extend 
than NK-cell activity. The NK-oell activity of EA-RFC reecver-
ed cells were not inhibited by immune complexes, whereas the 
K-cell activity was decreased. 
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SAMENVATTING 
In hoofdstuk I zijn de argumenten voor en tegen de im-
muunsurveillance theorie besproken en het is duidelijk ge-
worden dat er tot op heden geen sluitend bewijs geleverd is, 
hetwelk de waarde van het concept kan bevestigen of ontkennen. 
Ieder tumor-gastheer-systeem zal afzonderlijk op zijn 
merites als experimenteel model voor kankeronderzoek ge-
toetst moeten worden en het belang van het immuunsysteem als 
een afweermechanisme tegen kanker zal mede afhangen van de 
etiologie van de verschillende vormen van maligniteiten. 
Voor de tumor-immunoloog is momenteel de belangrijkste 
vraag of er wel een basis is voor een gerechtvaardigde hoop 
voor een succesvolle immunologische benadering teneinde con-
trole over of zelfs genezing van het kankerproces bij mensen 
te bewerkstelligen, juist omdat de antigene structuur van de-
ze tumorcellen slechts in geringe mate verschilt met die van 
de analoge normale cellen. 
De auteur is van mening dat deze vraag voorzichtig be-
vestigend beantwoord kan worden wanneer, ondanks alle gerecht-
vaardigde haast, een serieus onderzoek naar de moleculaire ka-
rakterisering van tumor-antigenen en een grondig onderzoek 
van de immuuncapaciteit van de patiënt om tegen die antigenen 
een respons te geven mogelijk zal worden gemaakt. Dan zullen 
veeleer resultaten dan geloof de basis vormen voor toekomst-
ige pogingen tot immuuntherapie. 
In hoofdstuk II is de toepassing beschreven van de mi-
crocytotoxiciteitstest voor het bepalen van de lytische capa-
citeit van gezuiverde lymfocyten uit het perifere bloed van 
patiënten met blaaskanker, patiënten met andere vormen van 
kanker en gezonde donoren op gekweekte blaaskanker-, mela-
noom- en "normale" blaasepitheel-cellen. Tumorspecifieke cy-
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totoxiciteit is gedefinieerd als een statistisch signifikante 
en selectieve lyseren van de betreffende tumorcellen. Binnen 
de verschillende groepen donoren werd een enorme spreiding in 
de non-specifieke cytotoxische effecten van de lymfocyten te-
gen de verschillende cellijnen waargenomen. Het bleek dat de 
selectie van de achtergrondcontrole en van het type tumorcel-
controle zowel het niveau van de cytoxiciteit als de inter-
pretatie betreffende de specificiteit van de immuunrespons be-
invloedt. 
Teneinde te bepalen of een tumorspecifieke reactie gesu-
perponeerd was op de non-specifieke "natuurlijke killer" cel-
aktiviteit werden de totale cytotoxische effecten van de drie 
groepen donoren statistisch met elkaar vergeleken. Analyse van 
de resultaten onthulde dat de effector cellen van blaaskanker 
patiënten en tumorcontrole patiënten eenzelfde patroon van re-
activiteit hadden, wanneer deze getest werden ~ behandeling. 
Het cytotoxische effect van lymfocyten van blaaskankerpatiënten, 
indien getest vóór de aanvang van therapie, was groter in ver-
gelijking met de twee andere groepen van donoren, maar deze 
grotere cytotoxische reactiviteit tegen tumorcellen was niet 
tumorspecifiek. 
In hoofdstuk III is de statistische analyse van de re-
produceerbaarheid van de microcytotoxiciteitstest beschreven. 
oe experiment-tot-experiment variatie bleek groot, ondanks 
het feit dat dezelfde cryogepreserveerde effector en tumor 
cellen werden gebruikt. Een regelrnatig meten van de cytotoxi-
citeitcapaciteit, in onafhankelijk experimenten, van lymfo-
cyten van patiënten is dus niet mogelijk. Bovendien werd ge-
on ludeerd dat cryopreservering in het algemeen de lytische 
capaciteit van lymfocyten doet verminderen en de lyseerbaarheid 
van tumorcellen doet toenemen. 
In hoofdstuk IV is de identificatie van een nieuwe sub-
populatie van humane T-cellen met een membraan-gebonden 
receptor voor het Fe-gedeelte van IgM antilichamen beschreven. 
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Er werd aangetoond dat zowel vrije IgM antilichamen, als IgM-
antilichaarn-antigeen complexen kunnen binden aan de receptor 
op de lyrnfocytrnernbraan. 
De specificiteit van deze binding werd geillustreerd door 
het feit dat zowel IgM als Fe fragmenten van IgM, maar niet IgG, 
binding van de IgM-antigeen complexen aan de Fe receptor kon-
den remmen. Bovendien bleek het intakt zijn van de pentarnere 
struktuur van het IgM een voorwaarde voor binding aan de re-
ceptor. 
In hoofdstuk V werd de aard van de "natuurlijke killer" 
cellen onderzocht. Analyse van membraanstrukturen gaven aan-
leiding tot de volgende conclusies: 1. NK-cellen behoren tot 
de T-eel subpopulatie van lymfocyten; 2. B-cellen zijn niet 
betrokken bij het NK-cytotoxicische mechanisme, bestudeerd 
in de beschreven experimenten; 3. monocyten zijn niet be-
trokken bij het cytolytische proces van NK-cellen; 4. Een 
deel van de NK cellen heeft een IgG-Fc receptor op de mem-
braan. 
In hoofdstuk VI is de analyse van het functioneel be-
trokken zijn van de IgG-Fc receptor bestudeerd. wanneer cel-
len met IgG-Fc receptor op de membraan, na adsorptie aan IgG 
bedekte plastic petrischalen, werden teruggewonnen door deze 
schalen met cellen 18 uur te incuberen bij 37° C kon de vrij-
wel geen Fe receptoren meer gedecteerd worden op de membraan 
van deze cellen. Bovendien bleken deze cellen een signifikant 
lagere K-eel aktiviteit te vertonen. Het niveau van NK-cel 
aktiviteit daarentegen bleef gelijk of nam toe. Deze resulta-
ten geven aan dat alhoewel NK- zowel als K-cellen een Fe re-
ceptor hebben, deze Fe receptoren niet functioneel betrokken 
zijn bij het NK-cel lytische proces, dit in tegenstelling 
tot de betrokkenheid van de Fe receptor bij het antilichaam-
afhankelijke- cellulaire cytolytische proces (K-celaktiviteit). 
Dit illustreert dat antilichaamafhankelijke cellulaire 
cytolytische proces en het NK-cel cytotoxische proces ver-
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schillende mechanismen vertegenwoordigen. Deze conclusie 
werd bevestigd door de resultaten van een ander type experi-
ment hetwelk aantoonde dat immuuncomplexen de K-eel reactivi-
teit signifikant sterker remmen dan de NK-cel aktiviteit. De 
NK-cel aktiviteit van EA-Fc receptor-geisoleerde cellen werd 
niet geremd door immuuncomplexen, terwijl de K-eel aktiviteit 
verminderde. 
150 
ACKNOWLEDGEMENTS 
The author wishes to convey thanks to: 
- Miss H.R.E. Schuit, Mrs. J.M. Nocyen and Mr. C.P.M. Rondeltap for 
superb technica! assistance and collaboration. 
- Dr. J. Radl, Miss P. van den Berg, Dr. J. Molenaar and Dr. F. Gmelig-
Meyling for providing conjugates and antisera. 
- Dr. J.J. Haaijman for his support, discussions and statistica! advice 
for data presented in chapter III. 
- Dr. w. Hop for statistica! advice for data presented in chapter III. 
- Dr. A. Polak-Vogelenzang for checking the cultures for mycoplasma. 
- Dr. W. Zeylemaker for discussions regarding the K-cell system and for 
supplying the mouse mastocytoma cell line. 
- Mr. P.E.W. Kuijpers for keeping the material mobile. 
- Prof. Dr. E.P. van der werff-Messing for her interest in tumour immuno-
logical research. 
- Prof. Dr. D.W. van Bekkum, Prof. Dr. 0. Vos and Dr. W. Hijmans for 
critically ·reading the manuscript. 
- Prof. Dr. D.W. van Bekkum for his hospitality and providing the labo-
ratory and facilities in the Radiobiological Institute TNO. 
- Drs. Ph. Rümke and J. de Vries for discussions. 
- Dr. W.I. Brouwer for management support. 
- My colleagues in the Rotterdam Radio-Therapy Institute for their co-
operation in the patient related studies. 
- Technica! and scientific merobers of the REPGO-TNO Institutes, who made 
this thesis possible. 
- Mr. J.Ph. de Kler for the preparatien of the figures. 
- Mrs. Mea van der Sman for telling me in the morning what I wrote the 
night befare and typing the manuscript with verve. 
The work presented in this thesis was supported by a grant of the 
"Koningin Wilhelmina Fonds" of the Dutch National Cancer League for the 
investigation entitled: Immune resistance against tumours. 
151 

ADCC 
ALS 
BT 
c 
Cr 
CTX 
DMSO 
DTE 
Esh 
EA 
E-RFC 
EA-RFC 
Fe 
FITC 
Ig 
HD 
lt 
Ly 
Ly-IgM 
min 
MCT 
MSV 
NK 
nu/nu 
RFC 
st 
TA{T)A 
TRI TC 
Cell lines 
T24 
Colon-1 
MEL 
HCV 
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bladder cancer 
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cytotoxicity 
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sheep red blood cells 
erythrocyte-antibody complex 
rosette forming cells (lymphocytes) with Esh 
rosette forming cells with EA 
Fc-portion of immunoglobulin 
fluoresceine isothiocyanate 
immunoglobulin 
healthy donor 
long te= 
lymphocytes 
lymphocytes complexed with IgM 
minutes 
microcytotoxicity test 
mouse sarcoma virus 
natural killer 
nude mice 
rosette forming cells 
short te= 
tumour-associated {transplantation) antigeus 
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bladder cancer cell line 
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